28.12.2014 Views

BOARD FINANCE COMMITTEE MEETING - Palomar Health

BOARD FINANCE COMMITTEE MEETING - Palomar Health

BOARD FINANCE COMMITTEE MEETING - Palomar Health

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> <strong>MEETING</strong><br />

*<br />

TUESDAY, MARCH 30, 2010<br />

456 E. GRAND AVENUE<br />

5:30 p.m. (Buffet Dinner for Committee Members & Invited Guests Only) ESCONDIDO, CA<br />

6:00 p.m. Meeting 1 ST FLOOR CONFERENCE ROOM<br />

∗<br />

Time Page Target<br />

CALL TO ORDER............................................................................................................. ............ ............. 6:00 p.m.<br />

‣ Public Comments ......................................................................................................<br />

5 minutes allowed per speaker with a cumulative total of 15 minutes per group.<br />

For further details & policy, see Request for Public Comment notices available in meeting room.<br />

............. 5 ............. 6:05 p.m.<br />

‣ Information Item(s) ............. 5 ............. 6:10 p.m.<br />

1. * Approval: Revised Minutes – Tuesday, January 26, 2010 (Addendum A) ............. ............. 5 ..........AG3 6:15 p.m.<br />

2. * Approval: Minutes – Tuesday, February 23, 2010 (Addendum B) ......................... ............. 5 ..........AG4 6:20 p.m.<br />

3. * Approval: Updated Medical Director Agreement Template (Addendum C)............ ............. 5 ..........AG5 6:25 p.m.<br />

4. * Review/Approval: Medical Director Agreements ....................................................<br />

• John T. Steele, MD – Trauma Program – PMC<br />

• Mikhail Malek, MD – Cardiology – PMC<br />

• Steve K. Kuriyama, MD – Infectious Disease – PPH<br />

.......AG6-9<br />

...AG10-13<br />

...AG14-16<br />

5. * Review/Approval: Physician Advisor Agreement ...................................................<br />

• Charles Callery, MD – Bariatric Surgery – POM ...AG17-19<br />

6. * Review/Approval: Department Chair Agreement ...................................................<br />

• Chenggang Hu, MD – Department of Anesthesia – POM ...AG20-22<br />

7. * Review/Approval: Consultant Agreement – Amendment .......................................<br />

• Neighborhood <strong>Health</strong>care – Internal Medicine ...AG23-25<br />

8. * Review/Approval: Emergency On-Call Agreement Extensions – Ophthalmology<br />

– POM .......................................................................................................................<br />

• Brian Le, MD<br />

• Lillian Lee, MD<br />

9. * Review/Approval: Emergency On-Call Agreement Amendments –<br />

Ophthalmology – POM ..............................................................................................<br />

• Lorne Kapner, MD<br />

• Brian Le, MD<br />

• Erwin Omens, MD<br />

• Paras Shah, MD<br />

10. * Review/Approval: Emergency On-Call Agreement – Ophthalmology – POM ........<br />

• Lillian Lee, MD<br />

11. * Review/Approval: Increase in Line of Credit to <strong>Palomar</strong> Physician Network, Inc<br />

(Addendum D)...........................................................................................................<br />

........... 20<br />

...AG26-28<br />

...AG29-31<br />

...AG32-34<br />

...AG35-37<br />

...AG38-40<br />

...AG41-43<br />

...AG44-46<br />

6:45 P.M.<br />

........... 10 ........AG47 6:55 p.m.<br />

12. * Review/Approval: ICOC<br />

• Update on Pending Vacancies and Authorization to Begin Application Process..................... ...............5 ...AG48-49 7:00 p.m.<br />

• Updated Policies, Procedures & Guidelines – Addition of Advisory Panel (Addendum E)....... .............10 ........AG50 7:10 p.m.<br />

13. * Approval: Strategic Capital Allocation Criteria........................................................ ............. 5 ...AG51-52 7:15 p.m.<br />

∗ Asterisks indicate anticipated action. Action is not limited to those designated items.<br />

AG1


Board Finance Committee, Tuesday, January 26, 2010<br />

14. * Approval: February 2010 & YTD FY2010 Financial Report (Addendum F) ........... 15 ........AG53 7:30 p.m.<br />

ADJOURNMENT TO CLOSED SESSION ............... ............... 7:30 p.m.<br />

~ pursuant to California Government Code §54954.5(h)<br />

REPORT INVOLVING TRADE SECRET<br />

Discussion will concern proposed new service<br />

Estimated date of public disclosure: April 2010<br />

...........20 7:50 p.m.<br />

~ pursuant to California Government Code §54954.5(h)<br />

REPORT INVOLVING TRADE SECRET<br />

Discussion will concern proposed new facility<br />

Estimated date of public disclosure: 2010<br />

...........20 8:10 p.m.<br />

<br />

RESUMPTION OF OPEN SESSION<br />

‣ Action Resulting From Closed Session Discussion – IF ANY...................... .......... 5 8:15 p.m.<br />

FINAL ADJOURNMENT .............................................................................................. ............... ........... 8:15 p.m.<br />

NOTE: If you have a disability, please notify us at 760-740-6383 72 hours<br />

prior to the event so that we may provide reasonable accommodations<br />

2010-03-30 BoD Finance Agenda.doc AG2


REVISED Minutes<br />

Finance Committee – Tuesday, January 26, 2010<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

BY:<br />

Tanya Howell, Secretary<br />

Bob Hemker, CFO<br />

Background: The minutes of the Board Finance Committee meeting held on Tuesday,<br />

January 26, 2010, incorrectly stated the Committee’s recommendation regarding potential<br />

expansion of the expresscare clinics. That misstatement has been corrected, and the revised<br />

minutes (sans attachments) are respectfully submitted for approval (Addendum A).<br />

Budget Impact:<br />

N/A<br />

Staff Recommendation: Staff recommends approval of the revised minutes from the<br />

Tuesday, January 26, 2010, Board Finance Committee meeting.<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Rev'd Minutes 2010-01-26.doc<br />

AG3


Minutes<br />

Finance Committee – Tuesday, February 22, 2010<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

BY:<br />

Tanya Howell, Secretary<br />

Bob Hemker, CFO<br />

Background: The minutes of the Board Finance Committee meeting held on Tuesday,<br />

February 22, 2010, are respectfully submitted for approval (Addendum B).<br />

Budget Impact:<br />

N/A<br />

Staff Recommendation: Staff recommends approval of the Tuesday, February 22, 2010,<br />

Board Finance Committee minutes.<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Minutes.doc<br />

AG4


Medical Directorship Agreement<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2009<br />

FROM:<br />

Legal Department<br />

Background: The template used for Medical Directorship Agreements was<br />

approved by the Board three years ago. Due to changes in the law and changes<br />

in procedures at PPH, the template needed to be revised. A redlined version of<br />

the updated template is attached as Addendum C. All Medical Directorship Agreements<br />

presented at this evening's meeting have been drafted utilizing the new template.<br />

Budget Impact:<br />

None<br />

Staff Recommendation:<br />

Approve for use<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Medical Directorship Agreement - Updated Version.doc<br />

AG5


MEDICAL DIRECTOR AGREEMENT<br />

InInsert Subject Here<br />

Trauma Department – PMC<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

Kim Colonnelli, RN<br />

Chief Nursing Officer, Pomerado Hospital<br />

BACKGROUND: John Steele, MD, provides exclusive clinical services and medical director<br />

oversight for the trauma department at PMC and maintains his clinical competency as a practicing<br />

trauma surgeon.<br />

Dr. Steele has been supportive of the initiatives that are underway at PPH during his tenure in the<br />

position today, and this agreement represents a renewal of the exclusive agreement for another threeyear<br />

term.<br />

BUDGET IMPACT: None.<br />

STAFF RECOMMENDATION:<br />

Approval<br />

<strong>COMMITTEE</strong> QUESTIONS:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Dr Steele.doc<br />

AG6


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Medical Director Agreement – Trauma Program - PMC<br />

Preamble AGREEMENT DATE April 1, 2010<br />

Preamble PARTIES John T. Steele and <strong>Palomar</strong> Pomerado <strong>Health</strong><br />

Recitals E PURPOSE Clinical supervision and oversight of the Trauma Program.<br />

1.1, 1.2,<br />

1.3<br />

Exhibit 1.1<br />

SCOPE OF SERVICES Chair Department of Trauma, conduct peer review, represent<br />

program at County MAC (Medical Advisory Cmte) meetings,<br />

conduct M&M conferences, lead performance improvement and<br />

clinical research.<br />

PROCUREMENT Request For Proposal Discretionary<br />

METHOD<br />

4.1 TERM Three years<br />

RENEWAL<br />

None<br />

5.3 TERMINATION Without cause with 90 days written notice.<br />

2.1 COMPENSATION<br />

METHODOLOGY<br />

For cause as defined in the agreement<br />

Hourly for number of hours of service provided.<br />

$275.00 per hour with expected 83 hours per month of service.<br />

BUDGETED YES NO – IMPACT: $32,850<br />

EXCLUSIVITY []NO [x] YES – EXPLAIN: Required by the ACS<br />

JUSTIFICATION Required for compliance with County Trauma Designation<br />

Agreement.<br />

AGREEMENT NOTICED [] YES [x] NO Methodology & Response:<br />

1.1,<br />

Exhibit<br />

1.1<br />

ALTERNATIVES/IMPACT<br />

Duties<br />

COMMENTS<br />

Provision for Staff Education<br />

Provision for Medical Staff Education<br />

Provision for participation in Quality Improvement<br />

Provision for participation in budget process development<br />

APPROVALS REQUIRED<br />

CAO CFO CEO BOD Committee <strong>FINANCE</strong> BOD<br />

AG7


MEDICAL DIRECTORSHIP AGREEMENT<br />

by and between<br />

PALOMAR POMERADO HEALTH (“Hospital”)<br />

and<br />

JOHN T. STEELE, M.D. (“Practitioner”)<br />

AG8


MEDICAL DIRECTORSHIP AGREEMENT<br />

THIS MEDICAL DIRECTORSHIP AGREEMENT (this “Agreement”) is entered into<br />

as of April 1, 2010, by and between <strong>Palomar</strong> Pomerado <strong>Health</strong>, a local health care district<br />

organized under Division 23 of the California <strong>Health</strong> and Safety Code, and JOHN T. STEELE,<br />

M.D., an individual (“Practitioner”). Hospital and Practitioner are sometimes referred to in this<br />

Agreement individually as a “Party” or, collectively, as the “Parties.”<br />

RECITALS<br />

A. Hospital owns and operates an acute care hospital facility located at 555 East<br />

Valley Parkway, Escondido, California, in which it operates a Trauma Department (the<br />

“Department”) under its acute care license.<br />

B. Practitioner is licensed to practice medicine in the State of California, board<br />

certified for the practice of medicine in the specialty of General Surgery and Trauma, and<br />

Critical Care (the “Specialty”) and a member in good standing of Hospital’s medical staff (the<br />

“Medical Staff”).<br />

C. Hospital desires to engage Practitioner as an independent contractor to provide<br />

medical and administrative oversight with respect to the Department, and believes that the<br />

requirements of the contract with the County of San Diego and goals of the program may be<br />

assured and achieved if Practitioner assumes such responsibility as set forth in this Agreement.<br />

D. Practitioner has the following qualifications and expertise to provide the services<br />

described in this Agreement: Board Certification in General Surgery and Trauma, and Critical<br />

Care.<br />

E. Hospital has considered the following factors in determining the necessity and<br />

amount of compensation payable to Practitioner pursuant to this Agreement:<br />

1. The nature of Practitioner’s duties as contemplated by this Agreement.<br />

2. Practitioner’s qualifications.<br />

3. The difficulty in obtaining a qualified physician to provide the services<br />

described in this Agreement.<br />

4. The benefits to Hospital and Hospital’s community resulting from<br />

Practitioner’s performance of the services described in this Agreement.<br />

5. The economic conditions locally and in the health care industry generally.<br />

Revised 3-11-2010 1<br />

AG9


PALOMAR POMERADO InInsert HEALTH/<strong>Palomar</strong> Subject Here Medical Center<br />

MEDICAL DIRECTOR/Mikhail Malek, MD – Cardiology Services<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: April, 2010<br />

FROM:<br />

Paul Patchen, Director of Cardiovascular Services<br />

BACKGROUND: Dr. Stein is stepping down as Medical Director for Cardiology. Dr. Malek<br />

has been selected as his replacement. Dr. Malek’s input will be key to our transformation<br />

process. Dr. Malek is an interventional cardiologist and therefore has a higher rate for<br />

reimbursement or hourly rate.<br />

BUDGET IMPACT: This change will increase the annual budget. We have compressed the<br />

total hours per month to help keep this cost down. It is our hope to use this position in a more<br />

focused and efficient manner to help defer some of the wage inflation.<br />

STAFF RECOMMENDATION:<br />

<strong>COMMITTEE</strong> QUESTIONS:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Dr Malek.doc<br />

AG10


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Medical Director Agreement – Cardiology, Mikhail Malek M.D.<br />

AGREEMENT DATE<br />

April 1, 2010<br />

PARTIES<br />

PURPOSE<br />

SCOPE OF SERVICES<br />

<strong>Palomar</strong> Medical Center & Mikhail Malek, M.D.<br />

Medical Director Agreement – Cardiology Services<br />

Administrative, clinical, quality, and business support of the<br />

service line<br />

PROCUREMENT<br />

METHOD<br />

TERM<br />

Request For Proposal<br />

One year<br />

x Discretionary<br />

RENEWAL<br />

Annually<br />

TERMINATION<br />

COMPENSATION<br />

METHODOLOGY<br />

Either Party may terminate this Agreement without cause,<br />

expense or penalty, effective Ninety (90) days after written notice<br />

of termination is given to the other Party<br />

Hourly rate with monthly compensation<br />

BUDGETED X YES NO – IMPACT:<br />

EXCLUSIVITY NO X YES – EXPLAIN: Medical Director is singular position<br />

for the service line<br />

JUSTIFICATION Current Medical Director of Cardiology is stepping down<br />

AGREEMENT NOTICED YES NO Methodology & Response:<br />

ALTERNATIVES/IMPACT Continue search for replacement, costs unkown<br />

Duties<br />

COMMENTS<br />

x Provision for Staff Education<br />

x Provision for Medical Staff Education<br />

x Provision for participation in Quality Improvement<br />

x Provision for participation in budget process development<br />

APPROVALS REQUIRED<br />

VP CFO CEO BOD Committee ____________ BOD<br />

AG11


MEDICAL DIRECTORSHIP AGREEMENT<br />

by and between<br />

PALOMAR POMERADO HEALTH (“Hospital”)<br />

and<br />

MIKHAIL MALEK, M.D. (“Practitioner”)<br />

AG12


MEDICAL DIRECTORSHIP AGREEMENT<br />

THIS MEDICAL DIRECTORSHIP AGREEMENT (this “Agreement”) is entered into<br />

as of April 1, 2010, by and between <strong>Palomar</strong> Pomerado <strong>Health</strong>, a local health care district<br />

organized under Division 23 of the California <strong>Health</strong> and Safety Code and (“Hospital”), and<br />

MIKHAIL MALEK, M.D., an individual (“Practitioner”). Hospital and Practitioner are<br />

sometimes referred to in this Agreement individually as a “Party” or, collectively, as the<br />

“Parties.”<br />

RECITALS<br />

A. Hospital owns and operates an acute care hospital facility located at 555 East<br />

Valley Parkway, Escondido, California 92025, in which it operates a Department of Diagnostic<br />

and Interventional Cardiology under its acute care license.<br />

B. Practitioner is licensed to practice medicine in the State of California, board<br />

certified for the practice of medicine in the specialty of Cardiovascular Disease (the “Specialty”)<br />

and a member in good standing of Hospital’s medical staff (the “Medical Staff”).<br />

C. Hospital desires to engage Practitioner as an independent contractor to provide<br />

medical and administrative oversight with respect to the Department of Diagnostic and<br />

Interventional Cardiology and believes that enhanced procedural standardization, economic<br />

efficiencies, professional proficiencies, and quality outcomes as well as enhanced coordination<br />

and cooperation among Department’s providers and users can be achieved if Practitioner<br />

assumes such responsibility as set forth in this Agreement.<br />

D. Practitioner has the following qualifications and expertise to provide the services<br />

described in this Agreement and is experienced and board certified in Cardiovascular Disease,<br />

Interventional Cardiology, and Internal Medicine and is a member of the Medical Staff of the<br />

Hospital.<br />

E. Hospital has considered the following factors in determining the necessity and<br />

amount of compensation payable to Practitioner pursuant to this Agreement:<br />

1. The nature of Practitioner’s duties as contemplated by this Agreement.<br />

2. Practitioner’s qualifications.<br />

3. The difficulty in obtaining a qualified physician to provide the services<br />

described in this Agreement.<br />

4. The benefits to Hospital and Hospital’s community resulting from<br />

Practitioner’s performance of the services described in this Agreement.<br />

5. The economic conditions locally and in the health care industry generally.<br />

Revised 3-11-2010 1<br />

AG13


PALOMAR InInsert POMERADO Subject HEALTH Here<br />

Infectious Disease Medical Director Agreement<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

Opal Reinbold, Chief Quality Officer<br />

BACKGROUND: This request is to approve the Contract Amendment #1 to<br />

extend the Agreement for three (3) months, from April 1, 2010, through June 30, 2010.<br />

BUDGET IMPACT:<br />

None<br />

STAFF RECOMMENDATION:<br />

Approval<br />

<strong>COMMITTEE</strong> QUESTIONS:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Kuriyama.doc<br />

AG14


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Infectious Disease Medical Director Agreement – Contract<br />

Amendment #1<br />

AGREEMENT DATE April 1, 2010<br />

PARTIES<br />

PURPOSE<br />

SCOPE OF SERVICES<br />

<strong>Palomar</strong> Pomerado <strong>Health</strong> and Steve K. Kuriyama, M.D.<br />

To provide medical and administrative oversight for the Infectious<br />

Disease Program and Antibiotic Oversight Use.<br />

Administrative services as set forth in Medical Director<br />

Agreement dated April 1, 2007<br />

PROCUREMENT Request For Proposal Discretionary<br />

METHOD<br />

4.1 TERM Three (3) months (April 1, 2010 – June 30, 2010)<br />

RENEWAL<br />

4.2 TERMINATION Immediately with cause or within 90 days’ with prior written notice<br />

without cause<br />

3.1 COMPENSATION<br />

METHODOLOGY<br />

BUDGETED<br />

Medical Director shall, on a monthly basis on or before the fifth<br />

(5 th ) day of each calendar month submit a written invoice to<br />

Hospital, detailing the date, time, number of hours and<br />

description of activities.<br />

YES NO – IMPACT:<br />

EXCLUSIVITY NO YES – EXPLAIN:<br />

JUSTIFICATION<br />

Compliance with JCAHO, DHS and Medicare Conditions of<br />

Participation for Medical Oversight of the Infectious Disease<br />

Program.<br />

AGREEMENT NOTICED YES NO Methodology & Response:<br />

ALTERNATIVES/IMPACT<br />

Duties<br />

COMMENTS<br />

Provision for Staff Education<br />

Provision for Medical Staff Education<br />

Provision for participation in Quality Improvement<br />

Provision for participation in budget process development<br />

APPROVALS REQUIRED<br />

VP CFO CEO BOD Committee Finance BOD<br />

AG15


CONTRACT AMENDMENT #1<br />

BETWEEN<br />

PALOMAR POMERADO HEALTH<br />

AND<br />

STEVE K. KURIYAMA, M.D.<br />

This Amendment is made by and between PALOMAR POMERADO HEALTH, a local<br />

healthcare district organized under Division 23 of the California <strong>Health</strong> and Safety Code<br />

(“PPH”), and STEVE K. KURIYAMA (“Medical Director”) on this 1st day of April,<br />

2010 (“Amendment Effective Date”).<br />

In consideration of the mutual promises of the parties, the receipt and sufficiency of<br />

which are hereby acknowledged, the Medical Director Agreement between the parties<br />

(“Agreement”), dated April 1, 2007 is hereby amended as follows:<br />

This Agreement is hereby extended through June 30, 2010.<br />

Medical Director shall be paid the same rate paid during the third twelve months<br />

of the Agreement pursuant to Section 3.1 of the Agreement.<br />

All other terms of the Agreement remain in full force and effect. In the event of a<br />

conflict, the provisions, terms and conditions of this Amendment shall prevail.<br />

The parties have executed the Amendment as of the date set forth below.<br />

STEVE K. KURIYAMA, M.D.<br />

By: __________________________<br />

Date:_________________________<br />

PALOMAR POMERADO HEALTH<br />

By:___________________________<br />

Robert A. Hemker<br />

Chief Financial Officer<br />

Date:_________________________<br />

February 2, 2009<br />

AG16


Physician Advisor Agreement for<br />

Bariatric Services Program<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

David Tam, CAO, Pomerado Hospital<br />

Background: Charles Callery, M.D., will act as the Physician Advisor of<br />

the Bariatric Services Program of the Surgery Department at Pomerado Hospital.<br />

The Physician Advisor will assist PPH and its bariatric surgery program in<br />

successfully maintaining its designation as a center that has achieved<br />

credentialing with the American Society for Metabolic Bariatric Surgery<br />

(“ASMBS”) Center of Excellence. The Physician Advisor will be the designated<br />

Medical Director for bariatric surgery and will participate in the relevant decisionmaking<br />

administrative meetings of PPH.<br />

Budget Impact:<br />

No Budget Impact, renewal of agreement<br />

Staff Recommendation: Approval<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Dr Callery.doc<br />

AG17


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Physician Advisor Between <strong>Palomar</strong> Pomerado <strong>Health</strong><br />

(Pomerado Hospital) and Charles Callery, M.D.<br />

AGREEMENT DATE April 1, 2010<br />

PARTIES<br />

1) PPH<br />

2) Charles Callery, M.D.<br />

PURPOSE<br />

Charles Callery, M.D. Physician Advisor shall act as the<br />

Physician Advisor of Bariatric Services Program of the<br />

Surgery Dept at Pomerado Hospital and as Medical Director<br />

for Bariatric Surgery.<br />

SCOPE OF SERVICES Physician Advisor will assist PPH and its bariatric surgery<br />

program in successfully maintaining its designation as a<br />

center that has achieved credentialing with the American<br />

Society for Metabolic Bariatric Surgery (“ASMBS”) Center of<br />

Excellence. Physician Advisor will be the designated<br />

Medical Director for bariatric surgery and will participates in<br />

the relevant decision-making administrative meetings of<br />

PPH.<br />

PROCUREMENT Request For Proposal<br />

METHOD<br />

TERM April 1, 2010 through March 31, 2011<br />

RENEWAL<br />

N/A\<br />

Discretionary<br />

TERMINATION<br />

A. Immediately for cause<br />

B. Not less than 90 Days of written notice without cause<br />

COMPENSATION<br />

METHODOLOGY<br />

Monthly Installments on or before the 15 th of the month with<br />

supporting documentation of the prior month’s time record<br />

BUDGETED<br />

YES NO – IMPACT:<br />

EXCLUSIVITY NO YES – EXPLAIN:<br />

JUSTIFICATION Medical oversight for our Bariatric Surgical Program is a<br />

requirement of our credentialing with the American Society for<br />

Bariatric Surgery<br />

AGREEMENT NOTICED YES NO Methodology & Response:<br />

ALTERNATIVES/IMPACT Proceeding without this agreement would cause our services to<br />

be out of compliance with ASBS standards<br />

Duties<br />

COMMENTS<br />

Provision for Staff Education<br />

Provision for Medical Staff Education<br />

Provision for participation in Quality Improvement<br />

Provision for participation in budget process development<br />

APPROVALS REQUIRED<br />

VP CFO CEO BOD Committee _Finance BOD<br />

AG18


MEDICAL DIRECTORSHIP AGREEMENT<br />

THIS MEDICAL DIRECTORSHIP AGREEMENT (this “Agreement”) is<br />

entered into as of April 1, 2010, by and between <strong>Palomar</strong> Pomerado <strong>Health</strong>, a local health<br />

care district organized under Division 23 of the California <strong>Health</strong> and Safety Code and<br />

(“Hospital”), and CHARLES D. CALLERY, M.D., an individual (“Practitioner”).<br />

Hospital and Practitioner are sometimes referred to in this Agreement individually as a<br />

“Party” or, collectively, as the “Parties.”<br />

RECITALS<br />

A. Hospital owns and operates an acute care hospital facility located at 15615<br />

Pomerado Road, Poway, California, in which it operates a Bariatric Surgery Services (the<br />

“Program”) under its acute care license.<br />

B. Practitioner is licensed to practice medicine in the State of California,<br />

board certified for the practice of medicine in the specialty of Bariatric Surgery Services<br />

(the “Specialty”) and a member in good standing of Hospital’s medical staff (the<br />

“Medical Staff”).<br />

C. Hospital desires to engage Practitioner as an independent contractor to<br />

provide medical and administrative oversight with respect to the Program, and believes<br />

that Bariatric Surgery Services can be achieved if Practitioner assumes such<br />

responsibility as set forth in this Agreement.<br />

D. Practitioner has the following qualifications and expertise to provide the<br />

services described in this Agreement.<br />

E. Hospital has considered the following factors in determining the necessity<br />

and amount of compensation payable to Practitioner pursuant to this Agreement:<br />

1. Hospital desires to retain Physician Advisor as an independent<br />

contractor to provide certain administrative services<br />

(“Administrative Services” in the operation of Services and has<br />

determined that this proposed arrangement with Physician Advisor<br />

will enhance the Service’s and Hospital’s organization, procedure<br />

standardization, economic efficiency,, professional proficiency,<br />

and provide other benefits to enhance coordination and cooperation<br />

among the Services’ provides and users.<br />

2. Practitioner is a physician who is qualified and licensed to practice<br />

medicine in the State of California, is experienced and qualified in<br />

the specialized field of General Surgery and Bariatric Surgery, and<br />

who is a member of the Medical Staff of Hospital (“Medical<br />

Staff”).<br />

AG19


nsert Subject Here<br />

POMERADO HOSPITAL<br />

ADMINISTRATIVE SERVICES AGREEMENT<br />

MEDICAL STAFF OFFICERS,<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

BY:<br />

David Tam, M.D., Chief Administrative Officer, Pomerado Hospital<br />

BACKGROUND: Pomerado Hospital Medical Staff Officers are compensated for services<br />

performed as required by the Medical Staff By-laws. These agreements serve to document<br />

the relationship of the medical staff officers to PPH and the duties to be performed as<br />

consideration for the stipend to assure compliance with Federal regulations.<br />

Presented is the Administrative Services Agreement for the Department Chair, Department of<br />

Anesthesia, for Pomerado Hospital.<br />

Chair, Department of Anesthesia – Chenggang Hu, M.D.<br />

BUDGET IMPACT: None<br />

STAFF RECOMMENDATION:<br />

Approval<br />

<strong>COMMITTEE</strong> QUESTIONS:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

form a - pom officers2010 Dr. Hu.doc<br />

AG20


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Department Chair Agreement - Chenggang Hu, M.D<br />

AGREEMENT DATE March 1, 2010<br />

PARTIES<br />

PURPOSE<br />

SCOPE OF SERVICES<br />

Department Chair, Pomerado Hospital and PPH<br />

To provide administrative services on behalf of Pomerado<br />

Hospital Medical Staff in accordance with Medical Staff Bylaws<br />

and policies<br />

As per duties defined in Pomerado Hospital Medical Staff Bylaws<br />

and policies.<br />

PROCUREMENT Request For Proposal • Discretionary<br />

METHOD<br />

TERM March 1, 2010 – December 31, 2011<br />

RENEWAL<br />

None<br />

TERMINATION As described under §5<br />

COMPENSATION Monthly.<br />

METHODOLOGY<br />

BUDGETED ■ YES □ NO – IMPACT:<br />

EXCLUSIVITY • NO YES – EXPLAIN:<br />

JUSTIFICATION<br />

These positions are elected by the Medical Staff in accordance<br />

with Medical Staff Bylaws.<br />

POSITION POSTED YES • NO Methodology & Response:<br />

Elected by the Pomerado Hospital Medical Staff<br />

ALTERNATIVES/IMPACT N/A<br />

DUTIES<br />

COMMENTS<br />

APPROVALS REQUIRED<br />

Defined in the Pomerado Hospital Medical Staff Bylaws<br />

The agreement template was developed by legal counsel. The<br />

Department Chair positions are voted upon by Active members of<br />

the Medical Staff.<br />

• VP •CFO •CEO •BOD Committee <strong>FINANCE</strong> •BOD<br />

AG21


DEPARTMENT OF ANESTHESIA DEPARTMENT CHAIR AGREEMENT<br />

THIS DEPARTMENT OF ANESTHESIA CHAIR AGREEMENT<br />

(“Agreement”) is entered into on March 1, 2010, by and between <strong>Palomar</strong> Pomerado <strong>Health</strong><br />

(“PPH”), a California health district organized under Division 23 of the California <strong>Health</strong> and<br />

Safety Code and Chenggang Hu, M. D., (“Physician”), with respect to the following facts:<br />

RECITALS:<br />

A. PPH owns and operates <strong>Palomar</strong> Medical Center in Escondido, CA and<br />

Pomerado Hospital in Poway, CA (Individually “Hospital”, Collectively “Hospitals” or “PPH”).<br />

B. The physicians and other independent practitioners practicing in PPH have<br />

organized themselves into a Medical Staff in conformity with the Medical Staff Bylaws of<br />

Pomerado Hospital.<br />

C. Physician is the Department of Anesthesia Chair which has been<br />

established pursuant to the Medical Staff Bylaws and/or relevant Medical Staff Policies of<br />

Pomerado Hospital. As Department of Anesthesia Chair, Physician is required to perform a<br />

number of duties (the “Duties”) as set forth in this Agreement.<br />

D. The purpose of this Agreement is to provide a means of compensating<br />

Physician at no more than fair market value for performing the Duties required of a<br />

Department/Committee chair. Additionally, this Agreement will delineate the expectations of<br />

the parties and assure effective performance by Physician.<br />

NOW, THEREFORE, for good and valuable consideration, the receipt and<br />

sufficiency of which are hereby acknowledged by the parties, it is hereby agreed as follows:<br />

1. Recitals. The recitals set forth above are hereby incorporated into this Agreement as a<br />

material and substantive part of this Agreement.<br />

2. Duties. The Duties of Physician as the Department of Anesthesia Chair are as set forth<br />

in the Medical Staff Bylaws of Pomerado Hospital or relevant Medical Staff Policies, as they<br />

may be amended from time to time, and shall include, without limitation, the Duties set forth on<br />

Exhibit A attached hereto and incorporated herein by this reference (“Duties”).<br />

3. Compensation.<br />

3.1 Monthly Rate. PPH agrees to pay Physician $375.00 and the Medical Staff<br />

agrees to pay $375.00 totaling $750.00 per month for the months of March 1, 2010 through<br />

December 31, 2011 for Physician’s performance of the Duties as Department of Anesthesia<br />

Chair pursuant to the Medical Staff Bylaws/Policies, which shall average from four (4) to seven<br />

(7) hours per month. At the end of each month worked, Physician shall sign an Attestation Form<br />

1 – DEPARTMENT/<strong>COMMITTEE</strong> CHAIR AGREEMENT<br />

AG22


POMERADO HOSPITAL<br />

INTERNAL MEDICINE CONSULTANT – GERO-PSYCHIATRIC UNIT<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

Sheila Brown, R.N., M.B.A., Chief Clinical Outreach Officer<br />

Susan Linback, R.N., M.B.A., Director, Behavioral <strong>Health</strong> Services<br />

BACKGROUND: This is a request to approve the extension of the Internal Medicine<br />

Consultant Agreement with Neighborhood <strong>Health</strong>care. Neighborhood <strong>Health</strong>care will continue<br />

to provide Internal Medicine H&P and follow-up medical coverage for patients in the Pomerado<br />

Hospital Gero-Psychiatric Unit. By nature of their age, this Senior patient population exhibits<br />

concomitant medical conditions, and a medical H&P and follow-up by an internal medicine<br />

physician is a necessary component in the comprehensive evaluation and treatment of these<br />

patients. This unit provides inpatient psychiatric assessment and treatment for a vulnerable<br />

Senior population.<br />

BUDGET IMPACT:<br />

No Budget Impact<br />

STAFF RECOMMENDATION:<br />

Approve<br />

<strong>COMMITTEE</strong> QUESTIONS:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Internal Medicine Consultant Agreement for GPU April 1, 2010.doc<br />

AG23


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Internal Medicine Consultant Agreement – Pomerado Hospital<br />

Gero-Psychiatric Unit<br />

Neighborhood <strong>Health</strong>care<br />

AGREEMENT DATE April 1, 2010<br />

PARTIES<br />

1) PPH<br />

2) Neighborhood <strong>Health</strong>care<br />

Recitals E PURPOSE To provide H&P and Medical oversight for patients in Pomerado<br />

Hospital’s Gero-Psychiatric Unit<br />

Exhibit A SCOPE OF SERVICES Neighborhood <strong>Health</strong>care will continue to perform H&Ps and<br />

provide Internal Medicine coverage for patients in the Pomerado<br />

Hospital Gero-Psychiatric Unit. This Senior patient population<br />

exhibits concomitant medical conditions, and a medical H&P and<br />

follow-up by an internal medicine physician is a necessary<br />

component in the comprehensive evaluation and treatment of<br />

these patients.<br />

PROCUREMENT Request For Proposal • Discretionary<br />

METHOD<br />

5.1 TERM April 1, 2010 through December 31, 2010<br />

5.2<br />

5.3<br />

RENEWAL<br />

TERMINATION<br />

N/A<br />

a. Immediately for cause<br />

b. Not less than 30 days of written notice without cause<br />

2.1 COMPENSATION<br />

METHODOLOGY<br />

BUDGETED<br />

EXCLUSIVITY<br />

Monthly payment on or before the 15 th of each month with<br />

supporting documentation of the prior month’s time records.<br />

• YES NO – IMPACT: None<br />

• NO YES – EXPLAIN:<br />

JUSTIFICATION Medical H&P and follow-up is a community standard for Gero-<br />

Psychiatric inpatients.<br />

AGREEMENT NOTICED YES • NO Methodology & Response: Discussed with<br />

all eligible providers. RFP was done externally.<br />

ALTERNATIVES/IMPACT Proceeding without this arrangement would cause lack of medical<br />

support for medically compromised Senior patients on the Gero-<br />

Psychiatric Unit.<br />

Exhibit B Duties •Provision for Staff Education<br />

• Provision for Medical Staff Education<br />

• Provision for participation in Quality Improvement<br />

• Provision for participation in budget process development<br />

COMMENTS<br />

APPROVALS REQUIRED<br />

• VP •CFO •CEO•BOD Committee Finance Committee •BOD<br />

NH 2010<br />

AG24


CONTRACT AMENDMENT BETWEEN<br />

PALOMAR POMERADO HEALTH<br />

AND<br />

NEIGHBORHOOD HEALTHCARE<br />

1.) This amendment (“Amendment”) is made by and between PALOMAR POMERADO<br />

HEALTH, a local healthcare district organized under Division 23 of the California <strong>Health</strong><br />

and Safety Code, and Neighborhood <strong>Health</strong>care on this 1 st day of April, 2010.<br />

2.) In consideration of the mutual promises of the parties, the receipt and sufficiency of<br />

which are hereby acknowledged, the INTERNAL MEDICINE CONSULTANT<br />

AGREEMENT between the parties (“Agreement”), dated April 1, 2007 is hereby<br />

amended as follows:<br />

3.) This Agreement is hereby extended until March 31, 2011.<br />

All other terms of the Agreement remain in full force and effect. In the event of a<br />

conflict, the provisions, terms and conditions of this Amendment shall prevail.<br />

The parties have executed the Amendment as of the date set forth below.<br />

NEIGHBORHOOD HEALTHCARE<br />

PALOMAR POMERADO HEALTH<br />

By: __________________________<br />

Print: _________________________<br />

Title: _________________________<br />

Date:_________________________<br />

By:___________________________<br />

Print: __Robert A. Hemker________<br />

Title: __Chief Financial Officer____<br />

Date:_________________________<br />

AG25


Ophthalmology On-Call Agreement – Amendment<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

David Tam, CAO, Pomerado Hospital<br />

Background: Brian Le, MD Ophthalmology On-Call Agreement<br />

Amendment. This Amendment replaces the previously Board-approved<br />

Amendment #1, which incorrectly stated the term as three (3) years. The term of<br />

the original contract was extended to accommodate the development of a new<br />

amendment that incorporated adjustments for compliance with new requirements<br />

regarding Stark regulations and an updated Fair Market Value analysis.<br />

Budget Impact:<br />

None<br />

Staff Recommendation: Approval<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Brian Le Amend.doc<br />

AG26


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Emergency On-Call Agreement – Ophthalmology – Amendment<br />

AGREEMENT DATE January 1, 2010<br />

(Extension of original agreement dated January 1, 2009)<br />

PARTIES<br />

1) Pomerado Hospital<br />

2) Le, Brian M.D.<br />

Recitals E PURPOSE To serve on the On-Call Panel as required by the medical staff<br />

bylaws, and rules and regulations of PPH.<br />

Exhibit A SCOPE OF SERVICES Need for continued Ophthalmology consultation call coverage for<br />

the Emergency Department.<br />

PROCUREMENT Request For Proposal Discretionary<br />

METHOD<br />

5 TERM Three (3) months (January 1, 2010 to March 31, 2010)<br />

N/A RENEWAL None<br />

6 TERMINATION 1. Immediate for cause<br />

2. Not less than 90 days of written notice without cause<br />

2 COMPENSATION<br />

METHODOLOGY<br />

BUDGETED<br />

Monthly payment on or before the 15 th of the month with<br />

supporting documentation.<br />

YES NO – IMPACT:<br />

EXCLUSIVITY NO YES – EXPLAIN:<br />

JUSTIFICATION Need for continued Ophthalmology consultation call coverage for<br />

the Emergency Room.<br />

AGREEMENT NOTICED YES NO Methodology & Response:<br />

ALTERNATIVES/IMPACT N/A<br />

1 Duties Physician shall provide On-Call Panel Coverage and professional<br />

services in accordance with the Hospital’s bylaws, rules and<br />

regulations, policies and procedures.<br />

COMMENTS<br />

APPROVALS REQUIRED<br />

Officers CFO CEO BOD Committee Finance BOD<br />

AG27


CONTRACT AMENDMENT #1<br />

BETWEEN<br />

PALOMAR POMERADO HEALTH<br />

AND<br />

BRIAN LE, M.D.<br />

This Amendment #1 is made by and between PALOMAR POMERADO HEALTH, a<br />

local healthcare district organized under Division 23 of the California <strong>Health</strong> and Safety<br />

Code, and BRIAN LE, M.D., on this the January 1, 2010 (“Effective Date of<br />

Amendment”).<br />

In consideration of the mutual promises of the parties, the receipt and sufficiency of<br />

which are hereby acknowledged, the Emergency On-Call Agreement between the<br />

parties (“Agreement”) that was entered into effective January 1, 2009, and is hereby<br />

amended as follows.<br />

This Agreement is hereby extended through March 31, 2010.<br />

All other terms of the Agreement remain in full force and effect. In the event of a<br />

conflict, the provisions, terms and conditions of this Amendment shall prevail.<br />

The parties have executed the Amendment as of the date set forth below.<br />

BRIAN LE, M.D.<br />

By: __________________________<br />

Date:_________________________<br />

PALOMAR POMERADO HEALTH<br />

By:___________________________<br />

Robert A. Hemker<br />

Chief Financial Officer<br />

Date:_________________________<br />

AG28


Ophthalmology On-Call Agreement – Amendment<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

David Tam, CAO, Pomerado Hospital<br />

Background: Lillian Lee, MD Ophthalmology On-Call Agreement<br />

Amendment. The term of the original contract is being extended to<br />

accommodate the development of a new amendment that incorporated<br />

adjustments for compliance with new requirements regarding Stark regulations<br />

and an updated Fair Market Value analysis.<br />

Budget Impact:<br />

None<br />

Staff Recommendation: Approval<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Lillian Lee Amend.doc<br />

AG29


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Emergency On-Call Agreement – Ophthalmology – Amendment<br />

AGREEMENT DATE February 1, 2010<br />

(Extension of original agreement dated February 1, 2009)<br />

PARTIES<br />

1) Pomerado Hospital<br />

2) Lee, Lillian M.D.<br />

Recitals E PURPOSE To serve on the On-Call Panel as required by the medical staff<br />

bylaws, and rules and regulations of PPH.<br />

Exhibit A SCOPE OF SERVICES Need for continued Ophthalmology consultation call coverage for<br />

the Emergency Department.<br />

PROCUREMENT Request For Proposal Discretionary<br />

METHOD<br />

5 TERM Two (2) months (February 1, 2010 to March 31, 2010)<br />

N/A RENEWAL None<br />

6 TERMINATION 1. Immediate for cause<br />

2. Not less than 90 days of written notice without cause<br />

2 COMPENSATION<br />

METHODOLOGY<br />

BUDGETED<br />

Monthly payment on or before the 15 th of the month with<br />

supporting documentation.<br />

YES NO – IMPACT:<br />

EXCLUSIVITY NO YES – EXPLAIN:<br />

JUSTIFICATION Need for continued Ophthalmology consultation call coverage for<br />

the Emergency Room.<br />

AGREEMENT NOTICED YES NO Methodology & Response:<br />

ALTERNATIVES/IMPACT N/A<br />

1 Duties Physician shall provide On-Call Panel Coverage and professional<br />

services in accordance with the Hospital’s bylaws, rules and<br />

regulations, policies and procedures.<br />

COMMENTS<br />

APPROVALS REQUIRED<br />

Officers CFO CEO BOD Committee Finance BOD<br />

AG30


CONTRACT AMENDMENT #1<br />

BETWEEN<br />

PALOMAR POMERADO HEALTH<br />

AND<br />

LILLIAN LEE, M.D.<br />

This Amendment #1 is made by and between PALOMAR POMERADO HEALTH, a<br />

local healthcare district organized under Division 23 of the California <strong>Health</strong> and Safety<br />

Code, and Lillian Lee M.D., on this the February 1, 2010 (“Effective Date of<br />

Amendment”).<br />

In consideration of the mutual promises of the parties, the receipt and sufficiency of<br />

which are hereby acknowledged, the Emergency On-Call Agreement between the<br />

parties (“Agreement”) that was entered into effective February 1, 2009, and is hereby<br />

amended as follows.<br />

This Agreement is hereby extended through March 31, 2010.<br />

All other terms of the Agreement remain in full force and effect. In the event of a<br />

conflict, the provisions, terms and conditions of this Amendment shall prevail.<br />

The parties have executed the Amendment as of the date set forth below.<br />

LILLIAN LEE, M.D.<br />

By: __________________________<br />

Date:_________________________<br />

PALOMAR POMERADO HEALTH<br />

By:___________________________<br />

Robert A. Hemker<br />

Chief Financial Officer<br />

Date:_________________________<br />

AG31


Ophthalmology On-Call Agreement<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

David Tam, CAO, Pomerado Hospital<br />

Background: Lorne Kapner, MD Ophthalmology On-Call Agreement<br />

Amendment. Amendment to Ophthalmology On-Call Agreement to incorporate<br />

adjustments for compliance with new requirements regarding Stark regulations<br />

and an updated Fair Market Value analysis.<br />

Budget Impact: Increase in collective annual collective compensation to<br />

include costs of district-wide Ophthalmology needs.<br />

Staff Recommendation: Approval<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Kapner.doc<br />

AG32


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Emergency On-Call Agreement – Ophthalmology<br />

AGREEMENT DATE April 1, 2010.<br />

PARTIES<br />

1) PPH District<br />

2) Kapner, Lorne, M.D.<br />

Recitals E PURPOSE To serve on the On-Call Panel as required by the medical staff<br />

bylaws, and rules and regulations of PPH.<br />

Exhibit A SCOPE OF SERVICES To provide On-Call coverage pursuant to the On-Call Agreement<br />

for the specialty of Ophthalmology services district wide.<br />

PROCUREMENT Request For Proposal Discretionary<br />

METHOD<br />

5 TERM Three (3) years (April 1, 2010 through March 31, 2013)<br />

N/A RENEWAL None<br />

6 TERMINATION 1. Immediate for cause<br />

2. Not less than 90 days of written notice without cause<br />

2 COMPENSATION<br />

METHODOLOGY<br />

BUDGETED<br />

Monthly payment on or before the 15 th of the month with<br />

supporting documentation.<br />

YES NO – IMPACT:<br />

EXCLUSIVITY NO YES – EXPLAIN:<br />

JUSTIFICATION Adjustment of Ophthalmology On Call Agreement to meet the<br />

newly required established Stark regulations as well as Fair<br />

Market Value analysis.<br />

AGREEMENT NOTICED YES NO Methodology & Response:<br />

ALTERNATIVES/IMPACT N/A<br />

1 Duties Physician shall provide On-Call Panel Coverage and professional<br />

services in accordance with the Hospital’s bylaws, rules and<br />

regulations, policies and procedures.<br />

COMMENTS<br />

APPROVALS REQUIRED<br />

Officers CFO CEO BOD Committee Finance BOD<br />

AG33


CONTRACT AMENDMENT #1<br />

BETWEEN<br />

PALOMAR POMERADO HEALTH<br />

AND<br />

LORNE KAPNER, M.D.<br />

This Amendment is made by and between PALOMAR POMERADO HEALTH, a<br />

local healthcare district organized under Division 23 of the California <strong>Health</strong> and Safety<br />

Code, and LORNE KAPNER, M.D., on this the 1st day of April, 2010 (“Effective Date<br />

of Amendment”).<br />

In consideration of the mutual promises of the parties, the receipt and sufficiency of<br />

which are hereby acknowledged, the Emergency On-Call Agreement between the<br />

parties (“Agreement”) that was entered into effective September 1, 2009, and is hereby<br />

amended as follows:<br />

2. Compensation to Physician.<br />

2.1 As of April 1, 2010, PPH shall pay Physician for the provision of On-Call<br />

Panel Coverage in accordance with the On-Call Panel schedule described in Section 1.2<br />

above, and pursuant to the payment schedule set forth on Exhibit B, attached hereto and<br />

incorporated herein by this reference. Physician shall, on a monthly basis on or before<br />

the fifth (5th) day of each calendar month during the entire term of this Agreement,<br />

commencing with the second (2nd) calendar month of the term of this Agreement, submit<br />

a written invoice to PPH in form and detail acceptable to PPH detailing the dates and<br />

number of twenty four (24) hour On-Call Panel periods covered (as defined in Exhibit A)<br />

made by Physician during the immediately preceding calendar month. Payments by PPH<br />

to Physician shall be made on or before the fifteenth (15th) day of the calendar month<br />

following the month in which such services are rendered.<br />

5. Term of Agreement.<br />

The effective date this Agreement shall remain September 1, 2009 and shall terminate on<br />

the earlier to occur of (i) March 31, 2013, or (ii) the date on which PPH implements a<br />

new On-Call Panel arrangement, provided that PPH shall provide Physician with no<br />

fewer than fourteen (14) days prior written notice thereof.<br />

EXHIBIT A – PHYSICIAN SERVICES<br />

As of April 1, 2010, this Agreement shall provide for the provision of On-Call Coverage<br />

by Physician for the specialty of Ophthalmology at Pomerado Hospital. This shall<br />

include accepting patients from other <strong>Palomar</strong> Pomerado <strong>Health</strong> facilities, including but<br />

not limited to, <strong>Palomar</strong> Medical Center, for services not provided at that other facility.<br />

1<br />

AG34


Ophthalmology On Call Agreement<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

David Tam, CAO, Pomerado Hospital<br />

Background: Brian Le, MD, Ophthalmology On-Call Agreement.<br />

Amendment to Ophthalmology On-Call Agreement to incorporate adjustments<br />

for compliance with new requirements regarding Stark regulations and an<br />

updated Fair Market Value analysis.<br />

Budget Impact: Increase in collective annual collective compensation to<br />

include costs of district-wide Ophthalmology needs.<br />

Staff Recommendation: Approval<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Brian Le New.doc<br />

AG35


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Emergency On-Call Agreement – Ophthalmology<br />

AGREEMENT DATE April 1, 2010<br />

PARTIES<br />

1) Pomerado Hospital<br />

2) Le, Brian M.D.<br />

Recitals E PURPOSE To serve on the On-Call Panel as required by the medical staff<br />

bylaws, and rules and regulations of PPH.<br />

Exhibit A SCOPE OF SERVICES Need for continued Ophthalmology consultation call coverage for<br />

the Emergency Department district wide.<br />

PROCUREMENT Request For Proposal Discretionary<br />

METHOD<br />

5 TERM Three (3) years (April 1, 2010 to March 31, 2013)<br />

N/A RENEWAL None<br />

6 TERMINATION 1. Immediate for cause<br />

2. Not less than 90 days of written notice without cause<br />

2 COMPENSATION<br />

METHODOLOGY<br />

BUDGETED<br />

Monthly payment on or before the 15 th of the month with<br />

supporting documentation.<br />

YES NO – IMPACT:<br />

EXCLUSIVITY NO YES – EXPLAIN:<br />

JUSTIFICATION Adjustment of Ophthalmology On Call Agreement to meet the<br />

newly required established Stark regulations as well as Fair<br />

Market Value analysis.<br />

AGREEMENT NOTICED YES NO Methodology & Response:<br />

ALTERNATIVES/IMPACT N/A<br />

1 Duties Physician shall provide On-Call Panel Coverage and professional<br />

services in accordance with the Hospital’s bylaws, rules and<br />

regulations, policies and procedures.<br />

COMMENTS<br />

APPROVALS REQUIRED<br />

Officers CFO CEO BOD Committee Finance BOD<br />

AG36


BRIAN LE, MD – ON CALL AGREEMENT - CONTRACT AMENDMENT #2<br />

CONTRACT AMENDMENT #2<br />

BETWEEN<br />

PALOMAR POMERADO HEALTH<br />

AND<br />

BRIAN LE, M.D.<br />

This Amendment is made by and between PALOMAR POMERADO HEALTH, a<br />

local healthcare district organized under Division 23 of the California <strong>Health</strong> and Safety<br />

Code, and Brian Le, M.D., on this the 1st day of April, 2010 (“Effective Date of<br />

Amendment”).<br />

In consideration of the mutual promises of the parties, the receipt and sufficiency of<br />

which are hereby acknowledged, the Emergency On-Call Agreement between the<br />

parties (“Agreement”) that was entered into effective January 1, 2009, and is hereby<br />

amended as follows:<br />

1.1 Physician shall serve as a member of the On-Call Panel on a rotating basis,<br />

at such times as shall be determined by the appropriate PPH Department in accordance<br />

with Section 1.2 below, to provide On-Call Panel Coverage and professional services,<br />

regardless of payor class, to: (1) patients who are not currently assigned to any particular<br />

physician at the time coverage and services are provided, and (2) patients, including<br />

inpatients, who may be assigned to a particular physician, but who require consultation or<br />

other physician services from an On-Call Panel physician during the physician’s<br />

scheduled On-Call Panel period (collectively, “Coverage Patients”). Specifically,<br />

Physician shall provide those services set forth on Exhibit A, attached hereto and<br />

incorporated herein by this reference, which he or she is qualified and privileged by the<br />

respective Hospital to provide, when PPH or either of the Hospitals request that Physician<br />

provide such services to a Coverage Patient during Physician’s scheduled On-Call Panel<br />

period. For purposes of this Agreement, “On-Call Panel Coverage” shall mean Physician<br />

is either physically present in the applicable Department or immediately available by<br />

telephone and/or pager to arrive at the applicable Department during his or her scheduled<br />

on-call rotation within the time frame specified in the applicable Hospital medical staff<br />

bylaws, rules and regulations, in order to provide professional services to Coverage<br />

Patients.<br />

1.2 Each month PPH shall, on a departmental basis, schedule Physician to be<br />

on-call for periods of twenty-four (24) continuous hours and shall make available to<br />

Physician the On-Call Panel schedule for the applicable Department. Physician shall<br />

provide On-Call Panel Coverage in accordance with the monthly call schedule.<br />

Particular days may be requested by Physician. However, PPH shall have the right to<br />

disapprove Physician’s monthly proposed schedule of on-call days before it is finalized.<br />

PPH has the right to require that Physician provide On-Call Panel Coverage for days<br />

other than those requested by Physician, in order to assure appropriate coverage for the<br />

Departments.<br />

AG37


Ophthalmology On Call Agreement<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

David Tam, CAO, Pomerado Hospital<br />

Background: Erwin Omens, MD Ophthalmology On Call Agreement<br />

Amendment. Amendment to Ophthalmology On-Call Agreement to incorporate<br />

adjustments for compliance with new requirements regarding Stark regulations<br />

and an updated Fair Market Value analysis.<br />

Budget Impact: Increase in collective annual collective compensation to<br />

include costs of district-wide Ophthalmology needs.<br />

Staff Recommendation: Approval<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Omens.doc<br />

AG38


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Emergency On-Call Agreement – Ophthalmology<br />

AGREEMENT DATE April 1, 2010.<br />

PARTIES<br />

1) Pomerado Hospital<br />

2) Omens, Erwin M.D.<br />

Recitals E PURPOSE To serve on the On-Call Panel as required by the medical staff<br />

bylaws, and rules and regulations of PPH.<br />

Exhibit A SCOPE OF SERVICES To provide On-Call coverage pursuant to the On-Call Agreement<br />

for the specialty of Ophthalmology district wide.<br />

PROCUREMENT Request For Proposal Discretionary<br />

METHOD<br />

5 TERM Three (3) years (April 1, 2010 through March 31, 2013)<br />

N/A RENEWAL None<br />

6 TERMINATION 1. Immediate for cause<br />

2. Not less than 90 days of written notice without cause<br />

2 COMPENSATION<br />

METHODOLOGY<br />

BUDGETED<br />

Monthly payment on or before the 15 th of the month with<br />

supporting documentation.<br />

YES NO – IMPACT:<br />

EXCLUSIVITY NO YES – EXPLAIN:<br />

JUSTIFICATION Adjustment of Ophthalmology On Call Agreement to meet the<br />

newly required established Stark regulations as well as Fair<br />

Market Value analysis.<br />

AGREEMENT NOTICED YES NO Methodology & Response:<br />

ALTERNATIVES/IMPACT N/A<br />

1 Duties Physician shall provide On-Call Panel Coverage and professional<br />

services in accordance with the Hospital’s bylaws, rules and<br />

regulations, policies and procedures.<br />

COMMENTS<br />

APPROVALS REQUIRED<br />

Officers CFO CEO BOD Committee Finance BOD<br />

AG39


CONTRACT AMENDMENT #1<br />

BETWEEN<br />

PALOMAR POMERADO HEALTH<br />

AND<br />

ERWIN OMENS, M.D.<br />

This Amendment is made by and between PALOMAR POMERADO HEALTH, a<br />

local healthcare district organized under Division 23 of the California <strong>Health</strong> and Safety<br />

Code, and ERWIN OMENS, M.D., on this the 1st day of April, 2010 (“Effective Date<br />

of Amendment”).<br />

In consideration of the mutual promises of the parties, the receipt and sufficiency of<br />

which are hereby acknowledged, the Emergency On-Call Agreement between the<br />

parties (“Agreement”) that was entered into effective September 1, 2009, and is hereby<br />

amended as follows:<br />

2. Compensation to Physician.<br />

2.1 As of April 1, 2010, PPH shall pay Physician for the provision of On-Call<br />

Panel Coverage in accordance with the On-Call Panel schedule described in Section 1.2<br />

above, and pursuant to the payment schedule set forth on Exhibit B, attached hereto and<br />

incorporated herein by this reference. Physician shall, on a monthly basis on or before<br />

the fifth (5th) day of each calendar month during the entire term of this Agreement,<br />

commencing with the second (2nd) calendar month of the term of this Agreement, submit<br />

a written invoice to PPH in form and detail acceptable to PPH detailing the dates and<br />

number of twenty four (24) hour On-Call Panel periods covered (as defined in Exhibit A)<br />

made by Physician during the immediately preceding calendar month. Payments by PPH<br />

to Physician shall be made on or before the fifteenth (15th) day of the calendar month<br />

following the month in which such services are rendered.<br />

5. Term of Agreement.<br />

The effective date this Agreement shall remain September 1, 2009 and shall terminate on<br />

the earlier to occur of (i) March 31, 2013, or (ii) the date on which PPH implements a<br />

new On-Call Panel arrangement, provided that PPH shall provide Physician with no<br />

fewer than fourteen (14) days prior written notice thereof.<br />

EXHIBIT A – PHYSICIAN SERVICES<br />

As of April 1, 2010, this Agreement shall provide for the provision of On-Call Coverage<br />

by Physician for the specialty of Ophthalmology at Pomerado Hospital. This shall<br />

include accepting patients from other <strong>Palomar</strong> Pomerado <strong>Health</strong> facilities, including but<br />

not limited to, <strong>Palomar</strong> Medical Center, for services not provided at that other facility.<br />

1<br />

AG40


Ophthalmology On-Call Agreement<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

David Tam, CAO, Pomerado Hospital<br />

Background: Paras Shah, MD Ophthalmology On-Call Agreement<br />

Amendment. Amendment to Ophthalmology On-Call Agreement to incorporate<br />

adjustments for compliance with new requirements regarding Stark regulations<br />

and an updated Fair Market Value analysis.<br />

Budget Impact: Increase in collective annual collective compensation to<br />

include costs of district-wide Ophthalmology needs.<br />

Staff Recommendation: Approval<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Shah.doc<br />

AG41


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Emergency On-Call Agreement – Ophthalmology<br />

AGREEMENT DATE April 1, 2010.<br />

PARTIES<br />

1) Pomerado Hospital<br />

2) Shah, Paras M.D.<br />

Recitals E PURPOSE To serve on the On-Call Panel as required by the medical staff<br />

bylaws, and rules and regulations of PPH.<br />

Exhibit A SCOPE OF SERVICES To provide On-Call coverage pursuant to the On-Call Agreement<br />

for the specialty of Ophthalmology district wide.<br />

PROCUREMENT Request For Proposal Discretionary<br />

METHOD<br />

5 TERM Three (3) years (April 1, 2010 through March 31, 2013)<br />

N/A RENEWAL None<br />

6 TERMINATION 1. Immediate for cause<br />

2. Not less than 90 days of written notice without cause<br />

2 COMPENSATION<br />

METHODOLOGY<br />

BUDGETED<br />

Monthly payment on or before the 15 th of the month with<br />

supporting documentation.<br />

YES NO – IMPACT:<br />

EXCLUSIVITY NO YES – EXPLAIN:<br />

JUSTIFICATION Adjustment of Ophthalmology On Call Agreement to meet the<br />

newly required established Stark regulations as well as Fair<br />

Market Value analysis.<br />

AGREEMENT NOTICED YES NO Methodology & Response:<br />

ALTERNATIVES/IMPACT N/A<br />

1 Duties Physician shall provide On-Call Panel Coverage and professional<br />

services in accordance with the Hospital’s bylaws, rules and<br />

regulations, policies and procedures.<br />

COMMENTS<br />

APPROVALS REQUIRED<br />

Officers CFO CEO BOD Committee Finance BOD<br />

AG42


CONTRACT AMENDMENT #1<br />

BETWEEN<br />

PALOMAR POMERADO HEALTH<br />

AND<br />

PARAS SHAH, M.D.<br />

This Amendment is made by and between PALOMAR POMERADO HEALTH, a<br />

local healthcare district organized under Division 23 of the California <strong>Health</strong> and Safety<br />

Code, and PARAS SHAH, M.D., on this the 1st day of April, 2010 (“Effective Date of<br />

Amendment”).<br />

In consideration of the mutual promises of the parties, the receipt and sufficiency of<br />

which are hereby acknowledged, the Emergency On-Call Agreement between the<br />

parties (“Agreement”) that was entered into effective August 1, 2009, and is hereby<br />

amended as follows:<br />

2. Compensation to Physician.<br />

2.1 As of April 1, 2010, PPH shall pay Physician for the provision of On-Call<br />

Panel Coverage in accordance with the On-Call Panel schedule described in Section 1.2<br />

above, and pursuant to the payment schedule set forth on Exhibit B, attached hereto and<br />

incorporated herein by this reference. Physician shall, on a monthly basis on or before<br />

the fifth (5th) day of each calendar month during the entire term of this Agreement,<br />

commencing with the second (2nd) calendar month of the term of this Agreement, submit<br />

a written invoice to PPH in form and detail acceptable to PPH detailing the dates and<br />

number of twenty four (24) hour On-Call Panel periods covered (as defined in Exhibit A)<br />

made by Physician during the immediately preceding calendar month. Payments by PPH<br />

to Physician shall be made on or before the fifteenth (15th) day of the calendar month<br />

following the month in which such services are rendered.<br />

5. Term of Agreement.<br />

The effective date this Agreement shall remain August 1, 2009 and shall terminate on the<br />

earlier to occur of (i) March 31, 2013, or (ii) the date on which PPH implements a new<br />

On-Call Panel arrangement, provided that PPH shall provide Physician with no fewer<br />

than fourteen (14) days prior written notice thereof.<br />

EXHIBIT A – PHYSICIAN SERVICES<br />

As of April 1, 2010, this Agreement shall provide for the provision of On-Call Coverage<br />

by Physician for the specialty of Ophthalmology at Pomerado Hospital. This shall<br />

include accepting patients from other <strong>Palomar</strong> Pomerado <strong>Health</strong> facilities, including but<br />

not limited to, <strong>Palomar</strong> Medical Center, for services not provided at that other facility.<br />

1<br />

AG43


Ophthalmology On Call Agreement<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

David Tam, CAO, Pomerado Hospital<br />

Background: Lillian Lee, MD, Ophthalmology On-Call Agreement.<br />

New Ophthalmology On-Call Agreement to incorporate adjustments for<br />

compliance with new requirements regarding Stark regulations and an<br />

updated Fair Market Value analysis.<br />

Budget Impact: Increase in collective annual collective compensation to<br />

include costs of district-wide Ophthalmology needs.<br />

Staff Recommendation: Approval<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Lillian Lee New.doc<br />

AG44


PALOMAR POMERADO HEALTH - AGREEMENT ABSTRACT<br />

Section<br />

Reference Term/Condition Term/Condition Criteria<br />

TITLE<br />

Emergency On-Call Agreement – Ophthalmology<br />

AGREEMENT DATE April 1, 2010<br />

PARTIES<br />

1) Pomerado Hospital<br />

2) Lee, Lillian M.D.<br />

Recitals E PURPOSE To serve on the On-Call Panel as required by the medical staff<br />

bylaws, and rules and regulations of PPH.<br />

Exhibit A SCOPE OF SERVICES Need for continued Ophthalmology consultation call coverage for<br />

the Emergency Department district wide.<br />

PROCUREMENT Request For Proposal Discretionary<br />

METHOD<br />

5 TERM Three (3) years (April 1, 2010 to March 31, 2013)<br />

N/A RENEWAL None<br />

6 TERMINATION 1. Immediate for cause<br />

2. Not less than 90 days of written notice without cause<br />

2 COMPENSATION<br />

METHODOLOGY<br />

BUDGETED<br />

Monthly payment on or before the 15 th of the month with<br />

supporting documentation.<br />

YES NO – IMPACT:<br />

EXCLUSIVITY NO YES – EXPLAIN:<br />

JUSTIFICATION Adjustment of Ophthalmology On Call Agreement to meet the<br />

newly required established Stark regulations as well as Fair<br />

Market Value analysis.<br />

AGREEMENT NOTICED YES NO Methodology & Response:<br />

ALTERNATIVES/IMPACT N/A<br />

1 Duties Physician shall provide On-Call Panel Coverage and professional<br />

services in accordance with the Hospital’s bylaws, rules and<br />

regulations, policies and procedures.<br />

COMMENTS<br />

APPROVALS REQUIRED<br />

Officers CFO CEO BOD Committee Finance BOD<br />

AG45


EMERGENCY ON-CALL AGREEMENT<br />

THIS EMERGENCY ON-CALL AGREEMENT (“Agreement”) is made and entered into<br />

effective as of the first day of April 1, 2010 by and between <strong>Palomar</strong> Pomerado <strong>Health</strong>, a<br />

California local health care district created under Division 23 of the California <strong>Health</strong> and Safety<br />

Code (“PPH”), and Lillian Lee, M.D. (“Physician”).<br />

RECITALS<br />

A. PPH owns and operates two general acute care hospitals: <strong>Palomar</strong> Medical Center<br />

and Pomerado Hospital (collectively, the “Hospitals”), and provides emergency services to patients<br />

who present themselves for evaluation and treatment through the emergency and various other<br />

departments of the Hospitals, including, but not limited to, the intensive care unit and other<br />

inpatient departments of the Hospitals (collectively, the “Departments”).<br />

B. Pursuant to state and federal law, the Hospitals have established “on-call” panels of<br />

physicians (“On-Call Panel”) in order to assure the availability of adequate physician coverage for<br />

the Departments.<br />

C. Physician is licensed to practice medicine in the State of California, is Board<br />

certified or eligible for certification in his or her appropriate specialty, is a member of the medical<br />

staff of one or both Hospitals, and is approved by one or both of the Hospital medical staffs to<br />

serve on the On-Call Panel.<br />

D. PPH and Physician each recognize that the On-Call Panel performs a necessary<br />

patient care function at PPH and Physician agrees to render coverage and services as a member of<br />

said On-Call Panel in assuring prompt and continuous availability of services to PPH’s patients.<br />

E. Physician acknowledges his or her responsibility to serve on the On-Call Panel as<br />

required by the medical staff bylaws, and rules and regulations, of the applicable Hospital(s).<br />

NOW, THEREFORE, in consideration of the recitals, covenants, conditions and promises<br />

herein contained, the parties hereby agree as follows:<br />

1. Physician’s On-Call Panel Coverage Services.<br />

1.1 Physician shall serve as a member of the On-Call Panel on a rotating basis, at such<br />

times as shall be determined by the appropriate PPH Department in accordance with Section 1.2<br />

below, to provide On-Call Panel Coverage and professional services, regardless of payor class, to:<br />

(1) patients who are not currently assigned to any particular physician at the time coverage and<br />

services are provided, and (2) patients, including inpatients, who may be assigned to a particular<br />

physician, but who require consultation or other physician services from an On-Call Panel<br />

physician during the physician’s scheduled On-Call Panel period (collectively, “Coverage<br />

Patients”). Specifically, Physician shall provide those services set forth on Exhibit A, attached<br />

hereto and incorporated herein by this reference, which he or she is qualified and privileged by the<br />

AG46


<strong>Palomar</strong> Physician Network, Inc.<br />

Line of Credit<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

Bob Hemker, CFO<br />

Background: The PPH Board approved the creation and funding of a physician<br />

foundation at the November 2009 Board meeting. The <strong>Palomar</strong> Physician Network, Inc.<br />

(PPN) has been organized and is looking forward to a start date of April 1, 2010. At the<br />

February 2010 meeting, the Board approved a Line of Credit (LoC) in the amount of<br />

$250,000 from PPH to the PPN to bridge their costs until that start date.<br />

PPN is requesting an increase in the LoC as a result of the anticipated acquisition of<br />

Centre for <strong>Health</strong> Care (CCMS and PTMA) on April 1, 2010. The LoC is for coverage<br />

of working capital needs for payroll and other operating expenses resulting from the lag<br />

in accounts receivable collections from fee-for-service business. It is expected that the<br />

lag will be normalized within ninety (90) days. A redline version of the LoC including<br />

the increase is attached.<br />

Budget Impact: The requested increase is for $1,000,000 above the existing line,<br />

for a total LoC of $1,250,000.<br />

Staff Recommendation:<br />

Approval.<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - PPN LOC.doc<br />

AG47


<strong>Palomar</strong> Pomerado <strong>Health</strong> Hospital, Emergency Care, Trauma Center<br />

Improvement and Repair Measure Bonds<br />

Independent Citizens’ Oversight Committee (ICOC)<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 31, 2009<br />

FROM:<br />

Bob Hemker, CFO<br />

Background: When the members of the ICOC were first seated, members were divided into<br />

three classes with initial term lengths of one, two or three years. All terms commenced on<br />

June 30, 2005, with expiration dates on June 30 th of the Class years 2006, 2007 and 2008,<br />

respectively. Subsequent to their initial term, the members of each Class were then to serve a<br />

second term of two years, with no member allowed to serve more than two consecutive terms.<br />

On June 30, 2010, the members of the Class of 2008 will each have completed their second<br />

and final terms of office. They are:<br />

• William L. Corwin – At Large<br />

• Marguerite Jackson Dill, PhD, RN, FAAN – Nurse<br />

• John McIver – Business Organization – Secretary<br />

• Margaret Moir – At Large – Chair<br />

The pending term expirations will in effect create three forms of vacancy:<br />

• A vacancy in number, as it will reduce the membership to six (6)<br />

o<br />

§5.1 of the Procedures, Policies & Guidelines (PP&G) of the ICOC states that the<br />

Committee shall consist of not less than nine (9) members<br />

• Vacancies in two of the four “Required Member” seats – Business Organization and<br />

Nurse Representative<br />

o<br />

§5.3 of the PP&G of the ICOC states that the Committee shall at all times, except<br />

during the period of a vacancy, include the following members (collectively, the<br />

“Required Members”):<br />

• (1) one member who is active in a business organization<br />

• (2) one member who is active in a senior citizens’ organization<br />

• (3) one member who is active in a bona fide taxpayers’ organization<br />

• (4) one member who is a nurse or physician<br />

Pursuant to §5.4 of the PP&G, the District Board shall appoint members to the ICOC utilizing<br />

the following process:<br />

• The District Board shall post notice of vacancies and solicit applications from the general<br />

public<br />

• The District Board designee [the Board Finance Committee] shall review and process<br />

applications and make recommendations to the District Board for applicants to fill the<br />

vacant position(s)<br />

Budget Impact:<br />

N/A<br />

Staff Recommendation:<br />

Staff recommends the following actions:<br />

• Posting of the three (3) vacancies created by the pending term expirations of the<br />

members of the Class of 2008, to include special notice for the two (2) “Required<br />

Member” positions that will be vacated<br />

Form A - ICOC Update.doc<br />

AG48


<strong>Palomar</strong> Pomerado <strong>Health</strong> Hospital, Emergency Care, Trauma Center<br />

Improvement and Repair Measure Bonds<br />

Independent Citizens’ Oversight Committee (ICOC)<br />

• Establishment of a deadline for receipt of applications<br />

o posting on April 13, 2010, with a deadline of May 14, 2010, would accommodate review<br />

of applications at the May Board Finance and June Board meetings, respectively)<br />

• Consistent with previous methodology, it is also recommended that the full Finance<br />

Committee evaluate all applicants (conducting phone and/or face-to-face interviews with<br />

the finalists as warranted) prior to recommending to the Board the proposed finalists for<br />

the vacant seats on the ICOC<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - ICOC Update.doc<br />

AG49


<strong>Palomar</strong> Pomerado <strong>Health</strong> Hospital, Emergency Care, Trauma Center<br />

Improvement and Repair Measure Bonds<br />

Independent Citizens’ Oversight Committee (ICOC)<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 31, 2009<br />

FROM:<br />

Bob Hemker, CFO<br />

Background: As reported at the January meeting of this Committee, the members of the<br />

ICOC proposed the creation of an Advisory Panel that would be composed of those members<br />

whose terms of office were expiring. The members of the Advisory Panel would not hold voting<br />

rights; however, their experience and knowledge from their years on the ICOC would be an<br />

asset to the newer members.<br />

Also discussed was the fact that the Policies, Procedures & Guidelines (PP&G) of the ICOC did<br />

not address the possibility of former members reapplying for membership at a future date.<br />

The attached draft of the PP&G has been amended to include provisions both for the creation of<br />

and appointment of members to an Advisory Panel, as well as for the addition of a “sun-setting”<br />

period, after which former members who so desire can reapply for future vacant seats.<br />

Budget Impact:<br />

N/A<br />

Staff Recommendation:<br />

Staff recommends approval<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - ICOC PP&G Amendment.doc<br />

AG50


Strategic Capital Prioritization Matrix<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

Robert Hemker, CFO<br />

Background: At the request of the Board during Strategic Planning<br />

workshops, Management has been collaborating on a tool for use in prioritizing<br />

the strategic projects on which to allocate capital. The tool as presented at the<br />

December 8, 2009, Finance Committee meeting contained two options ranging<br />

from 3 to 6 separate criteria.<br />

The Finance Committee reached a consensus that the criteria and weights<br />

recommended would be a useful tool, and expressed a preference for the use of<br />

Option 1, with its complement of 6 criteria. Management was requested to refine<br />

the tool then return it to the Finance Committee for review and to solicit Board<br />

member comments.<br />

The updated matrix from Management is attached. No comments were received<br />

from non-Finance Committee Board members<br />

Budget Impact:<br />

N/A<br />

Staff Recommendation:<br />

Matrix as attached.<br />

Approval of the Strategic Capital Prioritization<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Prioritization.doc<br />

AG51


<strong>Palomar</strong> Pomerado <strong>Health</strong><br />

Board Directed Strategic Capital Allocation Criteria<br />

Recommended Criteria and Weighting<br />

Criteria<br />

Average<br />

Weight<br />

Grow the Business: 32.2%<br />

Financial Impacts: 20.6%<br />

Consumerism / Community Benefit: 11.6%<br />

Quality & Safety: 14.7%<br />

Regulatory Requirements: 13.4%<br />

Workforce & Workplace Matters: 7.5%<br />

Total Weight: 100.0%<br />

AG52


February 2010 & YTD FY2010 Financial Report<br />

TO:<br />

Board Finance Committee<br />

<strong>MEETING</strong> DATE: Tuesday, March 30, 2010<br />

FROM:<br />

Robert Hemker, CFO<br />

Background: The Board Financial Reports (unaudited) for February 2010<br />

and YTD FY2010 are submitted for the Finance Committee’s approval<br />

(Addendum F).<br />

Budget Impact:<br />

N/A<br />

Staff Recommendation:<br />

Staff recommends approval.<br />

Committee Questions:<br />

<strong>COMMITTEE</strong> RECOMMENDATION:<br />

Motion:<br />

Individual Action:<br />

Information:<br />

Required Time:<br />

Form A - Financial Report.doc<br />

AG53


ADDENDUM A<br />

ADD A-1


B OARD F INANCE C OMMITTEE M EETING<br />

A TTENDANCE R OSTER & M EETING M INUTES<br />

C ALENDAR Y EAR 2010<br />

<strong>MEETING</strong> DATES:<br />

1/26/10<br />

MEMBERS<br />

LINDA GREER, R.N. – CHAIR P<br />

TED KLEITER P<br />

BRUCE KRIDER, MA P<br />

MICHAEL COVERT, FACHE P<br />

FRANK MARTIN, M.D. P<br />

JOHN LILLEY, M.D. E<br />

– ALTERNATE<br />

– 2 ND ALTERNATE<br />

– 3 RD ALTERNATE<br />

– 4TH ALTERNATE<br />

STAFF ATTENDEES<br />

BOB HEMKER P<br />

GERALD BRACHT P<br />

DAVID TAM P<br />

TANYA HOWELL – SECRETARY P<br />

INVITED GUESTS<br />

SEE TEXT OF MINUTES FOR NAMES OF GUEST PRESENTERS<br />

2010-01-26 Finance Minutes - Revised.doc 1 ADD A-2


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – REVISED <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

CALL TO ORDER<br />

• The meeting – held in the First Floor Conference Room at 456 E. Grand Avenue, Escondido, CA – was called to order at 6:00 p.m. by Chair Linda Greer, RN<br />

ESTABLISHMENT OF QUORUM<br />

• See roster<br />

PUBLIC COMMENTS<br />

• There were no public comments<br />

ADJOURNMENT TO CLOSED SESSION<br />

Chair Greer adjourned to Closed Session at 6:01 p.m., citing the following Brown Act provisions:<br />

• PURSUANT TO CALIFORNIA GOVERNMENT CODE §54954.5(H)<br />

REPORT INVOLVING TRADE SECRET<br />

DISCUSSION WILL CONCERN PROPOSED NEW SERVICE<br />

ESTIMATED DATE OF PUBLIC DISCLOSURE: APRIL 2010<br />

RESUMPTION OF OPEN SESSION<br />

Following the Closed Session, Chair Greer resumed the Open Session at 6:38 p.m.<br />

• Action Resulting From Closed Session<br />

Discussion, IF ANY<br />

MOTION: By Michael Covert, seconded Director Krider and<br />

carried to approve up to $200K for the design and investigation<br />

process for 3 additional expresscare centers in San Elijo Hills,<br />

Oceanside & Temecula<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

N<br />

INFORMATION ITEM(S)<br />

• Request by ICOC for the Creation of an ICOC Advisory Panel<br />

o The Finance Committee is the conduit for ICOC to the PPH Board<br />

• Faced with the dilemma that all members are beginning to cycle off<br />

Original seats were filled with staggered terms of 1-3 years, with a<br />

maximum of two consecutive terms<br />

• At this stage of construction, ICOC has identified the need for continuity of<br />

experience on the Committee<br />

• Members wanted to know if there was any way to keep the experienced<br />

members on, even though they cannot be reappointed<br />

Proposed an Advisory Group that would retain members of the senior body<br />

(a) No ability to vote<br />

(b) Gain to new members of their experience and guidance<br />

o Would require a rewrite of the PP&G that govern the ICOC<br />

Information only<br />

• Management to work with ICOC<br />

Counsel to re-write the ICOC PP&G<br />

to include:<br />

o Sun-setting period of 2 years<br />

o Creation of an advisory panel<br />

• Criteria for appointment at<br />

end of second consecutive<br />

term<br />

• Term of 2 years<br />

• Final draft to be returned through<br />

Finance Committee for<br />

recommendation to the Board<br />

2010-01-26 Finance Minutes - Revised.doc 2 ADD A-3<br />

N


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – REVISED <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

• Will require a Board decision<br />

• Current PP&G do not specify a period of time between appointments<br />

<br />

Just cannot serve more than two consecutive terms<br />

Suggestion that a “sun-setting” period be embedded, denoting how many<br />

years a member had to be off the ICOC before they could apply for reappointment<br />

• Advisory panel membership<br />

Should be a minimum of 2 years<br />

Criteria for appointment at expiration of second consecutive term<br />

1. MINUTES – DECEMBER 8, 2009<br />

• No discussion MOTION: By Director Kleiter, seconded by Director Krider and carried to approve the minutes of the<br />

December 8, 2009, Board Finance Committee meeting as presented. All in favor. None opposed.<br />

Y<br />

2. ANNUAL REVIEW OF <strong>FINANCE</strong> <strong>COMMITTEE</strong> BYLAWS<br />

• No discussion<br />

MOTION: By Director Kleiter, seconded by Director Krider and<br />

carried to approve the Bylaws with no recommended changes. All<br />

in favor. None opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting as<br />

Information<br />

Y<br />

3. <strong>BOARD</strong> MEMBER POSITION DESCRIPTION<br />

• No discussion<br />

MOTION: By Director Kleiter, seconded by Director Krider and<br />

carried to approve the Board Member Position Description with no<br />

recommended changes. All in favor. None opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting as<br />

Information<br />

Y<br />

4. <strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> SCHEDULE FOR CALENDAR YEAR 2010<br />

• Bob Hemker reported the results of a matrix poll distributed prior to the meeting<br />

o All meetings during the last week of the month, with consensus of availability for the<br />

following:<br />

− Last Tuesdays in the evening<br />

− Last Thursdays in the evening<br />

− Last Thursdays from Noon to 2:00 p.m.<br />

o There was discussion that the nature of the Board Finance Committee meetings<br />

precludes daytime scheduling<br />

− Meetings are rarely short due to topics that must go through on a regular basis<br />

− Topics under discussion are often of interest to the public, and daytime<br />

scheduling might hamper their ability to attend<br />

MOTION: By Director<br />

Kleiter, seconded by<br />

Director Krider and carried<br />

to hold Board Finance<br />

Committee meetings on the<br />

last Tuesday of the month<br />

at 6:00 p.m.; with<br />

consensus to hold the<br />

combined November/<br />

December meeting on<br />

Tuesday, November 30,<br />

2010 (Attachment 1). All in<br />

favor. None opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting as<br />

Information<br />

Y<br />

2010-01-26 Finance Minutes - Revised.doc 3 ADD A-4


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – REVISED <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

5. <strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> ACCOMPLISHMENTS FOR CALENDAR YEAR 2009<br />

• The annual recap of the Board Finance Committee’s accomplishments for Calendar Year<br />

2009 was presented for review before distribution to the Board<br />

• Bob Hemker acknowledged Past Chair Kleiter’s leadership during the past year<br />

• Michael Covert also recognized Bob Hemker and gave special thanks to Committee<br />

Secretary Tanya Howell for their diligent support of the Finance Committee during the year<br />

Chairman Greer gave<br />

permission to move the<br />

information to the full<br />

Board as written<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting as<br />

Information<br />

Y<br />

6. <strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> ANNUAL AGENDA<br />

• Bob Hemker discussed the schedule (Agenda<br />

page AG11) and requested flexibility for routine items<br />

to be moved, and/or for the addition of other items as<br />

needed<br />

MOTION: By Director Krider, seconded by Director Kleiter and<br />

carried to approve the Board Finance Committee Annual Agenda,<br />

with the additions and corrections noted under “Follow-up”. All in<br />

favor. None opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting as<br />

Information<br />

• Before sending the schedule to the<br />

Board, Secretary Tanya Howell is to<br />

amend it:<br />

o To include the Quarterly<br />

Initiatives Reviews in the<br />

months of April and July<br />

o To correct the topic of the June<br />

program review to a review of<br />

the new entity <strong>Palomar</strong><br />

Pomerado Imaging, LLC<br />

Y<br />

DONE<br />

7. PHYSICIAN INDEPENDENT CONTRACTOR AGREEMENTS – EHR PROJECTS – INFORMATION SYSTEMS SERVICES<br />

• Branislav Cizmar, MD [12/1/09-11/30/10] • Stephen Fortus Signer, MD [11/1/09-10/31/10]<br />

• Nabil Fatayerji, MD [12/1/09-11/30/10] • Chris Wiesner, MD [12/1/09-11/30/10]<br />

• Michael S. Rafii, MD [12/1/09-11/30/10] • Rady Children’s Specialists Medical Foundation [12/1/09-11/30/10]<br />

• No discussion<br />

MOTION: By Dr. Martin, seconded by Director Krider and carried<br />

to recommend approval of the 1-year Physician Independent<br />

Contractor Agreements for EHR Projects with all<br />

physicians/groups for terms as listed. All in favor. None opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

Y<br />

8. PHYSICIAN INDEPENDENT CONTRACTOR AGREEMENTS AMENDMENTS – EHR PROJECTS – INFORMATION SYSTEMS SERVICES<br />

• Lachlan Macleay, MD • Kevin Daly, MD<br />

• Marc Gipsman, MD • Steven Zgliniec, MD<br />

• Julie Chuan, MD<br />

• No discussion<br />

MOTION: By Dr. Martin, seconded by Director Krider and carried<br />

to recommend approval of the amended pay rates for Physician<br />

Independent Contractor Agreement Amendments for EHR<br />

Projects with all physicians as listed. All in favor. None opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

Y<br />

2010-01-26 Finance Minutes - Revised.doc 4 ADD A-5


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – REVISED <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

9. MEDICAL DIRECTOR AGREEMENT – EXTENSION – FORENSIC HEALTH - PPH<br />

• Mary J. Spencer, MD<br />

• No discussion<br />

10. CLINICAL DIRECTOR AGREEMENT – AMENDMENT – PMC INPATIENT BEHAVIORAL HEALTH<br />

• Irinel Chiriac, MD<br />

• The amendment doubled Dr. Chiriac’s time<br />

commitment from 4 to 8 hours per week<br />

MOTION: By Director Krider, seconded by Director Kleiter and<br />

carried to recommend approval of the 6-month [1/8/10 to 6/30/10]<br />

Extension to the Medical Director Agreement with Mary J.<br />

Spencer, MD, for the provision of Forensic <strong>Health</strong> Services at<br />

PPH. All in favor. None opposed.<br />

MOTION: By Director Kleiter, seconded by Dr. Martin and carried<br />

to recommend approval of the amendment to the 2.5-year Clinical<br />

Director Agreement with Irinel Chiriac, MD, for the provision of<br />

Behavioral <strong>Health</strong> Services at PMC. All in favor. None opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

11. EMERGENCY ON-CALL & PSYCHIATRIC HOSPITALIST MANAGEMENT AGREEMENT – AMENDMENT & EXTENSION – EMERGENCY DEPARTMENTS, INPATIENT BEHAVIORAL HEALTH UNITS, SNFS<br />

& ACUTE CARE AREAS – PMC & POM<br />

• Psychiatric Centers at San Diego (PCSD)<br />

• The agreement was extended for 1 year and the<br />

rate of pay was amended<br />

12. EMERGENCY ON-CALL AGREEMENT – EXTENSION – OPHTHALMOLOGY – POM<br />

• Brian Le, MD<br />

• Three-year extension was approved by the Board<br />

in December, but the agreement was never signed as<br />

Dr. Le only wanted to extend the Agreement for 1 year<br />

MOTION: By Dr. Martin, seconded by Director Krider and carried<br />

to recommend approval of the pay rate change and the 1-year<br />

[1/1/10 to 12/31/10] Extension of the Emergency On-Call &<br />

Psychiatric Hospitalist Management Agreement with PCSD. All in<br />

favor. None opposed.<br />

MOTION: By Dr. Martin, seconded by Director Krider and carried<br />

to recommend approval of the 1-year [1/1/10 to 12/31/10]<br />

Extension of the Emergency On-Call Agreement with Brian Le,<br />

MD, for the provision of Ophthalmology Services at POM. All in<br />

favor. None opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

13. ADMINISTRATIVE SERVICES AGREEMENTS – PMC<br />

• John J. Lilley, MD – Chief of Staff [1/1/10-12/31/11] • Margaret Riley-Hagan, MD – Dept. Chair - Pediatrics [1/1/10-12/31/11]<br />

• Richard C. Engel, MD – Chief of Staff Elect [1/1/10-12/31/11] • Peter M. Lucas, MD – Dept. Chair – Anesthesia [1/1/10-12/31/10]<br />

• Daniel C. Harrison, MD – Dept. Chair – QMC [1/1/10-12/31/11] • Julie J. Chuan, MD – Dept. Chair – Family Medicine [1/1/10-12/31/11]<br />

• Thomas S. Velky, MD – Dept. Chair – Surgery [1/1/10-12/31/11] • Jaime B. Rivas, MD – Dept. Chair – Emergency Medicine [1/1/10-12/31/11]<br />

• Norman W. Pincock, MD – Dept. Chair – Medicine [1/1/10-12/31/11] • Gregory K. Nicpon, MD – Dept. Chair - Radiology [1/1/10-12/31/11]<br />

• Kevin L. Metros, MD – Dept. Chair – Orthopaedic Surgery/Rehab [1/1/10-12/31/11] • Lachlan Macleay, Jr., MD – Dept. Chair – Pathology [1/1/10-12/31/11]<br />

• Jerome L. Sinsky, MD – Dept. Chair – OB/GYN [1/1/10-12/31/10] • John T. Steele, MD – Dept. Chair - Trauma [1/1/10-12/31/11]<br />

• No discussion<br />

MOTION: By Dr. Martin, seconded by Director Kleiter and carried<br />

to recommend approval of the 2-year [1/1/10 to 12/31/11]<br />

Administrative Services Agreements with the Chief of Staff, Chief<br />

of Staff Elect and Department Chairs at PMC for the terms as<br />

listed above. All in favor. None opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

2010-01-26 Finance Minutes - Revised.doc 5 ADD A-6<br />

Y<br />

Y<br />

Y<br />

Y<br />

Y


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – REVISED <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

14. ADMINISTRATIVE SERVICES AGREEMENTS – POM<br />

• Roger J. Acheatel, MD – Department Chair – QMC • Nabil Fatayerji, MD – Department Chair - Pediatrics<br />

• Roger J. Acheatel, MD – Department Chair - MSPRC • Jaime B. Rivas, MD – Department Chair – Emergency Medicine<br />

• Sabiha Pasha, MD – Department Chair – Medicine • Lachlan Macleay, Jr., MD – Department Chair - Pathology<br />

• Albert Lin, DDS – Department Chair – Surgery • Kathleen Flores-Dahms, MD – Department Chair - Radiology<br />

• Gary Gonsalves, MD – Department Chair - Anesthesia<br />

• PPH has been providing partial support and<br />

Medical Staff has been providing the other portion<br />

o Will be making a recommendation regarding<br />

the hospital level of support at a later date<br />

15. SECOND QUARTERLY UPDATE – FY2010 INITIATIVES<br />

MOTION: By Dr. Martin, seconded by Ted Kleiter and carried to<br />

recommend approval of the 2-year [1/1/10 to 12/31/11]<br />

Administrative Services Agreements with the Department Chairs<br />

at POM as listed above. All in favor. None opposed.<br />

• Bob Hemker stated that only those Initiatives associated with the finance domain are reviewed<br />

with this Committee. All the Initiatives will be reviewed at the Board Strategic Planning Committee<br />

meeting. He then led discussions utilizing the presentation deck included in the agenda packet as<br />

Addendum G, joined by EMT Sponsors and/or Initiative Managers as appropriate<br />

• Review of the key portions of each slide<br />

o If an Initiative covers multiple topics, the bolded section is applicable to the current slide<br />

o The red circle is in line with where the Initiative stands YTD<br />

o If green diamonds denoting milestones are yellow or red, there is some risk in terms of<br />

time or dollars<br />

o Not all Initiatives have sub-initiative measures<br />

o The Report Date on these slides is listed as January 18, 2010, as that is the date they<br />

were reviewed by Management before presentation to this Committee<br />

• Initiative1.1(a) – CDI Initiative<br />

o On track – ties back to global outcome measure<br />

− OEBITDA at 10.9% YTD, which is right on target<br />

o Sub-initiative is measured against the $3M put into budget as additional net revenue<br />

− At just over $2M through 11/09<br />

− On track to meet budgetary expectations at sub-initiative level<br />

− Tom Boyle has been asked to conduct a validation audit of the sub-initiative outcomes<br />

• Initiative 1.1(b) – Chargemaster Build/Rebuild<br />

o There are 3 phases, with the aggregate goal of having 9 departments built by the end of<br />

the fiscal year<br />

− 3 are done, and the next phase of 3 are in progress<br />

− Sub-initiative is on target<br />

1) Clean claim rate is currently at 45% against a goal of 70%<br />

a) Should be in the 60% range by the next review<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

Information only Forwarded to the February 4, 2010,<br />

Board Strategic Planning Committee<br />

meeting for review.<br />

2010-01-26 Finance Minutes - Revised.doc 6 ADD A-7<br />

Y<br />

Y


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

b) Rate jumped up due to Medicare edits<br />

(i)<br />

Every October Medicare updates their edits, but does not communicate<br />

that information to providers until claims are rejected<br />

(ii) Providers then must research from October through present to discover<br />

the updates<br />

2) Implant gross revenue increase shows a 10% target<br />

a) Don’t yet have YTD figures<br />

• Initiative 1.1(c) – Resource Optimization for Clinical Supplies<br />

o<br />

o<br />

o<br />

o<br />

o<br />

Overall measure is total operating expenses<br />

−<br />

$11,128 is new actual for December YTD<br />

Sub-initiative level is right on budget<br />

Steve Ellis, Director of Supply Chain Services, has now been here for 4.5 months and was<br />

introduced by Dr. David Tam<br />

Utilizing the attached presentation (Attachment 2), Mr. Ellis made a report on progress<br />

made by the Supply Optimization Committee (SOC) YTD<br />

−<br />

−<br />

−<br />

PPH spent $70M on supplies last FY and is on track to spend $72M this FY<br />

Costs of transportation and pharmaceuticals are up<br />

Areas of focus listed are high-level – not all-inclusive<br />

Hope to be able to reap some benefits by the end of the FY<br />

• Initiative 1.1(d) – Resource Optimization for Labor Resources<br />

o<br />

o<br />

o<br />

o<br />

Kim Colonnelli presented information on this Initiative<br />

The 3 discharge subgroups are newly formed<br />

−<br />

−<br />

Groups are working to ensure that people aren’t working are working together, not<br />

against each other<br />

Reviewing topics such as<br />

1) A potential need for MRIs on the weekends, whether resources would be<br />

available for after hours/weekend scheduling, etc.<br />

2) Whether physicians are making rounds and discharging in a timely manner<br />

LOC has really pulled the premium dollar, with aggregate dollars actually running ahead<br />

Sub-initiative is the departmental salary level<br />

−<br />

−<br />

Over 200 departmental levels are managed<br />

Around 10-12% of those are running negative dollar variances<br />

1) Offset by positive variances somewhere else<br />

o At $5285/adj discharge vs. budget of $5216<br />

o<br />

Managing volatility of volume and premium pay issue<br />

• Initiatives 1.2(a)-(d) are strategies for growing revenue, tied to additional margin for the budget<br />

2010-01-26 Finance Minutes - Revised.doc 7 ADD A-8


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – REVISED <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

o<br />

o<br />

Four service lines with overall indicator of additional net contribution margin<br />

Performance is an estimate<br />

−<br />

−<br />

−<br />

Have worked to pull together a model to accurately assess the results of growth<br />

efforts<br />

After bills have gone and collections have been received, there is about a 6-month lag<br />

Will have results for first quarter at the end of January<br />

− Estimate is the last validated quarter to estimate going forward $1.4M or 3.4%<br />

• Initiative 1.2(a) – Cardiovascular<br />

o<br />

o<br />

CRM has been underway since the beginning of the year<br />

−<br />

Expect to soon have first feedback on downstream revenues resulting from those<br />

efforts<br />

Diagnostic cats have been established at POM<br />

• Initiative 1.2(b) – Orthopedics<br />

o<br />

o<br />

On target and moving forward<br />

Seeing opportunities with Kaiser based on their standardized practices<br />

−<br />

8.22% increase in volume at December<br />

• Initiative 1.2(c) – General Surgery<br />

o<br />

o<br />

Dr. Link’s joining of the medical staff provides opportunity<br />

Kaiser activity is consistent, with requests for additional OR time<br />

−<br />

1.64% decline in Inpatient/increase in Outpatient<br />

1) Due to a change in physicians<br />

• Initiative 1.2(d) – Neurosciences<br />

o<br />

Working with SCMG to help them bring a candidate on board<br />

• Initiative 1.2(e) – Rady’s discussions<br />

o<br />

o<br />

o<br />

Relicensing of pediatric and NICU beds under Rady license to create a “hospital within a<br />

hospital”<br />

Need a waiver from DPH to continue to use excess capacity for mother baby overflow<br />

−<br />

−<br />

−<br />

Latest approach is to retain 10 beds on that unit and only relicense the remainder of<br />

the beds<br />

Not yet approved, but has been done before, and Rady believes they can obtain that<br />

waiver<br />

Agreement is predicated on waiver<br />

HR has done an incredible job of working through personnel issues<br />

−<br />

Brenda still has to meet and confer with union<br />

2010-01-26 Finance Minutes - Revised.doc 8 ADD A-9


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – REVISED <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

o Had expected Agreement to be final in October 2009<br />

−<br />

Reason for yellow diamond<br />

• Initiative 1.2(f) – RehabCare<br />

o<br />

Just got the next steps for the process after a presentation to the Board<br />

• Initiative 1.2(g) – North County Radiology (NCR)<br />

o<br />

DONE<br />

• Initiative 2.2 – Not-For-Profit Physician Organization<br />

o<br />

o<br />

o<br />

o<br />

The Board approved the creation of the <strong>Palomar</strong> Physicians Network (PPN)<br />

−<br />

Vicky Lister, Acting Director of the PPN, was welcomed<br />

The entity will be seen later as an agenda item, with a request for fiscal support to get it<br />

started<br />

In final due diligence with CHC for the creation of the 501(c)3 entity<br />

−<br />

Have filed an application for 501(c)3 status<br />

April 1, 2010, is the target date<br />

−<br />

All indications are that it is on timeline<br />

• Initiative 5.2(c) – Capital Campaign<br />

o<br />

o<br />

o<br />

Terry Green reported that of the $7M threshold, the Foundation currently has $4.3M in<br />

signed commitments<br />

−<br />

61% of threshold<br />

Oral commitments are not counted until given in writing<br />

Milestones 6&7 are yellow<br />

−<br />

Portions are underway, but the staff charged with those programs has been on LOA<br />

16. PROGRAM REVIEW – PHYSICIAN RECRUITMENT<br />

• Taken out of agenda order as first item following closed session in deference to guest –<br />

realigned for purpose of the minutes<br />

• Utilizing the presentation attached as Addendum H, Lisa Hudson, Director of Business &<br />

Physician Development, presented a review of physician recruitment efforts<br />

• 3-year review, from FY07 to present<br />

o FY10<br />

o<br />

o<br />

−<br />

Have been a little more conservative in recruitment while finalizing with physicians<br />

recruited in FY09<br />

Actively looking for a neurosurgeon<br />

Of the 20 physicians recruited over the past 3 years only 2 are no longer here<br />

−<br />

Dr. Chan<br />

Information only Forwarded to the February 8, 2010,<br />

Board of Directors meeting as<br />

Information<br />

N<br />

2010-01-26 Finance Minutes - Revised.doc 9 ADD A-10


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – REVISED <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

o<br />

o<br />

−<br />

Dr. Franey<br />

Updates on projected area needs for the following specialties were presented (ADD H-5 to<br />

ADD H-7)<br />

−<br />

−<br />

−<br />

Primary care<br />

Internal medicine<br />

Vascular surgery<br />

There are several options for recruitment for PPN physicians, including alignment through<br />

PPN<br />

17. RESOLUTION NO. 02.10.01(01)-01 RE: DESIGNATION OF AUTHORIZED PERSONS (CORPORATE ENTITY ACCOUNTS) – MORGAN STANLEY TRUST, N.A.<br />

• Bob Hemker reported that the spreadsheet of bank accounts and signatory authority<br />

historically used by the District is sometimes not enough for specific bank entities<br />

o<br />

PPH is opening an escrow account with Morgan Stanley into which payments on the<br />

DPR contract will be deposited<br />

−<br />

Morgan Stanley requires that we at least incorporate their document in form<br />

o The presented Resolution utilizes the standard PPH Resolution format while<br />

incorporating the forms required by Morgan Stanley<br />

18. LINE OF CREDIT (LOC) TO PALOMAR PHYSICIAN NETWORK, INC. (PPN)<br />

• The presented LOC is the initial capitalization and funding of PPN<br />

o PPN is requesting to borrow funds from PPH for their initial efforts<br />

− LOC will be in the amount of $250K<br />

− Drawdown period allows us to go out 5 years to normalize, with a 5-year<br />

repayment term at the end of he drawdown cycle<br />

1) Effectively a 10-year instrument<br />

− Rate is 1year LIBOR + 2%<br />

1) Bob Hemker reviewed various indices to determine which market rate to<br />

use and reflect our internal invested funds’ earning power<br />

2) May not 100% mirror an arms length cost of risk as external lenders<br />

evaluate additional risk factors in establishing their lending rate<br />

o Management and Legal Department have reviewed the substance of the attached<br />

draft of the LOC<br />

− Draft document has also been reviewed and approved by the PPN Board<br />

− Similar structure to the LOCs with other related entities<br />

o Matter will be returned via this Committee when the PPN is ready to work through<br />

working capital needs and capitalization as it grows its additional business<br />

PPN’s first transaction is contemplated with Centre for <strong>Health</strong>care (CHC)<br />

MOTION: By Director<br />

Kleiter seconded by<br />

Director Krider and carried<br />

to recommend approval of<br />

the Resolution as<br />

presented. All in favor.<br />

None opposed.<br />

MOTION: By Director<br />

Kleiter seconded by<br />

Director Krider and carried<br />

to recommend approval of<br />

the Line of Credit with the<br />

PPN in the amount of<br />

$250K. All in favor. None<br />

opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

Y<br />

Y<br />

2010-01-26 Finance Minutes - Revised.doc 10 ADD A-11


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – REVISED <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

19. DECEMBER 2009 AND YTD FY2010 FINANCIAL REPORT<br />

• Utilizing the presentation included in the revised agenda packet as Addendum J, Bob<br />

Hemker presented the December 2009 and YTD FY2010 financial statements. Only select<br />

slides were presented for discussion (listed below with any additional comments):<br />

• Balanced Scorecard (ADD J-2)<br />

o OEBITDA is blue<br />

• Executive Summary of Key Indicators (ADD J-5)<br />

o Saw some interesting volume shifts in December<br />

MOTION: By Director<br />

Kleiter seconded by Dr.<br />

Martin and carried to<br />

recommend approval of the<br />

Financial Report for<br />

December 2009 and YTD<br />

FY2010 as presented. All<br />

in favor. None opposed.<br />

Forwarded to the February 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval.<br />

Y<br />

o<br />

Still holding revenue per adjusted discharge above budget<br />

o Productivity is down against budget by about 1.5%<br />

o<br />

OEBITDA is at 11.15% MTD<br />

o<br />

Positive supply variance<br />

−<br />

Pharmaceutical costs were trued up for the mid-year, resulting in a favorable<br />

adjustment<br />

• Key Variance Explanations (ADD J-12-15)<br />

o December was not good for investment income<br />

− Still showing a negative variance to budget YTD of $582K<br />

o YTD calendar year employee benefits showed a negative variance of $598K<br />

−<br />

Will start seeing improvement since the change to Cigna for group health<br />

expense<br />

−<br />

Pension is starting to normalize based upon budgeted vs. final negotiated<br />

contracts<br />

o Supplies are positive to budget $605K<br />

−<br />

Due in large part to pharmaceuticals<br />

• Balance Sheet (ADD J-16)<br />

o Still holding cash position<br />

− Days Cash on Hand are at 123<br />

• Income Statement MTD (ADD J-18)<br />

o Operating income is slightly favorable to budget, continuing a FY10 trend<br />

• Income Statement YTD (ADD J-19)<br />

o Bottom bottom line is $129K favorable variance to budget<br />

o<br />

$900K negative variance in professional fees is due to significant IT projects under<br />

development<br />

o<br />

Total uncompensated care budgeted at $45M<br />

2010-01-26 Finance Minutes - Revised.doc 11 ADD A-12


<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – REVISED <strong>MEETING</strong> MINUTES – TUESDAY, JANUARY 26, 2010<br />

1. AGENDA ITEM<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

o<br />

o<br />

− Actual is a favorable $171K, a good outcome considering current economic<br />

conditions<br />

Bad debt is $200K favorable to budget<br />

−<br />

We budgeted at the level we saw last year and haven’t seen an erosion in<br />

terms of payer mix<br />

Capitation is performing well for the 2009 Plan Year<br />

Goes back to restructuring of the stop loss provisions<br />

• Income Statement vs. Prior Year ( ADD J-20)<br />

o Up over $7M in net revenues<br />

o<br />

o<br />

o<br />

o<br />

−<br />

We’re not seeing the same catastrophic occurrences as last year<br />

− Run-off will occur over the next 3 months before final results will be known<br />

−<br />

Up 10% in gross revenues<br />

Up 3.9% in net patient revenues<br />

SWC up approximately 2.4%<br />

−<br />

Consistent with union and non-union increases<br />

Up $2.5M on operating income<br />

−<br />

−<br />

Consistent with investment market conditions<br />

Investment interest is down approximately $1.9M<br />

o OEBITDA is 10.9% (up from 10.37%) and right on target for FY10<br />

• Statistical Indicators<br />

o (ADD J-31) Review of mix on patient days<br />

o<br />

o<br />

o<br />

(ADD J-44) No significant changes for payer mix<br />

(ADD J-45) Slight decline in case mix index<br />

(ADD J-47) Medicare showed a notable increase in December CMI<br />

• Cash Collections (ADD J-54) are only $.8M below goal<br />

o Represents a lot of hard work on the part of the collections department, especially in<br />

current economic conditions<br />

• Investment Fund (ADD J-59) – Quarterly reporting as required<br />

FINAL ADJOURNMENT The meeting was adjourned a t 8:24 p.m.<br />

Motion to adjourn<br />

<strong>COMMITTEE</strong> CHAIR<br />

SIGNATURES:<br />

<strong>COMMITTEE</strong> SECRETARY<br />

Linda Greer, RN<br />

Tanya Howell<br />

2010-01-26 Finance Minutes - Revised.doc 12 ADD A-13


ADDENDUM B<br />

ADD B-1


MEMBERS<br />

<strong>MEETING</strong> DATES:<br />

1/26/10 2/23/10<br />

LINDA GREER, R.N. – CHAIR P P<br />

TED KLEITER P E<br />

BRUCE KRIDER, MA P P<br />

MICHAEL COVERT, FACHE P P<br />

FRANK MARTIN, M.D. P E<br />

JOHN LILLEY, M.D. E P<br />

MARCELO RIVERA, MD – ALTERNATE E<br />

NANCY BASSETT, R.N., MBA – 2 ND ALTERNATE P<br />

– 3 RD ALTERNATE<br />

– 4TH ALTERNATE<br />

STAFF ATTENDEES<br />

BOB HEMKER P P<br />

GERALD BRACHT P P<br />

DAVID TAM P<br />

TANYA HOWELL – SECRETARY P P<br />

INVITED GUESTS<br />

DRAFT<br />

2010-02-23 BoD Finance Minutes.doc 1<br />

B O A R D F I N A N C E C O M M I T T E E M E E T I N G<br />

A T T E N D A N C E R O S T E R & M E E T I N G M I N U T E S<br />

C A L E N D A R Y E A R 2 0 1 0<br />

SEE TEXT OF MINUTES FOR NAMES OF GUEST PRESENTERS<br />

ADD B-2


1. AGENDA ITEM<br />

<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – <strong>MEETING</strong> MINUTES – TUESDAY, FEBRUARY 23, 2010<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

CALL TO ORDER<br />

• The meeting–held in the First Floor Conference Room at 456 E. Grand Avenue, Escondido, CA – was called to order at 6:03 p.m. by Chair Linda Greer, RN<br />

ESTABLISHMENT OF QUORUM<br />

• See roster<br />

PUBLIC COMMENTS<br />

• There were no public comments<br />

INFORMATION ITEM(S)<br />

• Request to change date of April 2010 BoD Finance Meeting<br />

o<br />

o<br />

Email poll of Committee members placed Thursday, April 29, 2010, as the best<br />

option<br />

Meeting will be held at the same time and place (5:30 dinner/6:00 meeting, 1 st Floor<br />

Conference Room, 456 E. Grand Avenue, Escondido)<br />

• Updated program review schedule<br />

o Bob Hemker distributed an updated schedule (Attachment 1)<br />

o<br />

At the request of the sponsor, the Perinatology Program review was moved to April<br />

• Financial Performance Bonus Barometer<br />

o<br />

o<br />

o<br />

o<br />

Bob Hemker distributed the new tool (Attachment 2) that was created as a<br />

collaborative effort between HR, Finance and Marketing<br />

Goal was to have a simple metric to assist staff in remaining engaged, enabling<br />

them to see where the district stands regarding financial performance and potential<br />

for an incentive compensation payout for year end<br />

DRAFT<br />

If you achieve the goal on the left side, the amount of money on the right side is<br />

how much we will be able to pay<br />

Chair Greer inquired what staff needed to do make reaching the bonus fund goal a<br />

reality<br />

• We need to continue to be right on budget, then push for extra to fund the<br />

incentive payout fund<br />

<br />

This includes getting all the charges in, not being wasteful, etc. – basically<br />

being as efficient as we can in our daily tasks<br />

• Marketplace – bonds, interest rates, etc.<br />

o<br />

o<br />

Bob Hemker stated that the 2006 Auction Rate Securities (Revenue Bonds) are still<br />

showing favorable resets<br />

Based on these results and other market factors, there is still no reason for the<br />

district to exit that strategy and look for a fixed-rate alternative at this time<br />

2010-02-23 BoD Finance Minutes.doc 2<br />

Information only • Forwarded to the March 8, 2010,<br />

Board of Directors meeting as<br />

Information<br />

Y<br />

ADD B-3


1. AGENDA ITEM<br />

<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – <strong>MEETING</strong> MINUTES – TUESDAY, FEBRUARY 23, 2010<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

1. MINUTES – JANUARY 26, 2010<br />

• No discussion MOTION: By Dr. Lilley, seconded by Director Krider and carried to approve the minutes of the<br />

January 26, 2010, Board Finance Committee meeting as presented. All in favor. None opposed.<br />

2. PHYSICIAN INDEPENDENT CONTRACTOR AGREEMENTS – EHR PROJECTS – INFORMATION SYSTEMS SERVICES<br />

• Jay Federhart, MD [2/1/10-1/31/11] • Sudabeh Moein, MD [11/1/09-10/31/10]<br />

• Mikhail Malek, MD [2/1/10-1/31/11] • Rod Serry, MD [2/1/10-1/31/11]<br />

• Elizabeth Rafii, MD [2/1/10-1/31/11]<br />

• No discussion<br />

3. JANUARY 2010 AND YTD FY2010 FINANCIAL REPORT<br />

MOTION: By Director Bassett, seconded by Director Krider<br />

and carried to recommend approval of the 1-year Physician<br />

Independent Contractor Agreements for EHR Projects with all<br />

physicians/groups for terms as listed. All in favor. None<br />

opposed.<br />

• Utilizing the presentation included in the revised agenda packet as Addendum B, Bob<br />

Hemker presented the January 2010 and YTD FY2010 financial statements. Only select<br />

slides were presented for discussion (listed below with any additional comments):<br />

• BSC (ADD B-3)<br />

o Collective OEBITDA is at 10.9%<br />

o<br />

o<br />

− YTD Budget is 10.8%<br />

−<br />

Above 100%, so blue indicator<br />

Raw dollars are ahead of budget<br />

Productivity is just under budget<br />

−<br />

Premium pay continues to show constant improvement<br />

• Executive Summary (ADD B-4)<br />

o<br />

YTD<br />

DRAFT<br />

− Adjusted Discharges – negative variance of 1.5%<br />

1) Strong outpatient business is offsetting the negative inpatient activity<br />

− Acute Admissions – negative variance of 6.5%<br />

− Total surgeries – negative variance of 6.4%<br />

1) Due in large part to Inpatient Surgeries – negative variance of 460<br />

− ER Admissions were down by 298<br />

− Acute Patient Days – negative variance of 5.4%<br />

− Births – negative variance of 7.2%<br />

− ER Visits & Admissions – positive variance of 8.7%<br />

− ER to Admission Conversion Rate – negative variance of 2%<br />

2010-02-23 BoD Finance Minutes.doc 3<br />

MOTION: By<br />

Director Krider<br />

seconded by<br />

Director Bassett<br />

and carried to<br />

recommend<br />

approval of the<br />

Financial Report<br />

for January 2010<br />

and YTD FY2010<br />

as presented. All<br />

in favor. None<br />

opposed.<br />

Forwarded to the March 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval<br />

Forwarded to the March 8, 2010,<br />

Board of Directors meeting with a<br />

recommendation for approval<br />

Y<br />

Y<br />

Y<br />

ADD B-4


1. AGENDA ITEM<br />

<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – <strong>MEETING</strong> MINUTES – TUESDAY, FEBRUARY 23, 2010<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

1) Roughly 1100 admissions below what we would expect for the amount of ER<br />

volume<br />

2) Doing really well with documentation initiative, which has an effect on<br />

conversation rate<br />

− Net Patient Revenue – slight negative variance of .29%<br />

− Total Net Revenue – negative variance of $900K<br />

−<br />

1) $700K of that delta is the January book of business<br />

Net Income is still about a quarter million dollars up<br />

− Bottom bottom line – positive by $568K<br />

−<br />

Cash on Hand is up to 117 days<br />

• MTD Variance Explanations (ADD B-8)<br />

o Investment Income – positive variance of $299K<br />

• YTD Variance Explanations (ADD B-9)<br />

o Salaries & Wages – negative variance of $730K<br />

o Contract Labor – positive variance of $970K<br />

o<br />

− Net delta is a positive variance of $240K<br />

Benefits<br />

−<br />

Group <strong>Health</strong>, FICA and pension will start normalizing though the remainder of<br />

the year<br />

1) Employer contribution to FICA increases at the beginning of a calendar year,<br />

and new plan rates for health coverage in January contributed to the<br />

negative variance of $1.18M<br />

• Balance Sheet (ADD B-12)<br />

o<br />

DRAFT<br />

Total of Cash with Board Designated Cash is up about $17M compared to prior year<br />

o Projects have grown by about $100M<br />

o Liabilities have dropped by about $15M<br />

o Year on year Total Fund Balance is $351M vs. $329M<br />

• MTD Income Statement (ADD B-13)<br />

o<br />

About half of the delta is made up in terms of volume and rate efficiencies<br />

o Negative Net Income volume variance of $19K<br />

− Opportunity column becomes rate efficiency, with a positive variance of $460K<br />

• YTD Income Statement (ADD B-14)<br />

o Net Income – positive variance of $279K<br />

−<br />

Driving about $400K of profitability based on how we’re managing the business<br />

2010-02-23 BoD Finance Minutes.doc 4<br />

ADD B-5


1. AGENDA ITEM<br />

<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – <strong>MEETING</strong> MINUTES – TUESDAY, FEBRUARY 23, 2010<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

−<br />

$364 per Adjusted Discharge is more than making up the delta<br />

o Non-Operating Income – positive variance of $290K<br />

− Investment Income – negative variance of $284K<br />

• Income Statement vs. Prior YTD (ADD B-15)<br />

o We are now at the 7-month mark, with figures setting the stage for the FY2011<br />

budget cycle<br />

o<br />

o<br />

Adjusted Discharges<br />

−<br />

−<br />

Effectively 2 years that are similar<br />

Net Revenue has grown by $8.5M<br />

1) Raised rates 8%, but Gross Revenues are up 9.3%<br />

2) Net Revenue realization can be seen on units of measure, which are up<br />

about 3.6%<br />

3) Growing through Managed Care contracts and the efficiency of contractual<br />

realizations<br />

(a) Stronger in ambulatory contracts<br />

Salaries, Wages & Contract Labor – up about 2.7% year on year<br />

−<br />

Consistent with union negotiations and non-union labor adjustments<br />

o Total Expenses are up about 2.2%<br />

o Translates to a stronger Net Income Margin, which is up 9%<br />

o OEBITDA is up to 10.9% from 10.3%<br />

o<br />

Investment Income<br />

−<br />

−<br />

−<br />

Last year was $3.3M<br />

Budgeted $2.2M this year and sitting at $1.9M<br />

DRAFT<br />

Up another $17M in cash to invest<br />

• Income Statement – FY Projection (ADD B-16)<br />

o<br />

o<br />

o<br />

7 months of actual with 5 months of budgeted<br />

Project about $13.8M in Operating Income<br />

Bottom-bottom line of about $26.4M<br />

−<br />

Need around $28M to achieve 100% funding of performance bonus<br />

4. PROGRAM REVIEW –VHA PURCHASING COALITION<br />

• Bob Hemker provided historical background<br />

o<br />

In 2006, the District made a decision to convert from Premier to VHA<br />

− Premised on many factors<br />

1) Better pricing – access to contracts available at national, regional and local<br />

levels<br />

2010-02-23 BoD Finance Minutes.doc 5<br />

Information only Forwarded to the March 8, 2010,<br />

Board of Directors meeting as<br />

Information<br />

Y<br />

ADD B-6


1. AGENDA ITEM<br />

<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – <strong>MEETING</strong> MINUTES – TUESDAY, FEBRUARY 23, 2010<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

2) Ability to integrate into and become involved in their networking structure<br />

a) PPH is a member owner, with CEO Michael Covert sitting on their Board<br />

b) CFO Bob Hemker (leadership role)—along with CAO’s David Tam and<br />

Gerald Bracht—sits on the CFO/COO Forum<br />

c) CHRO Brenda Turner is involved in a leadership role in their HR Forum<br />

• Mr. Hemker then introduced Steve Ellis, Director of Corporate Supply Chain Services<br />

o<br />

Utilizing the attached presentation (Attachment 3), Mr. Ellis provided an analysis of<br />

the benefits derived since the move to VHA<br />

−<br />

Information is based on calendar year, not fiscal year<br />

− Savings since 2006 total over $5M<br />

o PPH joined WestPac in January 2009<br />

−<br />

−<br />

−<br />

−<br />

Southern California collaborative formed last year<br />

1) Will aggregate purchasing power for local pricing to become better than<br />

that available nationally<br />

PPH is still part of VHA, but Westpac allows for regional purchasing<br />

opportunities<br />

Comprised of 11 healthcare systems<br />

We now have access to the purchasing power of the larger systems by co-oping<br />

with them<br />

5. PROGRAM REVIEW – SAN DIEGO RADIOSURGERY LLC & STEREOTACTIC RADIOSURGERY<br />

• Utilizing the attached presentation (Attachment 4) Gerald Bracht and Bob Hemker<br />

provided an update on the first full the first full calendar year of operations for the District’s<br />

joint venture in Stereotactic Radiosurgery (SRS) with U. S. Radiosurgery (formerly known as<br />

NeoSpine, LLC), under the name San Diego Radiosurgery, LLC (SDRS)<br />

DRAFT<br />

• Mr. Bracht indicated that Sheila Brown and a member of the SDRS board might join<br />

them for future program review updates<br />

• Mr. Bracht then provided background on how the transaction was structured, with<br />

operations beginning in late 2008<br />

o<br />

PPH was the first provider in San Diego County to obtain the Stereotactic upgrade<br />

to Varian Trilogy, which provided both SRS and soft tissue capabilities<br />

−<br />

Ramp up was slow by design in order to wait for and take advantage of the<br />

newer technology, which provided the ability to tap into the radiation therapy<br />

side with a small capital outlay<br />

o SDRS Services – (ATT 4-2)<br />

−<br />

PPH leases back the equipment 6 hours a day for traditional radiation therapy<br />

2010-02-23 BoD Finance Minutes.doc 6<br />

Information only Forwarded to the March 8, 2010,<br />

Board of Directors meeting as<br />

Information<br />

Y<br />

ADD B-7


1. AGENDA ITEM<br />

<strong>BOARD</strong> <strong>FINANCE</strong> <strong>COMMITTEE</strong> – <strong>MEETING</strong> MINUTES – TUESDAY, FEBRUARY 23, 2010<br />

• DISCUSSION CONCLUSION/ACTION FOLLOW UP/RESPONSIBLE PARTY FINAL<br />

o<br />

o<br />

o<br />

−<br />

SDRS utilizes the equipment for 6 hours a day to perform SRS procedures<br />

Marketing was implemented exactly as that done previously for the Denver market<br />

−<br />

399 contacts translated into 32 cases<br />

− There were many reasons for the conversion percentage (ATT 4-7)<br />

1) A large percentage was related to the San Diego County market, which has<br />

a much larger proportion of HMOs than that to which provider was<br />

accustomed<br />

Although not up to expectations, the venture did turn a small profit in CY2009<br />

Marketing strategies have been revised to fit the San Diego market, and a more<br />

realistic budget was created for CY2010<br />

−<br />

On target to meet or exceed budget for first two months<br />

FINAL ADJOURNMENT The meeting was adjourned at 7:25 p.m. MOTION: By Director Krider, seconded by Director<br />

Bassett and carried to adjourn<br />

SIGNATURES:<br />

<strong>COMMITTEE</strong> CHAIR<br />

<strong>COMMITTEE</strong> SECRETARY<br />

Linda Greer, RN<br />

Tanya Howell<br />

DRAFT<br />

2010-02-23 BoD Finance Minutes.doc 7<br />

ADD B-8


ATTACHMENT 1<br />

ATT 1-1 ADD B-9


FY2010/2011 Program Review Schedule<br />

DATE DUE PROGRAM FOLLOW-UP AT <strong>BOARD</strong> <strong>FINANCE</strong><br />

SPONSOR(S)<br />

1 December 2009 SNF Beds to Sub-Acute 1 Steve Gold<br />

2 January 2010<br />

3 February 2010 San Diego Radiosurgery, LLC & Stereotactic Radiosurgery (SRS)<br />

4<br />

February 2010<br />

5 April 2010 Da Vinci<br />

Physician Recruitment<br />

VHA Purchasing Coalition<br />

6 April 2010 2 Perinatology Program<br />

7 June 2010 <strong>Palomar</strong> Pomerado Imaging, LLC<br />

Gerald Bracht &<br />

Bruce Grendell<br />

Sheila Brown &<br />

Lorie Shoemaker<br />

Gerald Bracht,<br />

Sheila Brown &<br />

Bob Hemker<br />

8 August 2010 Wound Care Sheila Brown<br />

9 TBD NICU Expansion Gerald Bracht<br />

10 TBD PPH Retail Group, LLC Sheila Brown<br />

11 TBD Residency Programs (e.g., Family Practice, ED, etc.)<br />

Gerald Bracht &<br />

Lisa Hudson<br />

Gerald Bracht &<br />

Bob Hemker<br />

David Tam &<br />

Steve Ellis<br />

Gerald Bracht &<br />

David Tam<br />

1<br />

Reviews have been completed on those topics in green font ATT 1-2 ADD B-10<br />

2 Topics in red font have been rescheduled from original review date(s)


ATTACHMENT 2<br />

ATT 2-1 ADD B-11


ATT 2-2 ADD B-12


ATTACHMENT 3<br />

ATT 3-1 ADD B-13


VHA Purchasing Coalition<br />

Report to the Board of Directors<br />

February 2010<br />

David Tam, MD<br />

Chief Administrative Officer<br />

&<br />

Steve Ellis, MBA, CMRP<br />

Director, Corporate Supply Chain Services<br />

ATT 3-2 ADD B-14


Background<br />

• PPH Joined VHA in 2006 for administrative<br />

support and access to contracts available within<br />

the group purchasing organizations portfolio<br />

• Additionally, In January 2009, PPH joined the<br />

VHA Southern California Purchasing Coalition<br />

(WestPac)<br />

– 10 <strong>Health</strong>care Systems (Cedars Sinai, Presbyterian,<br />

Cottage, Pomona, Methodist, others)<br />

– Purpose: Leverage pricing through volume<br />

aggregation<br />

ATT 3-3 ADD B-15


VHA Services / Benefits<br />

• Capital Equipment Group Buys<br />

• Supplier & Distribution Contracts<br />

(Food, Medical/Surgical, Laboratory,<br />

Pharmacy, Laundry/Linen, Office &<br />

Administrative, & More)<br />

• Advisory & Consulting Services<br />

• Benchmarking<br />

• Spend Analysis & Solutions<br />

• Education Programs<br />

ATT 3-4 ADD B-16<br />

3


PPH Participation<br />

PPH Participates (Utilizes) 461 Contracts within the<br />

categories listed below:<br />

Anesthesia<br />

Capital Equipment<br />

Cardiology<br />

Diagnostic Imaging<br />

Facilities Mgmt.<br />

Food & Nutrition<br />

I.V. Therapy Systems<br />

Laboratory<br />

Medical Products<br />

Oncology<br />

Orthopedic<br />

Pharmacy<br />

Plasma/Blood<br />

Respiratory<br />

Surgical<br />

Womens/Infants/Children<br />

ATT 3-5 ADD B-17


Spend & Savings<br />

2006 2007 2008<br />

2009 (Q1-<br />

Q3) Total<br />

Contract<br />

Purchases $27,983,706 $37,995,968 $ 39,796,240 $34,778,881 $140,554,795<br />

Standardization<br />

Rebates $27,445 $97,159 $132,097 $121,302 $378,003<br />

Additional<br />

Manufacturer<br />

Rebates $78,615 $75,429 $85,250 $61,681 $300,975<br />

Savings $308,433 $113,520 $2,121,016 $2,536,079 $5,079,048<br />

ATT 3-6 ADD B-18


ATTACHMENT 4<br />

ATT 4-1 ADD B-19


San Diego Radiosurgery, LLC<br />

Board Finance Committee<br />

Program Update<br />

Gerald Bracht - CAO<br />

Bob Hemker - CFO<br />

ATT 4-2 ADD B-20


SDRS Background<br />

• Linear accelerator replacement approved in FY07<br />

• Operating agreement entered into on April 10, 2008<br />

• Ownership distribution: 51% NeoSpine LLC; 49% PPH<br />

• Structure:<br />

– Operating Agreement<br />

– Services Agreement<br />

• Provisions for Stereotactic Radiosurgery services<br />

– Block Lease Agreement<br />

• Lease of space occupied by SDRS<br />

• PPH use of space for Radiation Therapy<br />

– Contribution Agreement<br />

• Site improvements by PPH for Novalis TX equipment<br />

• Radiation Therapy operational May 2008<br />

• Stereotactic upgrade October 2008, operational November 2008<br />

ATT 4-3 ADD B-21<br />

2


SDRS Services<br />

• PPH Radiation Therapy<br />

– M-F 6 hours/day access<br />

– Treatment of soft tissue tumors<br />

– Enhanced IMRT capability<br />

• Stereotactic Radiosurgery<br />

– M-F 6 hours/day access<br />

– Brain tumors<br />

– Neurosurgeon directed<br />

ATT 4-4 ADD B-22<br />

3


PPH Benefits<br />

• State-of-the-Art service locally<br />

• Ancillary services activity:<br />

– MRI, CT, PET<br />

– Surgical placement of fiducial markers<br />

– Surgical tumor debulking<br />

• Benefits neurosurgical physicians<br />

• Enhanced marketing campaign<br />

• Spin-off radiation therapy activity<br />

ATT 4-5 ADD B-23<br />

4


SDRS, LLC Performance<br />

Activity<br />

CY08 CY09<br />

Budget 0 94<br />

Actual 7 32<br />

Variance 7 <br />

ATT 4-6 ADD B-24<br />

5


SDRS, LLC Performance<br />

Financial<br />

CY08<br />

CY09<br />

Net Income (Bud) $52,044 $457,640<br />

Net Income (Act) <br />

EBIDTA $410,006 $1,262,278<br />

Distributions 0 $200,000 *<br />

* Distribution in June 2009, NeoSpine, LLC $110,000; PPH $90,000<br />

ATT 4-7 ADD B-25<br />

6


SDRS Marketing<br />

Contacts by category:<br />

TV 302<br />

Radio 33<br />

Website 42<br />

Print 9<br />

MD* 8<br />

Total 399<br />

*through SDRS phone line<br />

ATT 4-8 ADD B-26<br />

7


SDRS<br />

Contact Conversions/Treatments<br />

• Conversions out of 399 contacts:<br />

– 24 consults<br />

– 3 Stereotactic patients (out of 32 total)<br />

– 3 Conventional Radiation Therapy/IMRT patients<br />

• Reasons for lack of conversions call to consult and treatment<br />

– Callers have out of network insurance<br />

• Example 58 patients that gave insurance information were Kaiser patients<br />

– Callers were not candidates for either modality<br />

• Example no cancer, widespread disease, not a condition that is treated with Radiation<br />

of any type<br />

– Callers were under treatment elsewhere already<br />

– Patients without certain tests completed were turned away until they had results<br />

– Lack of physician confidence in the physicist prevented the patients being treated<br />

ATT 4-9 ADD B-27<br />

8


SDRS CY10 Budget<br />

CY10<br />

Activity 60<br />

Net Income $107,749<br />

• January actual 5<br />

• February actual 7<br />

ATT 4-10 ADD B-28<br />

9


SDRS CY10<br />

Marketing Strategy<br />

• Coordinated SDRS and PPH activities<br />

• Direct to Physician visits<br />

– PCP’s, IM, Oncologists, Neurosurgeons, Urologists,<br />

Pulmonologist, Endocrinologists, Nephrologists, Neurologists,<br />

– Involving Radiation Oncologist<br />

– Involving Physicist<br />

• Community presentations<br />

• Gain access to all area contracts<br />

• Continued targeted TV campaign<br />

• CPM “Innovations” direct mail campaign<br />

• Print advertising<br />

10<br />

ATT 4-11 ADD B-29


San Diego Radiosurgery, LLC<br />

Questions<br />

11<br />

ATT 4-12 ADD B-30


ADDENDUM C<br />

ADD C-1


MEDICAL DIRECTORSHIP AGREEMENT<br />

by and between<br />

PALOMAR POMERADO HEALTH (“Hospital”)<br />

and<br />

Deleted: [for use with individual<br />

physician]<br />

Deleted: SYSTEM, doing business as<br />

_____________________<br />

_____________________, [M.D./D.O.] (“Practitioner”)<br />

Deleted: 12-27-07<br />

Formatted: Check spelling and<br />

grammar<br />

ADD C-2


MEDICAL DIRECTORSHIP AGREEMENT<br />

THIS MEDICAL DIRECTORSHIP AGREEMENT (this “Agreement”) is entered into<br />

as of ___________________, 20__, by and between <strong>Palomar</strong> Pomerado <strong>Health</strong>, a local health<br />

care district organized under Division 23 of the California <strong>Health</strong> and Safety Code and<br />

(“Hospital”), and __________________________, [M.D./D.O.], an individual<br />

(“Practitioner”). Hospital and Practitioner are sometimes referred to in this Agreement<br />

individually as a “Party” or, collectively, as the “Parties.”<br />

Deleted: System<br />

Deleted: doing business as<br />

_____________________<br />

RECITALS<br />

A. Hospital owns and operates an acute care hospital facility located at<br />

_______________________, California, in which it operates a _____________ [department (the<br />

“Department”)/program (the “Program”)] under its acute care license.<br />

Deleted: in<br />

B. Practitioner is licensed to practice medicine in the State of California, board<br />

[certified/eligible/admissible/qualified] for the practice of medicine in the specialty of<br />

_______________________ (the “Specialty”) and a member in good standing of Hospital’s<br />

medical staff (the “Medical Staff”).<br />

C. Hospital desires to engage Practitioner as an independent contractor to provide<br />

medical and administrative oversight with respect to the [Department/Program], and believes that<br />

__________________________ can be achieved if Practitioner assumes such responsibility as<br />

set forth in this Agreement.<br />

D. Practitioner has the following qualifications and expertise to provide the services<br />

described in this Agreement: ____________________________.<br />

E. Hospital has considered the following factors in determining the necessity and<br />

amount of compensation payable to Practitioner pursuant to this Agreement:<br />

1. [The nature of Practitioner’s duties as contemplated by this Agreement.]<br />

2. [Practitioner’s qualifications.]<br />

3. [The difficulty in obtaining a qualified physician to provide the services<br />

described in this Agreement.]<br />

4. [The benefits to Hospital and Hospital’s community resulting from<br />

Practitioner’s performance of the services described in this Agreement.]<br />

5. [The economic conditions locally and in the health care industry<br />

generally.]<br />

6. [Surveys of practitioner compensation prepared by _____________.]<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 1<br />

ADD C-3


THE PARTIES AGREE AS FOLLOWS:<br />

AGREEMENT<br />

ARTICLE I.<br />

PRACTITIONER’S OBLIGATIONS<br />

1.1 Director Services. Practitioner shall provide to Hospital those medical director<br />

services set forth on Exhibit 1.1 (“Director Services”), upon the terms and subject to the<br />

conditions set forth in this Agreement. Practitioner shall ensure that all Director Services are<br />

performed when and as needed, but shall also perform any Director Services when and as<br />

requested by Hospital from time to time.<br />

Deleted: and Exhibit 1.1 (a)<br />

1.2 Time Commitment. Practitioner shall devote whatever time is necessary to<br />

ensure the operation of a high-quality [Department/Program]; provided, however, that<br />

Practitioner shall perform Director Services a minimum of ____________ (_____) hours [and a<br />

maximum of __________ (_____) hours] per [week/month]. Practitioner shall allocate time to<br />

Director Services as reasonably requested by Hospital from time to time.<br />

1.3 Availability. On or before the first (1st) day of each month, Practitioner shall<br />

inform Hospital of Practitioner’s schedule and availability to perform Director Services during<br />

that month. Practitioner shall use his or her best efforts to adjust such schedule of availability if<br />

reasonably requested by Hospital in order to meet Hospital’s needs for Director Services.<br />

1.4 Personal Services; Absences. This Agreement is entered into by Hospital in<br />

reliance on the professional and administrative skills of Practitioner. Except as otherwise<br />

provided in this Agreement, Practitioner shall be solely responsible for performing Director<br />

Services and otherwise fulfilling the terms of this Agreement; provided, however, that if<br />

Practitioner is temporarily unable to provide Director Services due to illness, disability,<br />

continuing education responsibilities, or vacation, Practitioner shall designate a qualified<br />

replacement to provide Director Services pursuant to this Agreement. Such temporary<br />

replacement must be approved in writing by Hospital prior to the replacement providing Director<br />

Services. Practitioner shall ensure that any such designated replacement meets any and all<br />

qualifications, obligations and requirements of Practitioner under this Agreement. Practitioner<br />

shall be solely responsible for compensating and making any tax filings or withholdings with<br />

respect to any designated replacement providing Director Services on Practitioner’s behalf. If<br />

the length of Practitioner’s absence is anticipated by Hospital to be or actually is longer than<br />

sixty (60) calendar days, the person who provides Director Services in Practitioner’s absence<br />

shall execute a written document in form and substance acceptable to Hospital agreeing to be<br />

bound by this Agreement. Except in the event of absence due to illness or disability, Hospital<br />

shall have the right to approve the length of Practitioner’s absence, and any unapproved absence<br />

shall constitute a breach of this Agreement. Nothing in this Section shall be deemed to limit in<br />

any way Hospital’s right to terminate this Agreement in accordance with Section 5.2.<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 2<br />

ADD C-4


1.5 Time Reports. Practitioner shall maintain monthly time reports that provide a<br />

true and accurate accounting of the time spent each day by Practitioner in providing Director<br />

Services. Such reports shall be substantially in the form attached as Exhibit 1.5. Practitioner<br />

shall submit all time reports to Hospital no later than the tenth (10th) day of each month for<br />

Director Services provided by Practitioner during the immediately preceding month.<br />

1.6 Medical Staff. Practitioner shall be a member in good standing and in the “active<br />

staff” category or other applicable category, as defined in the Medical Staff Bylaws, of<br />

Hospital’s Medical Staff (the “Medical Staff”) and hold all clinical privileges at Hospital<br />

necessary for the performance of Practitioner’s obligations under this Agreement. If, as of the<br />

Effective Date (as defined in Section 5.1), Practitioner is not in the “active staff” category or<br />

other applicable category of the Medical Staff, Practitioner shall have a reasonable amount of<br />

time, which in no event shall exceed thirty (30) days, unless otherwise agreed to by the Parties,<br />

from the Effective Date, to obtain such applicable category; provided that Hospital may<br />

immediately terminate this Agreement if Hospital determines that Practitioner is not diligently<br />

pursuing such category in accordance with the normal procedures set forth in the Medical Staff<br />

Bylaws. Practitioner may obtain and maintain medical staff privileges at any other hospital or<br />

health care facility.<br />

1.7 Professional Qualifications. Practitioner shall be duly licensed and qualified to<br />

practice medicine in the State of California. Practitioner shall be board<br />

[certified/eligible/admissible/qualified] in the Specialty.<br />

Deleted: a member in good standing<br />

Deleted: or does not hold all clinical<br />

privileges at Hospital necessary for the<br />

performance of Practitioner’s obligations<br />

hereunder<br />

Deleted: ___________<br />

Deleted: (____)<br />

Deleted: membership<br />

Deleted: and/or clinical privileges<br />

Deleted: membership and/or clinical<br />

privileges<br />

1.8 Continuing Medical Education. Practitioner shall participate in continuing<br />

medical education as necessary to maintain licensure, professional competence and skills<br />

commensurate with the standards of the medical community, as otherwise required by the<br />

medical profession and as required to effectively perform Practitioner’s obligations under this<br />

Agreement.<br />

1.9 Performance Standards. Practitioner shall comply with and perform the duties<br />

under this Agreement in accordance with all bylaws, Medical Staff policies, rules and regulations<br />

of Hospital and the Medical Staff, and all protocols applicable to the performance of Director<br />

Services or the [Department/Program] (the “Protocols”).<br />

1.10 Conduct. With respect to Practitioner’s business dealings with Hospital and<br />

Practitioner’s performance of duties under this Agreement, Practitioner shall not act, or fail to<br />

act, in any manner which conflicts with or violates the Medical Staff Bylaws, including but not<br />

limited to, the Disruptive Conduct Policy. Practitioner shall not cause another person to act, or<br />

fail to act, in any manner which conflicts with or violates the Bylaws. Practitioner shall comply<br />

with the Bylaws as they relate to Practitioner’s business relationship with Hospital or any<br />

<strong>Palomar</strong> Pomerado <strong>Health</strong> affiliates, subsidiaries, employees, agents, servants, officers, directors,<br />

contractors and suppliers of every kind.<br />

1.11 Use of Space. Practitioner shall not use any part of the space that Hospital<br />

designates for the [Department/Program] as an office for the private practice of medicine, except<br />

in an emergency or with Hospital’s prior written consent.<br />

Deleted: Code of<br />

Deleted: Practitioner hereby<br />

acknowledges receipt of Hospital’s Code<br />

of Conduct, attached to this Agreement as<br />

Exhibit 1.10 (the “Code”).<br />

Deleted: Code, and shall<br />

Deleted: Code.<br />

Deleted: Code as it relates<br />

Deleted: System<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 3<br />

ADD C-5


1.12 Notification of Certain Events. Practitioner shall notify Hospital in writing<br />

within twenty-four (24) hours after Practitioner becomes aware of the occurrence of any one or<br />

more of the following events:<br />

(a) Practitioner becomes the subject of, or otherwise materially involved in,<br />

any government investigation of Practitioner’s business practices or the provision of professional<br />

services, including being served with a search warrant in connection with such activities;<br />

(b) Practitioner’s medical staff membership or clinical privileges at any<br />

hospital are denied, suspended, restricted, revoked or voluntarily relinquished, regardless of the<br />

availability of civil or administrative hearing rights or judicial review with respect thereto;<br />

(c) Practitioner becomes the subject of any suit, action or other legal<br />

proceeding arising out of Practitioner’s professional services;<br />

(d) Practitioner is required to pay damages or any other amount in any<br />

malpractice action by way of judgment or settlement;<br />

(e) Practitioner becomes the subject of any disciplinary proceeding or action<br />

before any state’s medical board or similar agency responsible for professional standards or<br />

behavior;<br />

(f) Practitioner becomes incapacitated or disabled from performing Director<br />

Services, or voluntarily or involuntarily retires from the practice of medicine;<br />

(g) Practitioner’s license to practice medicine in the State of California is<br />

restricted, suspended or terminated, regardless of the availability of civil or administrative<br />

hearing rights or judicial review with respect thereto;<br />

(h)<br />

Practitioner is charged with or convicted of a criminal offense;<br />

(i) any act of nature or any other event occurs which has a material adverse<br />

effect on Practitioner’s ability to provide Director Services;<br />

(j) Practitioner is debarred, suspended, excluded or otherwise ineligible to<br />

participate in any federal or state health care program;<br />

(k) any termination, non-renewal, cancellation or reduction in coverage of any<br />

insurance policy required to be maintained by Practitioner under this Agreement; or<br />

Agreement.<br />

(l)<br />

Practitioner fails or is otherwise unable to comply with any term of this<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 4<br />

ADD C-6


ARTICLE II.<br />

COMPENSATION<br />

2.1 Compensation. In exchange for Practitioner’s provision of Director Services,<br />

Hospital shall compensate Practitioner in accordance with the terms of Exhibit 2.1. Practitioner<br />

shall not be paid until he/she has complied with Section 1.5 (Time Reports).<br />

2.2 IRS Form W-9. Upon execution of this Agreement, Practitioner shall furnish a<br />

completed and executed copy of IRS Form W-9 which identifies Practitioner’s taxpayer<br />

identification number.<br />

ARTICLE III.<br />

INSURANCE AND INDEMNITY<br />

3.1 Malpractice Liability Insurance. Practitioner shall obtain and continuously<br />

maintain professional malpractice liability insurance coverage, issued by an insurance company<br />

licensed or otherwise qualified to issue professional liability insurance policies or coverage in the<br />

State of California, and acceptable to Hospital, in the amount of at least One Million Dollars<br />

($1,000,000) per occurrence or claim and Three Million Dollars ($3,000,000) in the annual<br />

aggregate for the acts and omissions of Practitioner. Such coverage shall provide for a date of<br />

placement preceding or coinciding with the Effective Date of this Agreement.<br />

3.2 Certificate of Insurance. On or before the Effective Date, Practitioner shall<br />

provide Hospital with an original certificate evidencing professional malpractice liability<br />

insurance coverage, and shall provide Hospital with proof of continued professional malpractice<br />

liability insurance coverage on an annual basis or as periodically requested by Hospital. Hospital<br />

shall be listed an additional endorsed insured on Certificate of Insurance. Practitioner shall<br />

provide Hospital with no less than thirty (30) calendar days’ prior written notice of cancellation<br />

or any material change in such professional malpractice liability insurance coverage.<br />

3.3 Tail Coverage. If Practitioner’s professional malpractice liability insurance is<br />

provided on a claims-made basis, upon the expiration or termination of this Agreement for any<br />

reason, Practitioner shall continuously maintain such insurance or purchase from an insurance<br />

company licensed or otherwise qualified to issue professional liability insurance policies or<br />

coverage in the State of California, and acceptable to Hospital, extended reporting period (i.e.,<br />

“tail”) coverage for the longest extended reporting period then available to ensure that insurance<br />

coverage in the amount set forth in Section 3.1 of this Agreement is maintained for claims which<br />

arise from professional services provided by Practitioner during the term of this Agreement.<br />

This Section shall survive the expiration or termination for any reason of this Agreement.<br />

3.4 Indemnification.<br />

(a) Indemnification by Practitioner. Practitioner shall indemnify, defend and<br />

hold harmless Hospital against: (i) any and all liability arising out of Practitioner’s failure to<br />

comply with the terms of this Agreement, and any injury, loss, claims, or damages arising from<br />

the negligent operations, acts, or omissions of Practitioner or Practitioner’s employees or agents<br />

relating to or arising out of Director Services or this Agreement; and (ii) any and all costs and<br />

Deleted: (<br />

Deleted: ).<br />

Deleted: [Option A:]<br />

[<br />

Formatted: Bullets and Numbering<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 5<br />

ADD C-7


expenses, including reasonable legal expenses, incurred by or on behalf of Hospital in<br />

connection with the defense of such claims.<br />

(b) Indemnification by Hospital. To the extent allowable under law, Hospital<br />

shall indemnify, defend and hold harmless Practitioner against: (i) any and all liability arising<br />

out of Hospital’s failure to comply with the terms of this Agreement, and any injury, loss, claims,<br />

or damages arising from the negligent operations, acts, or omissions of Hospital or its employees<br />

or agents relating to or arising out of this Agreement; and (ii) any and all costs and expenses,<br />

including reasonable legal expenses, incurred by or on behalf of Practitioner in connection with<br />

the defense of such claims.<br />

3.5 Cooperation.<br />

(a) The Parties recognize that, during the term of this Agreement and for an<br />

undetermined time period thereafter, certain risk management issues, legal issues, claims or<br />

actions may arise that involve or could potentially involve the Parties and their respective<br />

employees and agents. The Parties further recognize the importance of cooperating with each<br />

other in good faith when such issues, claims or actions arise, to the extent such cooperation does<br />

not violate any applicable laws, cause the breach of any duties created by any policies of<br />

insurance or programs of self-insurance, or otherwise compromise the confidentiality of<br />

communications or information regarding the issues, claims or actions. As such, the Parties<br />

hereby agree to cooperate in good faith, using their best efforts, to address such risk management<br />

and legal issues, claims, or actions.<br />

(b) The Parties further agree that if a controversy, dispute, claim, action or<br />

lawsuit (each, an “Action”) arises with a third party wherein both the Parties are included as<br />

defendants, each Party shall promptly disclose to the other Party in writing the existence and<br />

continuing status of the Action and any negotiations relating thereto. Each Party shall make<br />

every reasonable attempt to include the other Party in any settlement offer or negotiations. In the<br />

event the other Party is not included in the settlement, the settling Party shall immediately<br />

disclose to the other Party in writing the acceptance of any settlement and terms relating thereto,<br />

if allowed by the settlement agreement.<br />

Deleted:<br />

Deleted: ]<br />

Deleted: [Option B:]<br />

3.4 [Hold Harmless. Each Party shall<br />

be responsible for its own acts and<br />

omissions and the acts and omissions of<br />

its employees and agents; neither Party<br />

shall be responsible for the acts and<br />

omissions of the other Party or the other<br />

Party’s employees and agents in carrying<br />

out this Agreement. Neither Party shall<br />

be liable for any judgment, settlement,<br />

award, fine or otherwise, which arises out<br />

of the acts and omissions of such other<br />

Party, or its employees and agents, under<br />

this Agreement. To the extent either<br />

Party utilizes its own equipment,<br />

products, or other personal property in the<br />

performance of its obligations under this<br />

Agreement, such Party shall ensure that<br />

such equipment, product, or other<br />

personal property is suitable and fit for<br />

the purpose intended by such Party, free<br />

from defects which may damage the other<br />

Party, and otherwise operates in<br />

accordance with applicable government<br />

standards and safety regulations.]<br />

Formatted: Bullets and Numbering<br />

3.6 Survival of Obligations. The Parties’ obligations under this Article III shall<br />

survive the expiration or termination for any reason of this Agreement.<br />

ARTICLE IV.<br />

RELATIONSHIP BETWEEN THE PARTIES<br />

4.1 Independent Contractor. Practitioner is and shall at all times be an independent<br />

contractor with respect to Hospital in meeting Practitioner’s responsibilities under this<br />

Agreement. Nothing in this Agreement is intended nor shall be construed to create a partnership,<br />

employer-employee or joint venture relationship between Hospital and Practitioner.<br />

4.2 Limitation on Control. Hospital shall neither have nor exercise any control or<br />

direction over Practitioner’s professional medical judgment or the methods by which Practitioner<br />

performs professional medical services; provided, however, that Practitioner shall be subject to<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 6<br />

ADD C-8


and shall at all times comply with the Protocols and the bylaws, guidelines, policies and rules<br />

applicable to other members of the Medical Staff.<br />

4.3 Practice of Medicine. Practitioner and Hospital acknowledge that Hospital is<br />

neither authorized nor qualified to engage in any activity which may be construed or deemed to<br />

constitute the practice of medicine. To the extent that any act or service required of, or reserved<br />

to, Hospital in this Agreement is construed or deemed to constitute the practice of medicine, the<br />

performance of such act or service by Hospital shall be deemed waived or unenforceable, unless<br />

this Agreement can be amended to comply with the law, in which case the Parties shall make<br />

such amendment.<br />

4.4 No Benefit Contributions. Hospital shall have no obligation under this<br />

Agreement to compensate or pay applicable taxes for, or provide employee benefits of any kind<br />

(including contributions to government mandated, employment-related insurance and similar<br />

programs) to or on behalf of, Practitioner or any other person employed or retained by<br />

Practitioner. Notwithstanding the foregoing, if Hospital determines or is advised that it is<br />

required by law to compensate or pay applicable taxes for, or provide employee benefits of any<br />

kind (including contributions to government mandated, employment-related insurance and<br />

similar programs) to or on behalf of, Practitioner or any other person employed or retained by<br />

Practitioner, Practitioner shall reimburse Hospital for any such expenditure within thirty (30)<br />

calendar days after being notified of such expenditure.<br />

4.5 Non-Solicitation. During the term of this Agreement and for a period of one (1)<br />

year thereafter, Practitioner shall not solicit for employment or actually employ any employee of<br />

Hospital, or interfere with any relationship, contractual or otherwise, between Hospital and any<br />

of its employees.<br />

4.6 Referrals. Practitioner shall be entitled to refer patients to any hospital or other<br />

health care facility or provider deemed by Practitioner best qualified to deliver medical services<br />

to any particular patient; provided, however, that Practitioner shall not refer any Hospital patient<br />

to any provider of health care services which Practitioner knows or should have known is<br />

excluded or suspended from participation in, or sanctioned by, any state or federal health care<br />

program. No term of this Agreement shall be construed as requiring or inducing Practitioner to<br />

refer patients to Hospital. Practitioner’s rights under this Agreement shall not be dependent in<br />

any way on the referral of patients or business to Hospital by Practitioner.<br />

4.7 Physician Compensation Arrangements. Practitioner represents and warrants<br />

to Hospital that the compensation paid or to be paid by Practitioner to any physician who is<br />

employed or contracted with Practitioner is and will at all times be fair market value for services<br />

and items actually provided by such physician, not taking into account the value or volume of<br />

referrals or other business generated by such physician for Hospital or any Affiliate. Practitioner<br />

further represents and warrants to Hospital that Practitioner has and will at all times maintain a<br />

written agreement with each physician receiving compensation from Practitioner.<br />

4.8 No Competing Services. During the term of this Agreement, Practitioner shall<br />

not own any interest in, manage, operate, or provide any administrative, consulting, or other<br />

items or director services to or on behalf of, any person or entity (whether as director, officer,<br />

Deleted: (as defined in Section<br />

[5.4/5.5])<br />

Deleted: [<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 7<br />

ADD C-9


employee, partner, shareholder, member, agent, representative, security holder, consultant or<br />

otherwise), that furnishes or intends to furnish any items or services competitive with those<br />

furnished by Hospital or its Affiliates, without the prior written consent of Hospital.<br />

Notwithstanding the foregoing, nothing in this Section shall prohibit Practitioner from owning<br />

securities in any publicly traded company that furnishes services furnished by Hospital or its<br />

Affiliates.<br />

Deleted: ]<br />

ARTICLE V.<br />

TERM AND TERMINATION<br />

5.1 Term. This Agreement shall become effective on _______________, 20__ (the<br />

“Effective Date”), and shall continue until _______________, 20__ (the “Expiration Date”),<br />

subject to the termination provisions of this Agreement.<br />

5.2 Termination by Hospital. Hospital shall have the right to terminate this<br />

Agreement immediately upon the occurrence of any one or more of the following events:<br />

(a) breach of this Agreement by Practitioner where the breach is not cured<br />

within thirty (30) calendar days after Hospital gives written notice of the breach to Practitioner;<br />

(b)<br />

death or permanent disability of Practitioner;<br />

Deleted: [On the Expiration Date[, and<br />

on each of the following _________<br />

(___) annual anniversary dates of this<br />

Agreement thereafter], this Agreement<br />

shall automatically renew for an<br />

additional one (1) year term, unless and<br />

until either Party gives the other Party<br />

written notice of its intention not to renew<br />

this Agreement at least thirty (30)<br />

calendar days prior to the expiration of<br />

the immediately preceding one (1) year<br />

term.]<br />

(c)<br />

Practitioner’s voluntary retirement from the practice of medicine;<br />

(d) neglect of professional duty by Practitioner in a manner that violates<br />

Hospital’s policies, rules or regulations or the Protocols;<br />

(e) Practitioner’s clinical privileges at any hospital are suspended, restricted,<br />

revoked or voluntarily relinquished, or Practitioner’s medical staff membership at any hospital is<br />

suspended or terminated, for reasons relating to quality of care, regardless of the availability of<br />

civil or administrative hearing rights or judicial review with respect thereto;<br />

(f) Practitioner’s license to practice medicine in the State of California is<br />

restricted, suspended or terminated, regardless of the availability of civil or administrative<br />

hearing rights or judicial review with respect thereto;<br />

(g) except as provided in Section 1.6, Practitioner at any time during the term<br />

of the Agreement for any reason is not a member in good standing in the “active staff” category<br />

of the Medical Staff or does not hold all clinical privileges at Hospital necessary for<br />

Practitioner’s performance of Director Services;<br />

(h)<br />

Practitioner is charged with or convicted of a criminal offense;<br />

(i) Practitioner’s performance of Director Services, in the sole determination<br />

of Hospital, jeopardizes the mental or physical health or well-being of patients of Hospital;<br />

(j) Practitioner is debarred, suspended, excluded or otherwise ineligible to<br />

participate in any federal or state health care program;<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 8<br />

ADD C-10


(k)<br />

(l)<br />

(m)<br />

for any reason.<br />

Practitioner acts in a manner which violates the Bylaws;<br />

breach of any HIPAA Obligation (as defined in Exhibit 6.5); or<br />

Practitioner is rendered unable to comply with the terms of this Agreement<br />

Deleted: , or causes another person to<br />

act,<br />

Deleted: conflicts with or<br />

Deleted: Code<br />

5.3 Termination without Cause. Either Party may terminate this Agreement<br />

without cause, expense or penalty, effective _______ (__) days after written notice of<br />

termination is given to the other Party. If this Agreement is terminated prior to the date that is<br />

twelve (12) months from the Effective Date (the “One Year Anniversary”), the Parties shall<br />

not, at any time prior to the One Year Anniversary, enter into any other agreement or<br />

arrangement for the provision of Director Services that modifies, changes, or alters in any way<br />

the provisions of this Agreement. The foregoing sentence shall survive termination of this<br />

Agreement pursuant to this Section.<br />

Deleted: [<br />

Deleted: ]<br />

5.4 Termination by Practitioner. Practitioner shall have the right to terminate this<br />

Agreement upon breach of this Agreement by Hospital where the breach is not cured within<br />

thirty (30) calendar days after Practitioner gives written notice of the breach to Hospital.<br />

5.5 Termination or Modification in the Event of Government Action.<br />

(a) In the event of any Government Action (as defined below), the Parties<br />

shall, within ten (10) days after one Party gives written notification of such Government Action<br />

to the other Party, meet and confer and negotiate in good faith to attempt to amend this<br />

Agreement in order to comply with the Government Action.<br />

(b) If the Parties, after good faith negotiations that shall not exceed thirty (30)<br />

days, are unable to mutually agree upon the amendments necessary to comply with the<br />

Government Action, or, alternatively, if either Party determines in good faith that compliance<br />

with the Government Action is impossible or infeasible, either Party may terminate this<br />

Agreement effective ten (10) days after a written notice of termination is given to the other Party.<br />

(c) For the purposes of this Section, “Government Action” shall mean any<br />

legislation, statute, law, regulation, rule or procedure passed, adopted or implemented by any<br />

federal, state or local government or legislative body or any private agency, or any decision,<br />

finding, interpretation or action by any governmental or private agency, court or other third party<br />

which, in the opinion of counsel to either Party, as a result or consequence, in whole or in part, of<br />

the arrangement between the Parties set forth in this Agreement, if or when implemented, could<br />

reasonably be expected to result in or present a material risk of any one or more of the following:<br />

(i)<br />

(ii)<br />

revocation or threat of revocation of the status of any license,<br />

certification or accreditation granted to Hospital or any Affiliate<br />

(as defined in Section 5.5(d));<br />

revocation or threat of revocation of the federal, state or local taxexempt<br />

status of Hospital, or any Affiliate, or their respective taxexempt<br />

financial obligations;<br />

Deleted: [<br />

Deleted: 4/<br />

Deleted: .5]<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 9<br />

ADD C-11


(iii)<br />

(iv)<br />

(v)<br />

(vi)<br />

(vii)<br />

prohibit or restrict the ability of Hospital or any Affiliate to issue<br />

tax-exempt bonds, certificates of participation or other tax-exempt<br />

financial obligations;<br />

prevent Practitioner from being able to access and use the facilities<br />

of Hospital or any Affiliate of Hospital;<br />

violation of or threat of prosecution under 42 U.S.C. Section<br />

1320a-7b(b) (commonly referred to as the “Anti-Kickback law”),<br />

42 U.S.C. Section 1395nn (commonly referred to as the “Stark<br />

law”) or any comparable state law governing kickbacks, bribes,<br />

rebates or patient referrals if Practitioner referred patients to<br />

Hospital or any Affiliate;<br />

violation by Hospital of, or threat of prosecution of Hospital under,<br />

any law, regulation, rule or procedure applicable to Hospital;<br />

prohibit Practitioner, Hospital or any Affiliate from submitting<br />

claims or materially reducing the reimbursement received by<br />

Hospital or any Affiliate for services provided to patients referred<br />

by Practitioner; or<br />

(viii) subject Hospital, Practitioner, any Affiliate, or any of their<br />

respective officers, directors, employees or agents, to civil action<br />

or criminal prosecution by any governmental authority or other<br />

person or entity or the imposition of any sanction (including any<br />

excise tax penalty under Internal Revenue Code Section 4958), on<br />

the basis of their approval of or participation in this Agreement or<br />

performing their respective obligations under this Agreement.<br />

(d) For the purposes of this Agreement, “Affiliate” shall mean any entity<br />

which, directly or indirectly, controls, is controlled by, or is under common control with<br />

Hospital.<br />

5.6 Effect of Termination or Expiration. Upon any expiration or termination for<br />

any reason of this Agreement:<br />

(a) all rights and obligations of the Parties shall cease except (i) those rights<br />

and obligations that have accrued and remain unsatisfied prior to the expiration or termination<br />

for any reason of this Agreement, and (ii) those rights and obligations which expressly survive<br />

the expiration or termination for any reason of this Agreement;<br />

(b) upon Hospital’s request, Practitioner shall immediately vacate the<br />

[Department/Program] premises, removing any and all of Practitioner’s personal property, and<br />

Hospital may remove and store, at Practitioner’s expense, any personal property that Practitioner<br />

has not so removed;<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 10<br />

ADD C-12


(c) Practitioner shall immediately return to Hospital all of Hospital’s property,<br />

including Hospital’s equipment, supplies, furniture, furnishings and patient records, in<br />

Practitioner’s possession or under Practitioner’s control; and<br />

(d) Practitioner shall not do anything or cause any other person to do anything<br />

that interferes with Hospital’s efforts to engage any other person or entity for the provision of<br />

Director Services, or interferes in any way with any relationship between Hospital and any other<br />

person or entity who may be engaged to provide Director Services to Hospital.<br />

(e) The expiration or termination for any reason of this Agreement shall not<br />

entitle Practitioner to the right to a “fair hearing” or any other similar rights or procedures more<br />

particularly set forth in the Medical Staff Bylaws.<br />

ARTICLE VI.<br />

GENERAL PROVISIONS<br />

6.1 Amendment. This Agreement may be modified or amended only by mutual<br />

written agreement of the Parties. Any such modification or amendment must be in writing,<br />

dated, signed by the Parties and attached to this Agreement.<br />

6.2 Assignment. Practitioner may not assign any of Practitioner’s rights, interests,<br />

duties, or obligations under this Agreement without Hospital’s prior written consent, which<br />

consent may be given or withheld in Hospital’s sole discretion. Any attempted or purported<br />

assignment by Practitioner in violation of this Section shall be void. Hospital may, in its sole<br />

discretion, assign any or all of its rights, interests, duties, or obligations hereunder to any person<br />

or entity without the prior written consent of Practitioner. Subject to the foregoing, this<br />

Agreement shall be binding on and shall inure to the benefit of the Parties and their respective<br />

heirs, successors, assigns and representatives.<br />

6.3 Attorneys’ Fees. If either Party brings an action for any relief or collection<br />

against the other Party, declaratory or otherwise, arising out of the arrangement described in this<br />

Agreement, the losing Party shall pay to the prevailing Party a reasonable sum for attorneys’ fees<br />

and costs actually incurred in bringing such action, including without limitation fees incurred in<br />

arbitration, at trial, on appeal and on any review therefrom, all of which shall be deemed to have<br />

accrued upon the commencement of such action and shall be paid whether or not such action is<br />

prosecuted to judgment, provided, however, that the fees are deemed reasonable and appropriate<br />

by a court of competent jurisdiction in San Diego County, California. Any judgment or order<br />

entered in such action shall contain a specific provision providing for the recovery of attorneys’<br />

fees and costs incurred in enforcing such judgment. For the purpose of this Section, attorneys’<br />

fees shall include fees incurred in connection with discovery, post judgment motions, contempt<br />

proceedings, garnishment and levy.<br />

6.4 Choice of Law. This Agreement shall be construed in accordance with and<br />

governed by the internal laws of the State of California, except choice of law rules that would<br />

require the application of the laws of any other jurisdiction.<br />

6.5 Compliance with HIPAA and HITECH. Practitioner shall take all reasonable<br />

steps to protect Protected <strong>Health</strong> Information (“PHI”) provided to it by Hospital in a manner Deleted: 12-27-07<br />

Revised 3-11-2010 11<br />

ADD C-13


such that the Security and Privacy of such PHI will be maintained and appropriate safeguards<br />

will be used to prevent unauthorized or improper use or disclosure of the PHI. Practitioner shall<br />

comply with the HIPAA Obligations specifically defined and set forth in Exhibit 6.5. The<br />

HIPAA Obligations shall survive the expiration or termination for any reason of this Agreement.<br />

6.6 Compliance with Laws. Practitioner shall comply with all applicable laws,<br />

ordinances, codes and regulations of federal, state and local governments, including without<br />

limitation laws that require Practitioner to disclose any economic interest or relationship with<br />

Hospital, and the policies, standards, requirements, guidelines and recommendations of the Joint<br />

Commission.<br />

Deleted: as<br />

Deleted: on Accreditation of<br />

<strong>Health</strong>care Organizations (“JCAHO”).<br />

6.7 Compliance with Medicare Rules. To the extent required by law or regulation,<br />

Practitioner shall make available, upon written request from Hospital, the Secretary of <strong>Health</strong><br />

and Human Services, the Comptroller General of the United States, or any duly authorized agent<br />

or representative of the foregoing, a copy of this Agreement and Practitioner’s books, documents<br />

and records to the extent necessary to certify the nature and extent of Hospital’s costs for<br />

services provided by Practitioner. Practitioner shall preserve and make available such books,<br />

documents and records for a period which is the longer of ten (10) years after the end of the term<br />

of this Agreement or the length of time required by state or federal law. If Practitioner is<br />

requested to disclose books, documents or records pursuant to this Section for any purpose,<br />

Practitioner shall notify Hospital of the nature and scope of such request, and Practitioner shall<br />

make available, upon written request of Hospital, all such books, documents or records.<br />

Practitioner shall indemnify and hold harmless Hospital if any amount of reimbursement is<br />

denied or disallowed because of Practitioner’s failure to comply with the obligations set forth in<br />

this Section. Such indemnity shall include, but not be limited to, the amount of reimbursement<br />

denied, plus any interest, penalties and legal costs.<br />

6.8 Confidentiality. Neither Party shall disclose any of the terms of this Agreement<br />

to any person or entity, other than its attorneys and accountants, without the prior written consent<br />

of the other Party, unless and only to the extent such disclosure is required by law or specifically<br />

allowed by this Agreement.<br />

6.9 Counterparts, Electronic and Facsimile Signatures. This Agreement may be<br />

executed in one or more counterparts, each of which shall be deemed to be an original, but all of<br />

which together shall constitute one and the same instrument. In addition, both parties expressly<br />

agree that to the extent permitted by law, this Agreement may be executed and become effective<br />

by affixing either an electronic or handwritten signature in the appropriate location and<br />

transmitting such document to the other party using traditional, electronic, or facsimile methods<br />

of transmission. Such electronic or facsimile transmitted signature shall be deemed and carry the<br />

legal significance of an original signature.<br />

Formatted: Bullets and Numbering<br />

6.10 Dispute Resolution. In the event of any controversy or dispute related to or<br />

arising out of this Agreement, the Parties agree to promptly, and in no case longer than fifteen<br />

(15) business days, meet and confer in good faith to attempt to resolve the controversy or dispute<br />

without an adversary proceeding.<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 12<br />

ADD C-14


(a) If the Parties are unable to resolve the controversy or dispute to the mutual<br />

satisfaction of both parties within fifteen (15) business days of the meet and confer between the<br />

Parties, the Parties agree to first, in good faith, settle the dispute by mediation administered by<br />

the American Arbitration Association (“AAA”) under its Commercial Mediation Procedures,<br />

before resorting to arbitration, litigation, or some other dispute resolution procedure. The Parties<br />

agree that that there shall be one mediator, who shall be experienced in mediation and<br />

knowledgeable regarding the health care industry. The mediation shall be held in San Diego<br />

County, California. If either Party has a substantial need for information and documents in<br />

possession of the other Party in order to prepare for the mediation, the Parties shall, with the help<br />

of the mediator if needed, attempt to agree upon the extent of and schedule for the expeditious<br />

exchange of such information. Each Party shall bear its own costs and expenses of the<br />

mediation, including attorneys’ fees, except that the fees and costs of the mediator and the AAA<br />

shall be borne equally by the Parties. The decision of the mediator shall not be legally binding<br />

on either Party.<br />

(b) If the Parties are unable to resolve any and all controversies or disputes<br />

arising out of, relating to or in connection with this Agreement after mediation in accordance<br />

with this Section 6.10, either Party may commence litigation to resolve the dispute, with venue<br />

and jurisdiction exclusively in a California state court sitting in San Diego County, California.<br />

6.11 Entire Agreement. This Agreement is the entire understanding and agreement of<br />

the Parties regarding its subject matter, and supersedes any prior oral or written agreements,<br />

representations, understandings or discussions between the Parties. No other understanding<br />

between the Parties shall be binding on them unless set forth in a writing signed by the Parties.<br />

6.12 Exhibits. The attached exhibits, together with all documents incorporated by<br />

reference in the exhibits, form an integral part of this Agreement and are incorporated into this<br />

Agreement wherever reference is made to them to the same extent as if they were set out in full<br />

at the point at which such reference is made.<br />

6.13 Force Majeure. Neither Party shall be liable for nonperformance or defective or<br />

late performance of any of its obligations under this Agreement to the extent and for such periods<br />

of time as such nonperformance, defective performance or late performance is due to reasons<br />

outside such Party’s control, including acts of God, war (declared or undeclared), action of any<br />

governmental authority, riots, revolutions, fire, floods, explosions, sabotage, nuclear incidents,<br />

lightning, weather, earthquakes, storms, sinkholes, epidemics, or strikes (or similar<br />

nonperformance or defective performance or late performance of employees, suppliers or<br />

subcontractors).<br />

Deleted: In the event of any<br />

controversy or dispute related to or<br />

arising out of this Agreement, the Parties<br />

agree to meet and confer in good faith to<br />

attempt to resolve the controversy or<br />

dispute without an adversary proceeding.<br />

If the controversy or dispute is not<br />

resolved to the mutual satisfaction of the<br />

Parties within five (5) business days of<br />

notice of the controversy or dispute, the<br />

Parties agree to waive their rights, if any,<br />

to a jury trial and pre-trial discovery, and<br />

to submit the controversy or dispute to a<br />

retired judge or justice pursuant to<br />

Section 638 et seq. of the California Code<br />

of Civil Procedure, or any successor<br />

provision, for resolution in accordance<br />

with Chapter 6 (References and Trials by<br />

Referees), of Title 8 of Part 2 of the<br />

California Code of Civil Procedure, or<br />

any successor chapter. The Parties agree<br />

that the only proper venue for the<br />

submission of claims is the County of San<br />

Diego, California, and that the hearing<br />

before the referee shall be concluded<br />

within nine (9) months of the filing and<br />

service of the complaint. The Parties<br />

reserve the right to contest the referee’s<br />

decision and to appeal from any award or<br />

order of any court.<br />

6.14 Headings. The headings in this Agreement are intended solely for convenience<br />

of reference and shall be given no effect in the construction or interpretation of this Agreement.<br />

6.15 Litigation Consultation. Practitioner shall not accept consulting assignments or<br />

otherwise contract, agree, or enter into any arrangement to provide expert testimony or<br />

evaluation on behalf of a plaintiff in connection with any claim against Hospital or any Affiliate<br />

named, or expected to be named as a defendant. Practitioner shall not accept similar consulting<br />

assignments if (a) the defendants or anticipated defendants include a member of the medical staff<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 13<br />

ADD C-15


of Hospital or any Affiliate, and (b) the matter relates to events that occurred at Hospital or any<br />

Affiliate; provided, however, the provisions of this Section shall not apply to situations in which<br />

Practitioner served as a treating physician.<br />

6.16 Meaning of Certain Words. Wherever the context may require, any pronouns<br />

used in this Agreement shall include the corresponding masculine, feminine, or neuter forms, and<br />

the singular form of nouns shall include the plural and vice versa. Unless otherwise specified,<br />

“days” shall be considered “calendar days” and “months” shall be considered “calendar months”<br />

in this Agreement and its exhibits and attachments.<br />

6.17 No Conflicting Obligations. Practitioner represents and warrants that the<br />

execution and delivery of this Agreement and the performance of his or her respective<br />

obligations hereunder do not and will not: (a) present a conflict of interest or materially interfere<br />

with the performance of his or her respective duties under any other agreement or arrangement;<br />

or (b) violate, conflict with, or result in a breach of any provision of, or constitute a default (or an<br />

event which, with notice and/or lapse of time, would constitute a default) under, terminate,<br />

accelerate the performance required by, or result in a right of termination or acceleration under<br />

any of the terms, conditions or provisions of any other agreement, indebtedness, note, bond,<br />

indenture, security or pledge agreement, license, franchise, permit, or other instrument or<br />

obligation. Practitioner shall immediately inform Hospital of any other agreements to which<br />

Practitioner is a party that may present a conflict of interest or materially interfere with<br />

performance of his or her duties under this Agreement.<br />

6.18 Non-Discrimination. Practitioner shall not differentiate or discriminate in the<br />

provision of medical services on the basis of race, color, national origin, ancestry, religion, sex,<br />

marital status, sexual orientation, age, medical condition, medical history, genetics, evidence of<br />

insurability, or claims history, in violation of any applicable state, federal or local law or<br />

regulation, or Hospital Rules, including, without limitation, the Age Discrimination Act of 1975,<br />

the Americans with Disabilities Act and all regulations issued pursuant thereto and as may be<br />

amended from time to time. Practitioner and Hospital shall be in full compliance with<br />

Section 504 of the Rehabilitation Act of 1973, Titles VI and VII of the 1964 Civil Rights Act,<br />

and all regulations issued pursuant thereto and as may be amended from time to time.<br />

6.19 Notices. All notices or communications required or permitted under this<br />

Agreement shall be given in writing and delivered personally or sent by United States registered<br />

or certified mail with postage prepaid and return receipt requested or by overnight delivery<br />

service (e.g., Federal Express, DHL). Notice shall be deemed given when sent, if sent as<br />

specified in this Section, or otherwise deemed given when received. In each case, notice shall be<br />

delivered or sent to:<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 14<br />

ADD C-16


If to Hospital, addressed to:<br />

<strong>Palomar</strong> Pomerado <strong>Health</strong><br />

Legal Department<br />

15255 innovation drive<br />

San Diego, CA 92128<br />

Attn: General Counsel<br />

If to Practitioner, addressed to:<br />

6.20 Participation in Federal and State Programs. Practitioner hereby represents<br />

that Practitioner is not debarred, suspended, excluded or otherwise ineligible to participate in any<br />

federal or state health care program.<br />

6.21 Representations. Each Party represents with respect to itself that: (a) no<br />

representation or promise not expressly contained in this Agreement has been made by any other<br />

Party or by any Parties’ agents, employees, representatives or attorneys; (b) this Agreement is<br />

not being entered into on the basis of, or in reliance on, any promise or representation, expressed<br />

or implied, other than such as are set forth expressly in this Agreement; and (c) Party has been<br />

represented by legal counsel of Party’s own choice or has elected not to be represented by legal<br />

counsel in this matter.<br />

6.22 Severability. Except as otherwise provided in Section 5.5, if any provision of<br />

this Agreement is determined to be illegal or unenforceable, that provision shall be severed from<br />

this Agreement, and such severance shall have no effect upon the enforceability of the remainder<br />

of this Agreement.<br />

Deleted: [<br />

Deleted: 4/<br />

Deleted: .5])<br />

6.23 No Third Party Beneficiary Rights. The Parties do not intend to confer and this<br />

Agreement shall not be construed to confer any rights or benefits to any person, firm, group,<br />

corporation or entity other than the Parties.<br />

6.24 Trade Secrets. During the term of this Agreement, Practitioner will have access<br />

to and become acquainted with confidential information and trade secrets of Hospital, including<br />

information and data relating to payor contracts and accounts, clients, patients, patient groups,<br />

patient lists, billing practices and procedures, business techniques and methods, strategic plans,<br />

operations and related data (collectively, “Trade Secrets”). All Trade Secrets are the property<br />

of Hospital and used in the course of Hospital’s business, and shall be proprietary information<br />

protected under the Uniform Trade Secrets Act and the California Public Records Act.<br />

Practitioner shall not disclose to any person or entity, directly or indirectly, either during the term<br />

of this Agreement or at any time thereafter, any Trade Secrets, or use any Trade Secrets other<br />

than in the course of providing Director Services under this Agreement. All documents that<br />

Practitioner prepares, or Trade Secrets that might be given to Practitioner in the course of<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 15<br />

ADD C-17


providing Director Services under this Agreement, are the exclusive property of Hospital, and,<br />

without the prior written consent of Hospital, shall not be removed from Hospital’s premises.<br />

6.25 Waiver. No delay or failure to require performance of any provision of this<br />

Agreement shall constitute a waiver of that provision as to that or any other instance. Any<br />

waiver granted by a Party must be in writing to be effective, and shall apply solely to the specific<br />

instance expressly stated.<br />

6.26 Waiver of Injunctive or Similar Relief. Upon any breach or termination of this<br />

Agreement by Hospital that is determined to be improper by a court or by an arbitrator,<br />

Practitioner shall accept monetary damages, if any, as full and complete relief, to the exclusion<br />

of any specific performance, or injunctive or similar equitable relief.<br />

The Parties have executed this Agreement on the date first above written, and signify<br />

their agreement with duly authorized signatures.<br />

HOSPITAL<br />

<strong>Palomar</strong> Pomerado <strong>Health</strong><br />

Deleted: [signature page follows]<br />

Page Break<br />

Deleted: System, a local health care<br />

district organized under Division 23 of<br />

the California <strong>Health</strong> and Safety Code<br />

and doing business as<br />

_____________________<br />

By: Robert A. Hemker<br />

Its: Chief Financial Officer<br />

Date: _______________________________<br />

PRACTITIONER<br />

_____________________________________<br />

Deleted: , [M.D./D.O.], an individual<br />

Printed Name: _________________________<br />

Date: ________________________________<br />

Deleted: 12-27-07<br />

Revised 3-11-2010 16<br />

ADD C-18


Exhibit 1.1<br />

DIRECTOR SERVICES<br />

Practitioner shall:<br />

1. provide general administration of the day-to-day operations of the<br />

[Department/Program];<br />

2. implement the Hospital’s policies and procedures regarding the<br />

[Department/Program];<br />

3. ensure physician coverage of the [Department/Program];<br />

4. schedule, coordinate and supervise the provision of medical and ancillary services<br />

within the [Department/Program];<br />

5. ensure the maintenance of consistently high quality service, and advise Hospital<br />

in the development and implementation of an appropriate quality assurance program with respect<br />

to the [Department/Program];<br />

6. advise and assist in the organization and implementation of an effective utilization<br />

review program with respect to the [Department/Program] and related services;<br />

7. coordinate and consult with Hospital and medical staff regarding the efficiency<br />

and effectiveness of the [Department/Program], and make recommendations and analyses as<br />

needed for Hospital to improve services provided in the [Department/Program] and reduce costs;<br />

8. advise Hospital regarding budget, equipment, building, supplies, and other items<br />

for the proper and efficient operation of the [Department/Program];<br />

9. develop, review, and provide training programs for Medical Staff and Hospital<br />

personnel;<br />

10. ensure that the [Department/Program] is operated in accordance with all<br />

requirements of The Joint Commission, all applicable licensing requirements, and all other<br />

relevant requirements promulgated by any federal, state or local agency;<br />

Deleted: the JCAHO<br />

11. prepare such reports and records as may be required by this Agreement, Hospital<br />

or the Medical Staff;<br />

12. participate in Hospital and Medical Staff committees upon request by Hospital;<br />

13. participate in continuing medical education, research and teaching activities upon<br />

request by Hospital;<br />

Deleted: SD\614498.1<br />

Exhibit 1.5-1<br />

ADD C-19


14. participate in development and presentation of programs related to the marketing<br />

of the [Department/Program]’s services and enhancing Hospital/community relations; provided,<br />

however, that Practitioner shall not be required to participate in any advertising or commercials<br />

related to the [Department/Program]’s services;<br />

15. advise and assist in the development of protocols and policies for the<br />

[Department/Program];<br />

16. upon request by Hospital, be available at all times to respond/consult in the event<br />

of urgent or emergency situations;<br />

17. prepare a budget for the [Department/Program];<br />

18. supervise maintenance of financial, patient and personnel records for the<br />

[Department/Program];<br />

19. ensure and supervise compliance by Medical Staff and employees of the<br />

[Department/Program] with Hospital and Medical Staff rules and bylaws;<br />

20. [serve on Hospital’s emergency room on-call panel, as reasonably requested by<br />

Hospital;]<br />

21. [participate in utilization review programs, as reasonably requested by Hospital;]<br />

22. [participate in risk management and quality assurance programs, as reasonably<br />

requested by Hospital;]<br />

23. [accept third party insured patients and referrals of patients which are made by<br />

members of Medical Staff, subject only to the limitations of scheduling and Practitioner’s<br />

professional qualifications;]<br />

24. [work with Hospital to monitor and review the clinical performance of health care<br />

professionals who provide services to Hospital’s patients. Practitioner shall assist in monitoring<br />

the performance of those professionals who are not meeting Hospital quality and/or performance<br />

standards, and in disciplining any professionals who continue poor performance, recognizing that<br />

the Hospital Board of Directors is ultimately responsible for maintaining the standards of care<br />

provided to patients;]<br />

25. [assist Hospital management with preparation for, and conduct of, any inspections<br />

and on-site surveys of Hospital or the [Department/Program] conducted by governmental<br />

agencies, accrediting organizations, or payors contracting with Hospital[; and]]<br />

26. [additional services to be provided by Practitioner].<br />

Deleted: SD\614498.1<br />

Exhibit 1.5-2<br />

ADD C-20


Exhibit 1.5<br />

MONTHLY TIME REPORT<br />

See Attached.<br />

Deleted: <br />

<br />

Exhibit 1.1 (a)<br />

<br />

Medical Director, Robotic Surgery<br />

Position Description<br />

<br />

Practitioner will provide physician<br />

leadership for the establishment of a high<br />

quality robotic surgery program at<br />

<strong>Palomar</strong> Medical Center.<br />

Responsibilities include:<br />

Research best practices and protocols<br />

for robotic surgery programs to share that<br />

knowledge with the medical and clinical<br />

staffs at <strong>Palomar</strong> Medical Center. Utilize<br />

those best practices in the formation of all<br />

aspects of this new program.<br />

Take a leadership role in working<br />

with the Department of Surgery to<br />

establish certification and training<br />

requirements for physician credentialing<br />

to be able to perform robotic surgery at<br />

<strong>Palomar</strong> Medical Center.<br />

Take a leadership role in working<br />

with the appropriate medical staff<br />

departments to establish patient criteria<br />

for eligibility for robotic surgery at<br />

<strong>Palomar</strong> Medical Center.<br />

In conjunction with the medical staff<br />

and the PPH Quality Department,<br />

establish quality measures/metrics and<br />

benchmarks for robotic surgery.<br />

Establish policies and procedures for<br />

robotic surgery that ensure patient safety<br />

and adherence to best practices.<br />

Act as the physician liaison to work<br />

with the Marketing Department on<br />

collateral material development,<br />

physician outreach/marketing activities,<br />

journal article submissions, public<br />

relations activities, and employee<br />

awareness activities.<br />

Lead efforts to target physician<br />

awareness and referrals through such<br />

activities as CME and Grand Rounds at<br />

the hospital, set up a fast track robotic<br />

surgery consult program for area<br />

urologists and surgeons, establish an<br />

annual symposium within the robotic<br />

surgery product line, and networking with<br />

appropriate specialists such as urologists,<br />

gynecologists and surgeons.<br />

Work with the Physician<br />

Development Department to host office<br />

staff luncheons to introduce the program<br />

and access procedures to local physician<br />

offices.<br />

Work with the Managed Care<br />

Department to contact provider/payer<br />

representatives including the major IPAs<br />

to inform them of the new service and the<br />

need to establish contract rates.<br />

Work with the Marketing Department<br />

to develop content for the PPH Website<br />

for robotic surgery.<br />

Work with the Perioperative Educator<br />

and CNS on staff and physician ... [1]<br />

Deleted: SD\614498.1<br />

Exhibit 1.5-3<br />

ADD C-21


PRACTITIONER_________________________________________<br />

Administration Time Log<br />

MONTH/YEAR ________________________________<br />

ADMINISTRATION 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30<br />

31<br />

Medical Direction of [Department/Program]<br />

Supervision/Training of Technical Staff<br />

Physician/Staff Inservice<br />

Eval/approve/implement lab procedures<br />

[Department/Program] Meetings<br />

Committee Meetings<br />

Schedules and Planning<br />

Policies/Procedures<br />

Budget Activities<br />

Quality Improvement Utilization Review<br />

Advisory Duties<br />

Liaison Activities<br />

[Department/Program] Development<br />

Maintain Accrediting Standards<br />

Evaluate Staff Competency<br />

Evaluate Quality Control Results<br />

Other<br />

TOTAL HOURS<br />

PRACTITIONER CERTIFIES THAT THE ABOVE ACCURATELY REPRESENTS THE HOURS PRACTITIONER DEVOTED TO<br />

DIRECTOR SERVICES DURING THE PERIOD OF THIS REPORT.<br />

______________________, [M.D./D.O.] Date<br />

SD\614498.1<br />

Exhibit 1.5-Attachment<br />

ADD C-22


Exhibit 2.1<br />

COMPENSATION<br />

1. Compensation. Hospital shall pay to Practitioner the amount of<br />

____________________ Dollars ($_________) per hour for the provision of Director Services.<br />

2. Timing. Hospital shall pay the compensation due for Director Services performed<br />

by Practitioner in the immediately preceding month within thirty (30) days after Practitioner’s<br />

submission of the monthly time report in accordance with Section 1.5 of this Agreement.<br />

Deleted: Exhibit 1.10<br />

CODE<br />

<br />

See Attached.<br />

<br />

Section Break (Next Page)<br />

Deleted: five (5) business<br />

Deleted: ; provided, however, that if<br />

Practitioner does not submit a time sheet<br />

within sixty (60) days of the end of the<br />

month during which Director Services<br />

were performed, Hospital shall not be<br />

obligated to pay Practitioner for Director<br />

Services performed during that month<br />

Deleted: SD\614498.1<br />

Exhibit 2.1-1<br />

ADD C-23


Exhibit 6.5<br />

OBLIGATIONS UNDER THE HEALTH INSURANCE PORTABILITY AND<br />

ACCOUNTABILITY ACT OF 1996 (“HIPAA”)<br />

In the performance of duties and services under this Agreement, Practitioner shall comply<br />

with all requirements of The <strong>Health</strong> Insurance Portability and Accountability Act of 1996<br />

(“HIPAA”) and its regulations, as amended from time to time, and shall comply with the<br />

following:<br />

1. Definitions.<br />

a. “Designated Record Set” shall have the meaning given to such term under the<br />

Privacy Rule (as defined below).<br />

b. “HIPAA Obligations” means the obligations of Practitioner as set forth in this<br />

Exhibit.<br />

c. “Privacy Rule” means the HIPAA Regulation that is codified at Title 45 of the<br />

Code of Federal Regulations, Parts 160 and 164, or applicable successor<br />

provisions, as may be amended from time to time.<br />

d. “Protected <strong>Health</strong> Information” means any information, whether oral or<br />

recorded in any form or medium that: (i) relates to the past, present or future<br />

physical or mental condition of an individual; the provision of health care to an<br />

individual; or the past, present or future payment for the provision of health care<br />

to an individual, and (ii) identifies the individual or with respect to which there is<br />

a reasonable basis to believe the information can be used to identify the<br />

individual, or is defined as such under the Privacy Rule.<br />

e. “Protected Information” means Protected <strong>Health</strong> Information provided by<br />

Hospital to Practitioner or created or received by Practitioner on Hospital’s<br />

behalf.<br />

f. “Required by Law” shall have the meaning given to such term under the Privacy<br />

Rule.<br />

2. Use of Protected Information. Practitioner shall not use Protected Information except<br />

as permitted by and for the purpose of performing Practitioner’s obligations under this<br />

Agreement. Practitioner shall not use Protected Information in any manner that would<br />

constitute a violation of the Privacy Rule if so used by Hospital.<br />

3. Permitted Disclosures. Practitioner shall not disclose Protected Information in any<br />

manner that would constitute a violation of the Privacy Rule if disclosed by Hospital,<br />

except that Practitioner may disclose Protected Information in a manner permitted<br />

pursuant to this Agreement or as Required by Law.<br />

Deleted: <br />

SD\614498.1<br />

Exhibit 6.5-1<br />

ADD C-24


4. Appropriate Safeguards. Practitioner shall implement appropriate safeguards as are<br />

necessary to prevent the use or disclosure of Protected Information other than as<br />

permitted by this Agreement.<br />

5. Reporting of Improper Use or Disclosure. Practitioner shall notify Hospital in writing<br />

of any use or disclosure of Protected Information other than as provided for by this<br />

Agreement and this Exhibit within two (2) days of becoming aware of such use or<br />

disclosure.<br />

6. Practitioner’s Agents. Practitioner shall ensure that any agents of Practitioner,<br />

including subcontractors, to whom Practitioner provides Protected Information, agree in<br />

writing to the same restrictions and conditions that apply to Practitioner with respect to<br />

such Protected Information.<br />

7. Access to Protected Information. Practitioner shall make Protected Information<br />

maintained by Practitioner or Practitioner’s agents or subcontractors in Designated<br />

Record Sets available to Hospital for inspection and copying within ten (10) days of a<br />

request by Hospital to enable Hospital to fulfill its obligations under the Privacy Rule.<br />

8. Amendment of Protected <strong>Health</strong> Information. Within ten (10) days of receipt from<br />

Hospital for an amendment of Protected Information or a record about an individual<br />

contained in a Designated Record Set, Practitioner or Practitioner’s agents or<br />

subcontractors shall make such Protected Information available to Hospital for<br />

amendment and incorporate any such amendment to enable Hospital to fulfill its<br />

obligations under the Privacy Rule.<br />

9. Accounting Rights. Within ten (10) days of notice by Hospital of a request for an<br />

accounting of disclosures of Protected Information, Practitioner and Practitioner’s agents<br />

or subcontractors shall provide to Hospital an accounting of disclosures sufficient to<br />

enable Hospital to fulfill its obligations under the Privacy Rule. As set forth and as<br />

limited by the Privacy Rule, Practitioner shall not provide an accounting to Hospital of<br />

disclosures: (i) to carry out treatment, payment or health care operations; (ii) to<br />

individuals of Protected Information about them; (iii) to persons involved in the<br />

individual’s care or other notification purposes; (iv) for national security or intelligence<br />

purposes; or (v) to correctional institutions or law enforcement officials. [Practitioner<br />

agrees to implement a process that allows for an accounting to be collected and<br />

maintained by Practitioner and Practitioner’s agents or subcontractors for at least<br />

six (6) years prior to the request, but not before the compliance date of the Privacy<br />

Rule.] At a minimum, such information shall include: (A) the date of disclosure; (B) the<br />

name of the entity or person who received Protected Information and, if known, the<br />

address of the entity or person; (C) a brief description of Protected Information disclosed;<br />

and (D) a brief statement of purpose of the disclosure that reasonably informs the<br />

individual of the basis for the disclosure, or copy of the individual’s authorization, or a<br />

copy of the written request for disclosure.<br />

Deleted: <br />

SD\614498.1<br />

Exhibit 6.5-2<br />

ADD C-25


10. Governmental Access to Records. Practitioner shall make his or her internal practices,<br />

books and records relating to the use and disclosure of Protected Information available to<br />

Hospital or, at the request of Hospital, to the Secretary of the U.S. Department of <strong>Health</strong><br />

and Human Services, for purposes of determining Hospital’s compliance with the Privacy<br />

Rule.<br />

11. Retention of Protected Information. Except as provided in Sections 12 and 13 of this<br />

Exhibit, Practitioner and Practitioner’s agents or subcontractors shall retain all Protected<br />

Information throughout the term of this Agreement and shall continue to maintain the<br />

information required hereunder for a period of six (6) years after expiration or<br />

termination for any reason of this Agreement.<br />

12. Term of Obligations. Practitioner’s HIPAA Obligations shall commence as of the<br />

compliance date of the Privacy Rule, and shall terminate when all of the Protected<br />

Information is destroyed or returned to Hospital, or, if it is infeasible to return or destroy<br />

Protected Information, protections are extended to such information, in accordance with<br />

Section 14 of this Exhibit.<br />

13. Effect of Termination. Upon expiration or termination of this Agreement for any<br />

reason, Practitioner shall return or destroy all Protected Information that Practitioner or<br />

Practitioner’s agents or subcontractors still maintain in any form, and shall retain no<br />

copies of such Protected Information. If return or destruction is not feasible, Practitioner<br />

shall continue to extend the protections of this Exhibit to such information, and limit<br />

further use of such Protected <strong>Health</strong> Information to those purposes that make the return or<br />

destruction of such Protected <strong>Health</strong> Information infeasible.<br />

14. Amendment. The Parties agree to take such action as is necessary to amend HIPAA<br />

Obligations from time to time in order for Hospital to comply with the requirements of<br />

the Privacy Rule, HIPAA and other applicable laws relating to the security or<br />

confidentiality of Protected <strong>Health</strong> Information.<br />

15. Interpretation of Obligations. The HIPAA Obligations shall be interpreted as broadly<br />

as necessary to implement and comply with HIPAA and the Privacy Rule. The Parties<br />

acknowledge and agree that any ambiguity in the HIPAA Obligations shall be resolved in<br />

favor of a meaning that complies and is consistent with HIPAA and the Privacy Rule.<br />

Deleted: <br />

SD\614498.1<br />

Exhibit 6.5-3<br />

ADD C-26


Page 3: [1] Deleted pph March 11, 2010 11:24:00 AM<br />

Exhibit 1.1 (a)<br />

Medical Director, Robotic Surgery<br />

Position Description<br />

Practitioner will provide physician leadership for the establishment of a high quality robotic<br />

surgery program at <strong>Palomar</strong> Medical Center. Responsibilities include:<br />

Research best practices and protocols for robotic surgery programs to share that<br />

knowledge with the medical and clinical staffs at <strong>Palomar</strong> Medical Center. Utilize those<br />

best practices in the formation of all aspects of this new program.<br />

Take a leadership role in working with the Department of Surgery to establish<br />

certification and training requirements for physician credentialing to be able to perform<br />

robotic surgery at <strong>Palomar</strong> Medical Center.<br />

Take a leadership role in working with the appropriate medical staff departments to<br />

establish patient criteria for eligibility for robotic surgery at <strong>Palomar</strong> Medical Center.<br />

In conjunction with the medical staff and the PPH Quality Department, establish quality<br />

measures/metrics and benchmarks for robotic surgery.<br />

Establish policies and procedures for robotic surgery that ensure patient safety and<br />

adherence to best practices.<br />

Act as the physician liaison to work with the Marketing Department on collateral material<br />

development, physician outreach/marketing activities, journal article submissions, public<br />

relations activities, and employee awareness activities.<br />

Lead efforts to target physician awareness and referrals through such activities as CME<br />

and Grand Rounds at the hospital, set up a fast track robotic surgery consult program for<br />

area urologists and surgeons, establish an annual symposium within the robotic surgery<br />

product line, and networking with appropriate specialists such as urologists,<br />

gynecologists and surgeons.<br />

Work with the Physician Development Department to host office staff luncheons to<br />

introduce the program and access procedures to local physician offices.<br />

Work with the Managed Care Department to contact provider/payer representatives<br />

including the major IPAs to inform them of the new service and the need to establish<br />

contract rates.<br />

Work with the Marketing Department to develop content for the PPH Website for robotic<br />

surgery.<br />

Work with the Perioperative Educator and CNS on staff and physician inservices,<br />

education, and training.<br />

Collaborate with the Perioperative Director on establishing and assessing staff<br />

competencies.<br />

Section Break (Next Page)<br />

SD\614498.1<br />

Exhibit 1.1-1<br />

ADD C-27


ADDENDUM D<br />

ADD D-1


AMENDED LINE OF CREDIT AGREEMENT<br />

by and between<br />

PALOMAR POMERADO HEALTH (“PPH”)<br />

and<br />

PALOMAR PHYSICIAN NETWORK, INC. (“PPN”)<br />

ADD D-2


TABLE OF CONTENTS<br />

ARTICLE I. LINE OF CREDIT……………………………………………………………… 2<br />

1.1 Line of Credit…………………………………………………………………. 2<br />

1.2 Advances……………………………………………………………………. … 2<br />

1.3 Use of Advances ………………………………………………………………. 2<br />

1.4 Request and Delivery of Advances…………………………………………….. 2<br />

1.5 Contingencies to PPH’s Payment of Advances<br />

1.6 Repayment……………………………………………………………………… 3<br />

1.7 Promissory Note……………………………………………………………….. .4<br />

ARTICLE II. PROMISSORY NOTE; SECURITY AGREEMENT; GUARANTEE………….4<br />

2.1 PPN’s Deliverables………………………………………………………….. … 4<br />

2.2 Further Cooperation………………………………………………………….. ... 4<br />

ARTICLE III. TERM AND TERMINATION……………………………………………..……4<br />

3.1 Term……………….……………………………………..……………………... 4<br />

3.2 Termination by PPH……………………………………………………………. 4<br />

3.3 Termination by PPN……………….………………………………………..…...5<br />

3.4 Termination or Modifaction in the Event of Government Action………….…...5<br />

3.5 Rights upon Termination……………………………………………….……….6<br />

ARTICLE IV. GENERAL PROVISIONS………………………………………………. .……6<br />

4.1 Independent Contractor …………………………………………………….…....6<br />

4.2 Compliance with HIPAA……………………………………………………..….6<br />

4.3 Amendment…………………………………………………………………..…..6<br />

4.4 Dispute Resolution…………………………………………………………..…...6<br />

4.5 Assignment…………………………………………………………………..…..7<br />

4.6 Attorneys’ Fees……………………………………………………………..……7<br />

4.7 Authorized Persons……………………………………………………………....7<br />

4.8 Choice of Law………………………………………………………………..…..7<br />

4.9 Compliance with Laws…………………………………………………….…….7<br />

4.10 Counterparts………………………………………………………………..…….7<br />

4.11 Entire Agreement………………………………………………………….……..7<br />

4.12 Exhibits…………………………………………………………………………..8<br />

4.13 Force Majeure…………………………………………………………………....8<br />

4.14 Further Assurances; Good Faith………………………………………………....8<br />

4.15 Indemnification…………………………………………………………………..8<br />

4.16 Headings…………………………………………………………………………8<br />

Page<br />

- i-<br />

ADD D-3


4.17 Interruption of Services………………………………………………………….8<br />

4.18 Notices……………………………………………………………………….…..9<br />

4.19 Severability………………………………………………………………...…...10<br />

4.20 No Third-Party Beneficiary Rights………………………………………...…...10<br />

4.21 Waiver………………………………………………………………………......10<br />

4.22 Meaning of Certain Words……………………………………………………...10<br />

- ii-<br />

ADD D-4


Exhibits<br />

Exhibit 1.4 – Notice of Borrowing………………………………………………………..11<br />

Exhibit 2.1(a) – Promissory Note………………………………………………………....13<br />

Attachment to Exhibit 2.1(a) – Schedule of Advances…………………………...17<br />

Exhibit 2.1(b) – Security Agreement……………………………………………………...18<br />

Attachment A to Exhibit 2.1(b) – Description of Collateral………………………26<br />

Attachment B to Exhibit 2.1(b) – Notice of Security Interest in Account………...27<br />

Exhibit 4.2 – Business Associate Agreement…..….………………………………………28<br />

- iii-<br />

ADD D-5


AMENDED LINE OF CREDIT AGREEMENT<br />

THIS AMENDED LINE OF CREDIT AGREEMENT (this “Agreement”) is dated as of<br />

April 12, 2010, (the “Effective Date”) and supersedes the original Line of Credit dated February<br />

1, 2010 by and between PALOMAR POMERADO HEALTH, a local health care district<br />

organized under the laws of the State of California (“PPH”), and <strong>Palomar</strong> Physician Network,<br />

Inc., a California nonprofit Public Benefit Corporation (“PPN”). PPH and PPN are each<br />

sometimes referred to in this Agreement as a “Party” or, collectively, as the “Parties.”<br />

Deleted: February 1, 2010<br />

RECITALS<br />

A. PPH, a local health care district organized under the California Local Hospital<br />

District Law (California <strong>Health</strong> and Safety Code § 32000 et seq.) (the “Law”), owns and<br />

operates healthcare facilities for the benefit of the communities within its boundaries.<br />

B. PPN is a Public Benefit Corporation, organized pursuant to Section 1206(1) of the<br />

California <strong>Health</strong> and Safety Code as a medical foundation, and operated to provide and carry<br />

out charitable healthcare functions by establishing, operating and maintaining multi-specialty<br />

medical clinics for the provision of healthcare services in the communities served by PPH.<br />

C. The Parties believe that it is in the best interests of the public served by PPH to<br />

facilitate the proper operation of PPN so that it may fulfill its duties by entering in to this<br />

Agreement.<br />

D. PPN desires to obtain from PPH certain funds, and PPH has agreed to provide<br />

such funds to PPN to further the public purposes for which PPH and the PPN operate, in<br />

accordance with the California Constitution and according to the terms and conditions set forth<br />

herein.<br />

G. The Parties hereby reference the following additional agreements to which they<br />

are both parties:<br />

(i)<br />

Security Agreement dated February 1, 2010, and attached hereto as Exhibit<br />

2.1(b); and<br />

(ii) Business Associate Agreement dated February 1, 2010.<br />

(iii)<br />

Line of Credit Agreement dated February 1, 2010 (the “original” Line of<br />

Credit)<br />

Formatted: Bullets and Numbering<br />

1<br />

ADD D-6


AGREEMENT<br />

NOW THEREFORE, in consideration of the mutual covenants and agreements<br />

contained herein, the parties hereto agree as follows:<br />

ARTICLE I.<br />

LINE OF CREDIT<br />

1.1 Line of Credit. PPH shall make available to PPN, and PPN agrees to accept<br />

from PPH, a line of credit, the aggregate amount of which shall not exceed One Million -Two<br />

Hundred Fifty Thousand Dollars ($1,250,000.00) (“Line of Credit”), subject to the terms set<br />

forth in Article I. The Line of Credit shall expire in its entirety on June 30, 2015 (the “Credit<br />

Line Expiration Date”). This expiration date does not affect PPN’s repayment obligation.<br />

1.2 Advances. PPH shall advance to PPN amounts requested pursuant to Section 1.4<br />

of this Article (each, an “Advance”, and collectively, the “Advances”), from time to time prior<br />

to, but not including, the Credit Line Expiration Date. The aggregate amount of all outstanding<br />

Advances shall not exceed the Line of Credit. Notwithstanding the foregoing, both PPH’s Chief<br />

Executive Officer and Chief Financial Officer and PPN’s President and Treasurer shall approve<br />

in writing Advance requests exceeding One Hundred Thousand Dollars ($100,000.00).<br />

1.3 Use of Advances. PPN shall use the Advances for the following purposes only:<br />

(a) Up to One Million Two Hundred Fifty Thousand Dollars ($1,250,000.00)<br />

may be used for the purpose of assisting PPN in normalizing cash flow related to its business.<br />

PPN may make withdrawals for this purpose until June 30, 2015 based upon expected realizable<br />

patient services and capitation revenue collections for the then current month. No additional<br />

draws can be made upon this portion of the Line of Credit after June 30, 2015, nor can any<br />

undrawn portion be re-allocated to another portion of the Line of Credit. This portion of the<br />

LOC shall be referred to as the A/R Line of Credit (“A/R Line of Credit”);<br />

(b) Up to One Hundred-Twenty-five Thousand Dollars ($125,000.00) may be<br />

used by PPN to cover start up business expenses. This amount may be withdrawn for the months<br />

of February 2010 through June 2010. This portion of the Line of Credit shall be referred to as<br />

the Working Capital Line of Credit (“Working Capital Line of Credit”).<br />

Deleted: .<br />

Deleted:<br />

1.4 Request and Delivery of Advances. When PPN desires to obtain an Advance, it<br />

shall deliver to PPH a notice in the form attached hereto as Exhibit 1.4 (the “Notice of<br />

Borrowing”) at least three (3) Business Days prior to the date on which the Advance is to be paid<br />

(the “Proposed Funding Date”). The Notice of Borrowing shall specify the Proposed Funding<br />

Date (which shall be a Business Day), the amount of the requested Advance, and certify as to the<br />

satisfaction of each of the conditions set forth in Exhibit 1.4. “Business Day” shall mean any<br />

day which is not a Saturday, Sunday or a generally observed holiday for banks in the State of<br />

California.<br />

1.5 Contingencies to PPH’s Payment of Advances. PPH’s obligation to make any<br />

Advances to PPN under this Agreement shall be contingent upon the following:<br />

2<br />

ADD D-7


(a) Documentation. PPN’s submission to PPH, in form and substance<br />

satisfactory to PPH, this Agreement, the Note (as defined in Section 2.1(a)), the Security<br />

Agreement (as defined in Section 2.1(b)), and such other documents and instruments as PPH<br />

may reasonably request, all duly executed by PPN.<br />

(b) Notice of Borrowing. PPN’s submission to PPH of a Notice of Borrowing<br />

in which PPN certifies that as of the date of the Notice of Borrowing:<br />

(i) all of PPN’s representations and warranties contained in this<br />

Agreement shall be true, correct and complete in all material respects to the same extent as<br />

though made on and as of that date;<br />

(ii) no Event of Default (as defined in Exhibit 2.1(b)) shall have<br />

occurred and shall continue, or shall result from, making the Advance;<br />

(iii) no law or regulation shall prohibit, and no order, judgment or<br />

decree of any court, arbitrator or governmental authority shall purport to enjoin or restrain PPH<br />

from making the Advance; and<br />

(iv) no change having a Material Adverse Effect on PPN, either<br />

individually or in the aggregate, shall have occurred since the Execution Date. “Material<br />

Adverse Effect” shall mean a material adverse effect upon PPN’s purpose, function, operation or<br />

status or upon PPH’s security interest in the Collateral (as defined in Exhibit 2.1(b) attached<br />

hereto) or the priority thereof.<br />

(c) Perfection. The Account described in Exhibit 2.1(b) of this Agreement<br />

shall have been established in a manner satisfactory to PPH, in its sole discretion, and PPH shall<br />

be satisfied that all steps shall have been taken necessary to create and perfect in favor of PPH a<br />

first priority security interest in the Account and all other Collateral described in such Exhibit<br />

2.1(b).<br />

1.6 Repayment. Repayment of the Line of Credit is as follows:<br />

(a) Repayment of outstanding principle on the Line of Credit will commence<br />

effective July 1. 2015 and shall continue during its remaining term. Repayment shall be made in<br />

Sixty (60) equal installments. Should the Agreement be terminated prior to its natural expiration,<br />

for any reason, any and all principle amounts and accrued interest then currently outstanding are<br />

immediately due and payable.<br />

(b) The Line of Credit shall bear interest at the one year (1) LIBOR plus two<br />

(2 ) percent as of the actual date of funds disbursement (“Funding Date”) of each individual<br />

advance . Interest shall accrue from the Funding Date. Notwithstanding the foregoing, should<br />

PPN provide PPH with documentation that it is able to obtain a creditworthy loan on similar<br />

terms and conditions as that contemplated under the Line of Credit from a reputable third party<br />

lending institution at a lower interest rate, then PPH, in its sole discretion, may adjust the interest<br />

rate to match said documented fair market value rate.<br />

3<br />

ADD D-8


(c) PPN, may, without penalty, repay any and all principle and accrued<br />

interest at any time during the term of the Agreement.<br />

1.7 Promissory Note. PPN shall repay the Advances and accrued interest pursuant to<br />

the terms and conditions of the Note (as defined below). PPN authorizes PPH to record on the<br />

schedule annexed to the Note, the date and amount of each Advance made by PPH, the Interest<br />

Rate (as such term is defined in the Note) when each Advance is made, and each payment or<br />

prepayment of the Advances, and agrees that all such notations shall constitute prima facie<br />

evidence of the matters noted. PPN further authorizes PPH to attach to and make a part of the<br />

Note continuations of the schedule as necessary. No failure to make any such notations, nor any<br />

errors in making any such notations, shall affect the validity of PPN’s obligations to repay the<br />

Advances or PPN’s obligations under this Agreement, the Note, or any other document, contract<br />

or instrument delivered to PPH in connection with this Agreement (collectively, the “Line of<br />

Credit Documents”).<br />

ARTICLE II.<br />

PROMISSORY NOTE; SECURITY AGREEMENT; GUARANTEE<br />

2.1 PPN’s Deliverables. Concurrently with the execution of this Agreement, PPN<br />

shall execute and deliver to PPH:<br />

“Note”); and<br />

(a)<br />

the secured promissory note in the form attached as Exhibit 2.1(a) (the<br />

(b) the security agreement in the form attached as Exhibit 2.1(b) (the<br />

“Security Agreement”).<br />

2.2 Further Cooperation. PPH and PPN shall perform, or ensure the performance<br />

of, all actions and execute, or ensure the execution of, all documents necessary to perfect the<br />

security interests granted in the Security Agreement, as reasonably requested by PPH from time<br />

to time.<br />

ARTICLE III.<br />

TERM AND TERMINATION<br />

3.1 Term. This Agreement shall become effective on April 12, 2010 (the “Effective<br />

Date”), and shall continue until June 30, 2020 (the “Expiration Date”), subject to the termination<br />

provisions of this Agreement.<br />

Deleted: February 1<br />

3.2 Termination by PPH. PPH shall have the right to terminate this Agreement<br />

upon the occurrence of any one or more of the following events:<br />

(a) Breach of this Agreement by PPN where the breach is not cured within<br />

thirty (30) calendar days after PPH gives written notice of the breach to PPN;<br />

(b) Breach by PPN of the requirements under the <strong>Health</strong> Insurance Portability<br />

and Accountability Act of 1996 (“HIPAA”) (as set forth in the BAA);<br />

4<br />

ADD D-9


(c)<br />

any reason; or<br />

PPN is rendered unable to comply with the terms of this Agreement for<br />

other cases.<br />

(d)<br />

Upon ninety (90) calendar days written notice without cause to PPN in all<br />

3.3 Termination by PPN. PPN shall have the right to terminate this Agreement<br />

according to the following terms and conditions:<br />

(a) Breach of this Agreement by PPH where the breach is not cured within<br />

thirty (30) calendar days after PPN gives written notice of the breach to PPH or if the breach is<br />

not curable, then thirty (30) calendar days after PPN gives written notice of the breach to PPH;<br />

(b) PPN is rendered legally unable to comply with the terms of this<br />

Agreement for any reason, in which case termination shall be coterminous with the date of such<br />

legal inability; or<br />

other cases.<br />

(c)<br />

Upon ninety (90) calendar days written notice without cause to PPH in all<br />

3.4 Termination or Modification in the Event of Government Action. If the<br />

Parties receive notice of any Government Action (defined below), the Parties shall attempt to<br />

amend this Agreement in order to comply with the Government Action. If the Parties, acting in<br />

good faith, are unable to agree to the amendments necessary to comply with the Government<br />

Action, or, alternatively, if either Party determines in good faith that compliance with the<br />

Government Action is impossible or infeasible, this Agreement shall be terminated ten days after<br />

one party gives notice to the other of such fact. For the purposes of this Section, “Government<br />

Action” shall mean any legislation, regulation, rule or procedure passed, adopted or implemented<br />

by any federal, state or local government or legislative body or any private agency, or any notice<br />

of a decision, interpretation, finding, or action by any governmental or private agency, court or<br />

other third-party which, in the opinion of counsel to PPH, because of the arrangement between<br />

the Parties pursuant to this Agreement, if or when implemented, would:<br />

(a) revoke or jeopardize the status of any health facility license granted to<br />

PPH or any Affiliate (defined below) of PPH;<br />

(b)<br />

Affiliate of PPH; or<br />

prevent PPN from being able to access and use the facilities of PPH or any<br />

(c) subject PPH, any Affiliate of PPH, PPN, or any of their respective<br />

employees or agents, to civil or criminal prosecution (including any excise tax penalty under<br />

Internal Revenue Code Section 4958) on the basis of their participation in executing this<br />

Agreement or performing their respective obligations under this Agreement.<br />

(d) For the purposes of this Section, “Affiliate” shall mean any entity which,<br />

directly or indirectly, controls, is controlled by or is under common control with PPH.<br />

5<br />

ADD D-10


3.5 Rights upon Termination. Upon any termination or expiration of this<br />

Agreement, all rights and obligations of the Parties shall cease except those rights and<br />

obligations that have accrued or expressly survive such termination or expiration.<br />

Notwithstanding the above, upon termination of this Agreement by PPH and PPN pursuant to<br />

Sections 3.2 and 3.3, respectively, of this Agreement, the outstanding principal amount of the<br />

Advances and all accrued but unpaid interest shall automatically become due and payable.<br />

ARTICLE IV.<br />

GENERAL PROVISIONS<br />

4.1 Independent Contractor. PPH is and shall at all times be an independent<br />

contractor with respect to PPN in meeting PPH’s responsibilities under this Agreement. Nothing<br />

in this Agreement is intended nor shall be construed to create a partnership, employer-employee<br />

or joint venture relationship between PPH and PPN.<br />

4.2 Compliance with HIPAA. PPH and PPN shall comply with the HIPAA<br />

requirements as defined and set forth in Exhibit 4.2. The HIPAA requirements shall survive the<br />

expiration or termination of this Agreement for any reason.<br />

4.3 Amendment. This Agreement may be modified or amended only by mutual<br />

written agreement of the Parties. Any such modification or amendment must be in writing,<br />

dated, signed by the Parties and attached to this Agreement.<br />

4.4 Dispute Resolution. In the event of any disagreement, dispute or claim<br />

(collectively, a “Dispute”) arises between the Parties hereto with respect to whether an alleged<br />

breach hereof has or has not occurred, or with respect to any other matter related to or arising out<br />

of this Agreement, or the relationship or transactions contemplated hereby, the Dispute shall be<br />

resolved in accordance with the following procedures:<br />

(a) Meet and Confer. In the event of a Dispute, either Party may give written<br />

notice to the other Party setting forth the nature of the Dispute (the “Dispute Notice”). The<br />

Parties shall meet and confer to discuss in good faith and attempt to resolve the Dispute within<br />

fifteen (15) days of the Party receiving the Dispute Notice. The representatives of the Parties<br />

shall meet at such date(s) and time(s) as are mutually convenient to the representatives of each<br />

Party within the 15-day period.<br />

(b) Arbitration. Except as set forth below, any Dispute that cannot be<br />

resolved by the Parties under Section 4.4(a) within the 30-day meet-and-confer period, shall be<br />

submitted to final binding arbitration, as follows:<br />

(i) Designation of an Arbitrator. A single disinterested third party<br />

shall be selected by mutual agreement of the Parties. If the Parties are unable to mutually select<br />

an arbitrator within (15) days after each party notifies the other of its desire to arbitrate the<br />

Dispute, then the arbitrator shall be selected, and the arbitration shall be conducted, in<br />

accordance with JAMS’s then-current Comprehensive Arbitration Rules and Procedures or<br />

Streamlined Rules of Practice and Procedure, as appropriate, depending on the amount in<br />

dispute.<br />

6<br />

ADD D-11


(ii) Venue. The arbitration shall be conducted in the County of San<br />

Diego, California, unless the Parties mutually determine that another venue would be more<br />

convenient.<br />

(iii) Arbitrator’s Expenses and Fees. JAMS’ administrative fees and<br />

the expenses and fees of the arbitrator shall be divided among the Parties equally. Each Party<br />

shall pay its own counsel fees, witness fees, and other expenses incurred.<br />

4.5 Assignment. Except for assignment by PPH to an entity owned, controlled by, or<br />

under common control with PPH, neither Party may assign any interest or obligation under this<br />

Agreement without the other Party’s prior written consent. Subject to the foregoing, this<br />

Agreement shall be binding on and shall inure to the benefit of the Parties and their respective<br />

successors and assigns.<br />

4.6 Attorneys’ Fees. If either Party brings an action for any relief or collection<br />

against the other Party, declaratory or otherwise, arising out of the arrangement described in this<br />

Agreement, the losing Party shall pay to the prevailing Party a reasonable sum for attorneys’ fees<br />

and costs actually incurred in bringing such action, all of which shall be deemed to have accrued<br />

upon the commencement of such action and shall be paid whether or not such action is<br />

prosecuted to judgment. Any judgment or order entered in such action shall contain a specific<br />

provision providing for the recovery of attorneys’ fees and costs incurred in enforcing such<br />

judgment. For the purpose of this Section, attorneys’ fees shall include fees incurred in<br />

connection with discovery, post judgment motions, contempt proceedings, garnishment and levy.<br />

4.7 Authorized Persons. Whenever any consent, approval or determination of a<br />

Party is required pursuant to this Agreement, the consent, approval or determination shall be<br />

rendered on behalf of the Party by the person or persons duly authorized to do so, which the<br />

other Party shall be justified in assuming means any officer of the Party rendering such consent,<br />

approval or determination, or the Party’s board of directors.<br />

4.8 Choice of Law. This Agreement shall be construed in accordance with and<br />

governed by the laws of the State of California, except choice of law rules that would require the<br />

application of the laws of any other jurisdiction.<br />

4.9 Compliance with Laws. PPN shall comply with applicable laws, ordinances,<br />

codes and regulations of federal, state and local governments, including laws that require PPN to<br />

disclose any economic interest or relationship with PPH.<br />

4.10 Counterparts. This Agreement may be executed in one or more counterparts,<br />

each of which shall be deemed to be an original, but all of which together shall constitute one<br />

and the same instrument.<br />

4.11 Entire Agreement. This Agreement is the entire understanding and agreement of<br />

the Parties regarding its subject matter, and supersedes any prior oral or written agreements,<br />

representations, understandings, discussions or past practices between the Parties. No other<br />

understanding between the Parties shall be binding on them unless set forth in writing, signed<br />

and attached to this Agreement.<br />

7<br />

ADD D-12


4.12 Exhibits. The attached exhibits, together with all documents incorporated by<br />

reference in the exhibits, form an integral part of this Agreement and are incorporated into this<br />

Agreement wherever reference is made to them to the same extent as if they were set out in full<br />

at the point at which such reference is made.<br />

4.13 Force Majeure. Except with respect to obligations imposed with regard to<br />

payments to be paid by PPN under this Agreement, neither Party is liable for nonperformance or<br />

defective or late performance of any of its obligations under this Agreement to the extent and for<br />

such periods of time as such nonperformance, defective performance or late performance is due<br />

to reasons outside such Party’s control, including acts of God, war (declared or undeclared),<br />

action of any governmental authority, riots, revolutions, fire, floods, explosions, sabotage,<br />

nuclear incidents, lightning, weather, earthquakes, storms, sinkholes, epidemics, failure of<br />

utilities, or strikes (or similar nonperformance or defective performance or late performance of<br />

employees, suppliers or subcontractors).<br />

4.14 Further Assurances; Good Faith. Each Party shall, at the reasonable request of<br />

the other Party, execute and deliver to the other party all further instruments, assignments,<br />

assurances and other documents, and take any actions as the other Party reasonably requests in<br />

connection with the carrying out of this Agreement. In performing its obligations under this<br />

Agreement, each Party shall act in good faith.<br />

4.15 Indemnification. To the extent that such acts or omissions are not covered by<br />

insurance, each Party shall indemnify, hold harmless and defend the other Party and its officers,<br />

agents or employees, against any loss or liability arising out of or resulting in any way from the<br />

acts or omissions of such Party or its own officers, employees or agents, except that any such<br />

obligation to indemnify and hold harmless shall be reduced by any amount of such loss or<br />

liability arising from the contributory acts or omissions of the indemnified Party and its owners,<br />

employees or agents. This obligation shall not be qualified or eliminated by an allegation or<br />

finding that the other Party or any of its personnel is responsible for a passively negligent act or<br />

omission. This section shall survive the termination of this Agreement.<br />

4.16 Headings. The headings in this Agreement are intended solely for convenience<br />

of reference and shall be given no effect in the construction or interpretation of this Agreement.<br />

4.17 Interruption of Services. Notwithstanding any provision in this Agreement to<br />

the contrary, PPH shall not be liable to PPN in damages or otherwise for any failure to advance<br />

any funds contemplated by this Agreement. This Agreement contemplates a close operating<br />

relationship between PPH and PPN that will exist over a long period of time. Accordingly, in<br />

approving this Agreement and directing its officers to enter into this Agreement on its behalf, the<br />

Parties shall mutually review the performance of both Parties to this Agreement, identifying<br />

deficiencies in the performance of either or both Parties to this Agreement, developing (as<br />

necessary) a plan for addressing any such deficiencies, discussing potential modifications to the<br />

terms and conditions of this Agreement and the responsibilities of the Parties as set forth herein<br />

reviewing the outstanding principal amount of Advances, including all accrued but unpaid<br />

interest thereon, made pursuant to this Agreement and addressing repayment of such amounts,<br />

and at the appropriate time addressing a plan for PPN to attain self-sufficiency.<br />

8<br />

ADD D-13


4.18 Notices. All notices or communications required or permitted under this<br />

Agreement shall be given in writing and delivered personally or sent by United States registered<br />

or certified mail with postage prepaid and return receipt requested or by overnight delivery<br />

service (e.g., Federal Express, DHL). Notice is deemed given when sent, if sent as specified in<br />

this Section, or otherwise deemed given when received. In each case, notice shall be delivered<br />

or sent to:<br />

If to PPH, addressed to:<br />

<strong>Palomar</strong> Pomerado <strong>Health</strong><br />

456 E. Grand Ave<br />

Escondido, CA 92025<br />

Attention: Chief Financial Officer<br />

Copy to:<br />

<strong>Palomar</strong> Pomerado <strong>Health</strong><br />

15255 Innovation Drive<br />

San Diego, Ca 92128<br />

Attn: Legal Department<br />

If to PPN, addressed to:<br />

<strong>Palomar</strong> Physician Network<br />

456 E. Grand Avenue<br />

Escondido, Ca 92025<br />

Attn: PPN President<br />

Either Party may provide for a different address by notifying the other Party of such<br />

change as provided for in this Section.<br />

4.19 Severability. If any provision of this Agreement is determined to be illegal or<br />

unenforceable, that provision shall be severed from this Agreement, and such severance shall<br />

have no effect upon the enforceability of the remainder of this Agreement unless the purpose of<br />

this Agreement is thereby destroyed.<br />

4.20 No Third-Party Beneficiary Rights. The Parties do not intend to confer and this<br />

Agreement shall not be construed to confer any rights or benefits to any person, firm, group,<br />

corporation or entity other than the Parties, including but not limited to the Personnel.<br />

4.21 Waiver. No delay or failure to require performance of any provision of this<br />

Agreement shall constitute a waiver of that provision as to that or any other instance. Any<br />

waiver granted by a Party must be in writing to be effective, and shall apply solely to the specific<br />

instance expressly stated.<br />

9<br />

ADD D-14


4.22 Meaning of Certain Words. Wherever the context may require, any pronouns<br />

used in this Agreement shall include the corresponding masculine, feminine, or neuter forms, and<br />

the singular form of nouns shall include the plural and vice versa.<br />

The Parties have executed this Agreement on the date written below (the “Execution<br />

Date”).<br />

PALOMAR POMERADO HEALTH,<br />

a California local health care district<br />

Date:_____________, 2010<br />

By:<br />

Its:<br />

PALOMAR PHYSICIAN NETWORK, INC.<br />

Date: ____________, 2010<br />

By:<br />

Its:<br />

10<br />

ADD D-15


<strong>Palomar</strong> Physician Network, Inc.<br />

456 E. Grand Avenue<br />

Escondido, Ca. 92025<br />

Date: ___________________________, 201_<br />

EXHIBIT 1.4<br />

NOTICE OF BORROWING<br />

PALOMAR PHYSICIAN NETWORK, INC.<br />

Re:<br />

Notice of Borrowing<br />

To Whom It May Concern:<br />

Please take notice that <strong>Palomar</strong> Physician Network, Inc. (“PPN”), desires to borrow an<br />

Advance of _______________________________Dollars ($_____________) pursuant to the<br />

Amended Line of Credit dated April 12, 2010 from <strong>Palomar</strong> Pomerado <strong>Health</strong>, a local health<br />

care district organized under the laws of the State of California (“PPH”), on ___________ __,<br />

2010 (the “Funding Date”). Advance requests exceeding One Hundred Thousand Dollars<br />

($100,000) must be accompanied by signatures from PPH’s Chief Executive Officer and Chief<br />

Financial Officer and PPN’s President and Treasurer.<br />

PPN hereby certifies that as of the date of this Notice:<br />

(a) all of PPN’s representations and warranties contained in the Professional Services<br />

Agreement (the “Agreement”) and all exhibits to the Agreement shall be true, correct and<br />

complete in all material respects to the same extent as though made on and as of that date;<br />

(b) PPN shall not be in default of the Agreement, nor shall any default occur,<br />

continue, or result from, making the Advance;<br />

(c) no law or regulation of general application shall prohibit, nor any order, judgment<br />

or decree of any court, arbitrator or governmental authority specifically naming PPN and known<br />

to PPN, shall purport to enjoin or restrain PPH from making the Advance; and<br />

(d) no change having a material adverse effect on PPN (as such term is defined in the<br />

Agreement), either individually or in the aggregate, shall have occurred since the Execution<br />

Date.<br />

Sincerely,<br />

_________________________________________<br />

Name: ___________________________________<br />

11<br />

ADD D-16


Title: ___________________________________<br />

As Approved By<br />

PALOMAR POMERADO HEALTH,<br />

a California health care district<br />

Date: _______________<br />

________________________________________________<br />

By:<br />

Its: Chief Executive Officer<br />

PALOMAR POMERADO HEALTH,<br />

a California health care district<br />

Date: _______________<br />

________________________________________________<br />

By:<br />

Its: Chief Financial Officer<br />

PALOMAR PHYSICIAN NETWORK, INC.<br />

Date: _______________<br />

________________________________________________<br />

By:<br />

Its: President<br />

PALOMAR PHYSICIAN NETWORK, INC.<br />

Date: _______________<br />

________________________________________________<br />

By:<br />

Its: Treasurer<br />

12<br />

ADD D-17


EXHIBIT 2.1(a)<br />

PROMISSORY NOTE<br />

San Diego County<br />

Not to Exceed $1,250,000.00<br />

FOR VALUE RECEIVED, <strong>Palomar</strong> Physician Network, Inc. (“PPN”), promises to pay<br />

to the order of <strong>Palomar</strong> Pomerado <strong>Health</strong>, a local health care district organized under the laws of<br />

the State of California (“PPH”), the principal sum equal to the outstanding amount of Advances<br />

paid to PPN pursuant to the Amended Line of Credit Agreement by and between PPN and PPH<br />

dated as of April 12, 2010 (the “Agreement”). Unless otherwise defined in this Promissory Note<br />

(the “Note”), each capitalized term shall have the meaning given in the Agreement. The<br />

outstanding principal amount of the Advances provided to PPN pursuant to the Line of Credit<br />

(the “Principal”) shall not exceed One Million-Two Hundred Fifty Thousand Dollars<br />

($1,250,000.00).<br />

1. Advances of Principal; Interest.<br />

Deleted: ___________,<br />

Deleted:<br />

Formatted: Bullets and Numbering<br />

(a) PPN hereby promises to pay to the order of PPH, at such place as PPH<br />

may from time to time designate in writing, in lawful money of the United States of America, the<br />

Principal and accrued interest thereon.<br />

(b) Interest shall accrue on the Advances at a rate equal to two percent (2%)<br />

above the one (1) year LIBOR (the “Interest Rate”), computed annually on the basis of a 360-day<br />

year, and the number of days elapsed from the Funding Date each Advance is deposited into<br />

PPN’s Account until the outstanding Advances are repaid. Accrued interest shall be paid<br />

monthly in arrears on the first Business Day of each month. The first (1st) Advance shall fix<br />

the Interest Rate for that calendar quarter. Any subsequent Advance in that quarter shall be<br />

assigned the same Interest Rate. Notwithstanding any other provision of this Agreement, the<br />

Interest Rate shall not exceed the maximum rate permitted by applicable law (the “Permitted<br />

Rate”). If any payments in the nature of interest exceed the Permitted Rate, as finally determined<br />

by a court of competent jurisdiction, any such amount in excess shall be considered payment of<br />

Principal and the Principal outstanding shall be reduced accordingly.<br />

2. Repayment.<br />

Formatted: Bullets and Numbering<br />

(a) Notwithstanding any other provisions of this Note, Principal , accrued<br />

interest, and other applicable fees, costs and charges (“Costs”), if any, owing on this Note shall<br />

be payable as follows:<br />

(b) Repayment. Principal and accrued interest thereon shall be payable in<br />

sixty (60) equal monthly installments sufficient to fully amortize the unpaid balance of this Note.<br />

Principal and accrued interest thereon shall be payable on the first (1 st ) Business Day of each<br />

successive calendar month beginning on the Agreement Expiration Date and continuing until the<br />

earlier of (i) the date on which the Principal and all accrued interest thereon, and all Costs, if any,<br />

are paid in full, or (ii) the Maturity Date (as defined below). In all events, and subject to the<br />

13<br />

ADD D-18


emaining provisions of this Section 2, the entire then-outstanding balance of Principal and all<br />

accrued, unpaid interest thereon, and all Costs, if any, shall be due and payable to PPH no later<br />

than the Maturity Date, the “Maturity Date” shall mean the date that is sixty (60) months from<br />

the Agreement Expiration Date<br />

(c) Application of Payments. Unless otherwise agreed in writing in advance<br />

by PPH, each payment or forgiveness with respect to this Note shall be credited as follows: first,<br />

against PPN Expenses; second, against accrued and unpaid interest then due and owing; and<br />

third, against the Principal outstanding.<br />

(d) Prepayment. PPN shall have the right to prepay the Principal outstanding<br />

in whole or in part without penalty. Any partial prepayment shall be applied against the<br />

Principal outstanding and shall not postpone the due date or alter the amount of any subsequent<br />

monthly installment. Any amounts prepaid prior to the Agreement Expiration Date may be<br />

reborrowed.<br />

3. Events of Default. The termination for any reason of the business of PPN or the<br />

occurrence of any Event of Default of the Agreement shall constitute an event of default (“Event<br />

of Default”) under this Note.<br />

4. Acceleration. If either an Event of Default (as defined in Exhibit 2.1(b) of this<br />

Agreement) occurs, or if the Agreement is terminated by either PPH or PPN pursuant to Sections<br />

3.2 and 3.3, respectively, of the Agreement, PPH may, at its option, declare the entire Principal<br />

outstanding, together with accrued interest and all other PPN Expenses immediately due and<br />

payable to PPH; and PPH shall have all rights, powers and remedies available under the<br />

Agreement documents, or accorded by law to a beneficiary or a secured party, including the right<br />

to resort to any or all of the Collateral or any other security for any of the obligations of PPN.<br />

PPH may exercise its rights and remedies with respect to the Collateral without resorting or<br />

regard to other security or sources for payment. All rights, powers and remedies of PPH in<br />

connection with each of the Agreement documents may be exercised at any time by PPH, and<br />

from time to time after the occurrence of an Event of Default, are cumulative and not exclusive,<br />

and shall be in addition to any other rights, powers or remedies provided by law or equity.<br />

5. Termination. Upon the occurrence of an Event of Default or upon termination of<br />

the Agreement by PPH or PPN pursuant to Sections 3.2 and 3.3, respectively of the Agreement,<br />

the outstanding principal amount of the Advances, all accrued but unpaid interest and all other<br />

obligations of PPN under the Agreement may automatically become, or may be declared to be,<br />

due and payable in the manner, upon the conditions and with the effect provided in the<br />

Agreement.<br />

6. Costs of Collection. If PPH exercises its acceleration rights pursuant to this Note, in<br />

addition to the Principal outstanding and accrued interest thereon, PPH shall be entitled to collect<br />

all costs of collection, including reasonable attorneys’ fees incurred in connection with the<br />

protection or realization of collateral and PPH’s reasonable collection efforts, whether or not suit<br />

on this Note or any foreclosure proceeding is filed. Any and all such costs and expenses shall be<br />

payable on demand and secured by the Security Agreement.<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

14<br />

ADD D-19


7. Continuing Liability. Following the occurrence of an Event of Default, PPN’s<br />

liability under this Note shall not be affected by PPH’s pursuit or non-pursuit of any one or more<br />

of its rights, powers or remedies (including, without limitation, its option to accelerate the<br />

payment of this Note), regardless of the order in which or the extent to which PPH may pursue<br />

any of such rights, powers or remedies, it being understood that the liability of PPN shall cease<br />

only upon satisfaction in full of all of PPN’s obligations arising under this Note and the<br />

Professional Services Agreement.<br />

8. No Waiver. No failure on the part of PPH to exercise any right or remedy under this<br />

Note, whether before or after a default, shall constitute a waiver of such right or remedy, and no<br />

waiver of any past default shall constitute waiver of any future default. No acceptance of a past<br />

due installment or other indulgence granted for time to time shall constitute a waiver of the right<br />

to insist upon prompt payment, be deemed to be a novation of this Note or as a reinstatement of<br />

the debt evidenced by this Note, or be construed to preclude the exercise of any right which PPH<br />

may have under law, by agreement or otherwise. PPH and each endorser or guarantor hereby<br />

expressly waive the benefit of any statute or rule of law or equity which would produce a result<br />

contrary to or in conflict with the foregoing. PPN and endorsers of this Note consent to renewals<br />

and extensions of time at or after the maturity hereof, without notice, and hereby waive<br />

diligence, presentment, protest, demand and notice of every kind and, to the full extent permitted<br />

by law, the right to plead any statute of limitations as a defense to any demand under this Note.<br />

9. Waiver of Notice. PPN and each endorser or guarantor of this Note hereby (i)<br />

waives presentment, demand, protest and notice of presentment, notice of protest and notice of<br />

dishonor of this debt and any other notice respecting this Note, and (ii) agrees that PPH, at any<br />

time without notice to such party or such party’s consent, may grant extensions of time, without<br />

limit as to the number or the aggregate period of such extensions, for the payment of any<br />

Principal of or interest accrued thereon.<br />

10. Choice of Law. This Note shall be construed in accordance with and governed by<br />

the laws of the State of California, without giving effect to any choice of law or conflict of law<br />

rules or provisions that would cause the application of the laws of any jurisdiction other than the<br />

State. PPN and each endorser or guarantor hereby submit to jurisdiction in said State for the<br />

enforcement of PPN’s obligations under this Note and all other Agreement documents, and<br />

waive any and all rights under the laws of any other state to object to jurisdiction within such<br />

State.<br />

11. Amendments. This Note may be modified or amended only by mutual written<br />

agreement of the Parties. Any such modification or amendment must be in writing, dated, signed<br />

by the Parties and attached to this Note.<br />

12. Assignment. PPN shall not assign, sell, transfer or delegate any of the PPN’s rights<br />

or duties under this Note without the prior written consent of PPH. PPH may assign its rights<br />

and delegate its duties under this Note upon written notice to PPN.<br />

13. Notices. Any notice required or permitted to be given in this Note shall be given in<br />

accordance with the notices provision of the Agreement.<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

15<br />

ADD D-20


14. Security. This Note is secured by a first priority security interest granted by PPN to<br />

PPH in the Collateral described in that certain Security Agreement of even date herewith (the<br />

“Security Agreement”) by and between PPN and PPH. All of the provisions contained in the<br />

Security Agreement are hereby made a part of this Note to the same extent and with the same<br />

effect as if they were fully set forth in this Note.<br />

15. Severability. If any provision of this Note, in whole or in part, or the application of<br />

any provision, in whole or in part, is determined to be illegal, invalid or unenforceable by a court<br />

of competent jurisdiction, such provision or part of such provision shall be severed from this<br />

Note, and such severance shall have not effect upon the enforceability, performance or<br />

obligations of the remainder of this Note, including the remainder of such provision not<br />

determined to be illegal, invalid or unenforceable.<br />

16. Successors and Assigns. The provisions of this Note shall inure to the benefit of<br />

and shall be binding upon the heirs, assigns, successors and representatives of PPN and PPH,<br />

respectively. The term “PPN” shall mean PPN and each heir, successor, assign, and<br />

representative of PPN as obligor of this Note. The term “PPH” shall mean PPH and each<br />

successor, assign, and representative of PPH as payee or holder of this Note.<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

Formatted: Bullets and Numbering<br />

PPN has executed and delivered this Note as of the date and at the place first above<br />

written.<br />

<strong>Palomar</strong> Physician Network, Inc.<br />

By: ______________________________________<br />

Its: ______________________________________<br />

16<br />

ADD D-21


ATTACHMENT TO EXHIBIT 2.1(a)<br />

SCHEDULE OF ADVANCES<br />

Date Advance Current<br />

LIBOR Rate<br />

Prepayment or<br />

Repayment<br />

Outstanding<br />

Balance<br />

17<br />

ADD D-22


EXHIBIT 2.1(b)<br />

SECURITY AGREEMENT<br />

THIS SECURITY AGREEMENT (this “Security Agreement”), executed and delivered<br />

as of the same date of the Amended Line of Credit Agreement dated April 12, 2010<br />

(“Agreement”), by PALOMAR PHYSICIAN NETWORK, INC., (“Debtor”), for the benefit of<br />

PALOMAR POMERADO HEALTH, a local health care district organized under the laws of the<br />

State of California (“Secured Party”).<br />

RECITALS<br />

A. Debtor and Secured Party desire to enter into this Security Agreement to grant a<br />

security interest to Secured Party in the Collateral, as hereinafter defined, to secure the<br />

performance of the obligations and duties of Debtor under the Agreement.<br />

AGREEMENT<br />

NOW THEREFORE, in consideration of the mutual covenants and agreements contained<br />

herein, the parties hereto agree as follows:<br />

ARTICLE I.<br />

COLLATERAL AND SECURITY INTEREST<br />

1.1 Collateral and Grant of Security Interest. Debtor hereby grants to Secured<br />

Party a security interest of first priority in the Collateral, as described in Attachment A, to secure<br />

the payment and performance of all indebtedness, liabilities and obligations of Debtor to Secured<br />

Party under the Agreement and repayment of the principal amount of the Advances (as defined<br />

in Section 3.2 of the Agreement) and accrued interest thereon. The security interest created by<br />

this Security Agreement shall attach immediately on execution of this Security Agreement by<br />

Debtor.<br />

1.2 Perfection and Priority. Debtor shall take all action necessary to perfect the<br />

security interest granted to Secured Party in Section 1.1 of this Security Agreement. Secured<br />

Party’s security interest in the Collateral is, and will continue to be, a first priority security<br />

interest which is free and clear of all liens, claims, security interest and encumbrances, except<br />

with respect to any liens, claims, security interest and encumbrances granted by statute or<br />

pursuant to any other agreement executed by and between Secured Party and Debtor. Secured<br />

Party shall have no duty to collect or protect the Collateral, nor to preserve rights against prior<br />

parties or any other rights pertaining to the Collateral. Secured Party shall perfect its security<br />

interest in the Account (as defined in Section 1.5 herein) by sending to the appropriate financial<br />

institution a letter in the form of Attachment B.<br />

1.3 Further Assurances. Debtor shall, from time to time, at Debtor’s expense,<br />

execute and file any financing or continuation statements, or amendments thereto, and other<br />

instruments, endorsements or notices, and take other actions, reasonably necessary or as Secured<br />

Party reasonably requests, in order to perfect and preserve the assignments and security interests<br />

granted or purported to be granted by this Security Agreement. Debtor authorizes Secured Party<br />

18<br />

ADD D-23


to file one or more financing or continuation statements, and amendments thereto, relative to all<br />

or any part of the Collateral without Debtor’s signature where permitted by law. Copies of any<br />

such statement or amendment shall promptly be delivered to Debtor. Debtor shall notify Secured<br />

Party of any change in Debtor’s name, identity or corporate structure at least fifteen (15) days<br />

prior to any such change.<br />

1.4 Principal Place of Business. Debtor’s principal place of operation, where Debtor<br />

shall keep records regarding the Collateral, is located at 456 East Grand Avenue, Escondido, Ca.<br />

92025 . Debtor shall not relocate Debtor’s principal place of operation without providing at least<br />

sixty (60)-days prior written notice to Secured Party.<br />

1.5 Business Deposit Account. Debtor shall establish and maintain business deposit<br />

accounts (“Accounts”) with Bank of America, or such other financial institution as is mutually<br />

selected and approved in writing by Debtor and Secured Party (the “Depository Bank”). Debtor<br />

shall promptly deposit all donations and grants received by Debtor into the Account. If any<br />

Event of Default occurs, Secured Party may, by written notice to the Depository Bank, terminate<br />

Debtor’s right to make any withdrawal from the Account and exercise any other right under this<br />

Agreement, at law, equity or otherwise applicable to the proceeds of the Account.<br />

ARTICLE II.<br />

REPRESENTATIONS AND WARRANTIES<br />

Debtor makes the following representations and warranties to Secured Party, which shall<br />

be true and correct on and as of the date of this Agreement:<br />

2.1 Authorization and Validity. This Security Agreement, and any other document,<br />

contract or instrument delivered to Secured Party in connection with this Security Agreement<br />

have been duly authorized by Debtor, and are legal, valid and binding agreements and<br />

obligations of Debtor, enforceable in accordance with their respective terms, except as limited by<br />

bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights<br />

generally.<br />

2.2 Governmental Consents. No consent, approval, order or authorization of, or<br />

registration, qualification, designation, declaration or filing with, any federal, state or local<br />

governmental authority on the part of Debtor is required in connection with the consummation of<br />

the transactions contemplated by this Security Agreement.<br />

2.3 No Violation. The execution, delivery and performance by Debtor of this<br />

Security Agreement, and any other document, contract or instrument delivered to Secured Party<br />

in connection with this Security Agreement, do not violate any provision of any law or regulation<br />

or result in a breach of or constitute a default under any contract, obligation, indenture or other<br />

instrument to which Debtor is a party or by which Debtor may be bound, except for any such<br />

breach or default which has been duly waived or consented to by all necessary parties.<br />

2.4 No Events of Default. Debtor is not in default under any debt or obligation of<br />

Debtor and no event has occurred which would become an event of default under any such debt<br />

or obligation with or without the giving of notice, the lapse of time, or both.<br />

19<br />

ADD D-24


2.5 Collateral. Debtor owns the property granted by it as Collateral to Secured Party<br />

free and clear of any and all liens, claims, charges, pledges, security interests, deeds of trust,<br />

mortgages and other encumbrances in favor of third parties, or any other arrangements having<br />

the practical effect of the foregoing, or preferential arrangements of any other kind.<br />

2.6 No Litigation. There is no action, proceeding or investigation pending or<br />

threatened, or any basis therefore known to Debtor that questions the validity of this Security<br />

Agreement or the right of Debtor to enter into this Security Agreement, or that would have,<br />

either individually or in the aggregate, a Material Adverse Effect. “Material Adverse Effect”<br />

shall mean a material adverse effect upon Debtor’s purpose, function, operation or status or upon<br />

Secured Party’s security interest in the Collateral. There is no judgment, decree or order of any<br />

court in effect against Debtor and Debtor is not in default with respect to any order of any<br />

governmental authority to which Debtor is a party or by which Debtor is bound.<br />

2.7 Existence and Authority. Debtor is a public benefit corporation duly<br />

organized and validly existing in good standing under the laws of the State of California. Debtor<br />

has the power and authority, rights and franchises to own its properties and to carry on its<br />

operations as now conducted. Debtor has the power and authority to make and carry out this<br />

Security Agreement.<br />

ARTICLE III.<br />

COVENANTS OF DEBTOR<br />

Debtor covenants that so long as any indebtedness, liabilities and obligations (whether<br />

direct or contingent, liquidated or unliquidated) of Debtor to Secured Party under the Agreement<br />

(including payment of PPN Expenses or repayment of the principal amount of the Advances and<br />

accrued interest thereon) remain outstanding, and until payment and performance in full of all<br />

obligations of Debtor under this Security Agreement:<br />

3.1 Compliance with Laws. Debtor shall comply with the requirements of all laws,<br />

rules, regulations and orders of any governmental authority applicable to Debtor or its operation.<br />

3.2 Performance and Compliance with Other Agreements. Debtor shall perform<br />

and comply in all material respects with each of the provisions of each material indenture,<br />

contract and other agreement by which Debtor or any of its properties is bound.<br />

3.3 Taxes and Other Liabilities. Debtor shall pay and discharge when due any and<br />

all indebtedness, obligations, assessments and taxes, both real or personal and including federal<br />

and state income taxes, which in the aggregate the nonpayment of which would have a Material<br />

Adverse Effect, except such as Debtor may in good faith contest or as to which a bona fide<br />

dispute may arise, so long as provision is made to the satisfaction of Secured Party for eventual<br />

payment thereof if it is found that payment is an obligation of Debtor.<br />

3.4 Notices to Secured Party. Within ten (10) days after Debtor has actual<br />

knowledge of the occurrence of each such event or matter, Debtor shall give written notice to<br />

Secured Party of: (i) the occurrence of any Event of Default (defined below), or any condition,<br />

event or act which would become an Event of Default with or without the giving of notice; or (ii)<br />

the commencement, or threatened commencement (of which Debtor has received written notice)<br />

20<br />

ADD D-25


of any litigation, arbitration or other proceeding against Debtor involving a reasonably potential<br />

liability.<br />

3.5 Records and Reports. Debtor shall maintain books and records pertaining to the<br />

Collateral in such detail, form and scope as is consistent with good business practice, ensure that<br />

such books and records reflect Secured Party’s interest in the Collateral, and permit Secured<br />

Party or its agents to enter upon the premises of Debtor at any time and from time to time, during<br />

normal business hours and upon reasonable notice under the circumstances, and at any time at all<br />

on and after the occurrence of an Event of Default, for the purposes of inspecting and verifying<br />

the Collateral, and inspecting and/or copying (at Debtor’s expense) any and all records pertaining<br />

to the Collateral.<br />

3.6 Change in Collateral. Debtor shall not transfer or otherwise dispose of or<br />

encumber all or any part of the Collateral, without Secured Party’s prior written consent;<br />

provided, however, that in the absence of an Event of Default under this Agreement Debtor shall<br />

be entitled to utilize the Collateral in the ordinary course of business for the payment of the debts<br />

and obligations of Debtor in accordance with the terms set forth in the Agreement and any<br />

agreements, documents and exhibits incorporated in or ancillary to the Agreement. Debtor shall<br />

give Secured Party thirty (30) days’ prior written notice of any proposed change in the location<br />

of any Collateral or in the location of Debtor’s place of operation, advise Secured Party<br />

promptly, in sufficient detail, of any change relating to the type, quantity or quality of the<br />

Collateral, or any event which could have an adverse effect on the value of the Collateral or on<br />

the security interests granted to Secured Party in the Collateral, and defend the Collateral against<br />

all claims and demands of all persons at any time claiming the same or any interest in the<br />

Collateral.<br />

3.7 Guaranties. Debtor shall not agree to any guarantee or liability or become liable<br />

in any way as surety, endorser (other than as endorser of negotiable instruments for deposit or<br />

collection in the ordinary course of business), accommodation endorser or otherwise for, nor<br />

pledge or hypothecate any assets of Debtor as security for, any liabilities or obligations of any<br />

other person or entity, without Secured Party’s prior written consent.<br />

3.8 Change in Purpose and Operation. Debtor shall not make any substantial<br />

change in the present character of Debtor’s purpose and operation, without Secured Party’s prior<br />

written consent.<br />

ARTICLE IV.<br />

EVENTS OF DEFAULT<br />

4.1 Events of Default. The occurrence of any of the following shall constitute an<br />

“Event of Default” under this Agreement:<br />

(a) Failure, breach or default in the performance of the obligations and duties<br />

of Debtor under the Agreement including the payment of PPN Expenses or repayment of the<br />

Advances as provided in Section 1.6 of the Agreement;<br />

(b) Debtor fails to perform or satisfy when due any obligation, agreement,<br />

covenant or condition contained in this Security Agreement, and with respect to any such default<br />

21<br />

ADD D-26


which by its nature can be cured, such default continues for a period of thirty (30) days from its<br />

occurrence;<br />

(c) Any representation or warranty made by Debtor in connection with this<br />

Security Agreement or the Agreement proves to be false, incorrect or incomplete in any material<br />

respect when furnished or made;<br />

(d) Any levy upon, seizure or attachment of any of the Collateral, or any other<br />

event or circumstance pursuant to which Secured Party ceases to have a valid and perfected first<br />

priority security interest in the Collateral;<br />

(e) Debtor admits in writing its inability to pay its debts as they mature, or<br />

commences any voluntary proceedings under any bankruptcy, reorganization, arrangement,<br />

insolvency, readjustment of debt, dissolution, liquidation or other similar law of any jurisdiction;<br />

(f) Any application or proceeding described in (d) above is filed or<br />

commenced against Debtor, and Debtor indicates its approval, consent or acquiescence thereto,<br />

or an order is entered adjudicating Debtor bankrupt or insolvent and such order remains in effect<br />

for thirty (30) days;<br />

(g) Debtor transfers all or substantially all of its properties to, or merges with<br />

or into, any other entity; or<br />

(i) Any change having a Material Adverse Effect on Debtor, or any other<br />

event or condition which Secured Party reasonably and in good faith believes impairs, or is<br />

substantially likely to impair either: (i) the prospect of payment or performance by Debtor of its<br />

obligations under this Security Agreement or the Agreement; or (ii) the rights and remedies of<br />

Secured Party under this Security Agreement or the Agreement.<br />

4.2 Remedies. If an Event of Default occurs, Secured Party shall have all rights,<br />

powers and remedies available under this Security Agreement or the Agreement, or accorded by<br />

law to a beneficiary or a secured party, including the right to resort to any or all of the Collateral<br />

or any other security for any of the obligations of Debtor. Secured Party may exercise its rights<br />

and remedies with respect to the Collateral without resorting or regard to other security or<br />

sources for payment. All rights, powers and remedies of Secured Party in connection with this<br />

Security Agreement or the Agreement may be exercised at any time by Secured Party, and from<br />

time to time after the occurrence of an Event of Default, are cumulative and not exclusive, and<br />

shall be in addition to any other rights, powers or remedies provided by law or equity.<br />

4.3 Action on Collateral. If any Event of Default occurs and continues, Secured<br />

Party may exercise with respect to the Collateral: (a) all the rights and remedies of a secured<br />

party on default under the Uniform Commercial Code of the State of California (the “Code”)<br />

(whether or not the Code applies to the affected Collateral); (b) all of the rights and remedies<br />

provided for in this Security Agreement or the Agreement; and (c) such other rights and<br />

remedies as may be provided by law or otherwise.<br />

4.4 Waiver. Debtor waives (to the extent permitted by applicable law): (a) notice of<br />

the acceptance of this Security Agreement and all other notices, demands or protests to which<br />

22<br />

ADD D-27


Debtor might otherwise be entitled by law in respect to this Security Agreement, all other<br />

Agreement documents or the Collateral; and (b) all rights of redemption, stay and/or appraisal<br />

which Debtor now has or may at any time in the future have under any rule of law or statue now<br />

existing or hereafter enacted.<br />

ARTICLE V.<br />

GENERAL PROVISIONS<br />

5.1 Amendment. This Security Agreement may be modified or amended only by<br />

mutual written agreement of the Parties. Any such modification or amendment must be in<br />

writing, dated, signed by the Parties and attached to this Security Agreement.<br />

5.2 Dispute Resolution. In the event of any controversy or dispute related to or<br />

arising out of this Security Agreement, the Parties agree to meet and confer in good faith to<br />

attempt to resolve the controversy or dispute without an adversary proceeding. If the<br />

controversy or dispute is not resolved to the mutual satisfaction of the Parties within five (5)<br />

business days of notice of the controversy or dispute, the Parties agree to waive their rights, if<br />

any, to a jury trial, and to submit the controversy or dispute to a retired judge or justice pursuant<br />

to Section 638 et seq. of the California Code of Civil Procedure, or any successor provision, for<br />

resolution in accordance with Chapter 6 (References and Trials by Referees), of Title 8 of Part 2<br />

of the California Code of Civil Procedure, or any successor chapter. The Parties agree that the<br />

only proper venue for the submission of claims is the County of San Diego, California, and that<br />

the hearing before the referee shall be concluded within nine (9) months of the filing and service<br />

of the complaint. The Parties reserve the right to contest the referee’s decision and to appeal<br />

from any award or order of any court.<br />

5.3 Assignment. This Security Agreement shall be binding on and inure to the<br />

benefit of the heirs, executors, administrators, legal representatives, successors and assigns of the<br />

Parties; provided, however, that Debtor may not assign or transfer its interest or obligations<br />

under this Security Agreement without the prior written consent of Secured Party. Secured Party<br />

reserves the right to sell, assign, transfer, negotiate or grant participation in all or any part of, or<br />

any interest in, Secured Party’s rights and benefits under this Security Agreement, the Note and<br />

any other Line of Credit Document.<br />

5.4 Attorneys’ Fees, Costs and Expenses. Debtor shall hold Secured Party harmless<br />

from, and pay to Secured Party immediately upon demand, the full amount of all costs and<br />

expenses, including reasonable attorneys’ fees, incurred by Secured Party in connection with: (i)<br />

Secured Party’s administration of this Security Agreement or the Agreement (including any costs<br />

or other expenses incurred in establishing or maintaining the Collateral); (ii) the enforcement of<br />

Secured Party’s rights and/or the collection of any amounts which become due to Secured Party<br />

under the Agreement (including in connection with any bankruptcy, reorganization, or similar<br />

circumstance or proceeding); and (iii) the prosecution or defense of any claim, or action in any<br />

way arising out of or related to this Security Agreement, the Agreement or the transactions<br />

contemplated thereby, including without limitation any action for declaratory relief. Any<br />

judgment or order entered in such action shall contain a specific provision providing for the<br />

recovery of attorneys’ fees and costs incurred in enforcing such judgment. For the purpose of<br />

this Agreement, “attorneys’ fees” shall include fees incurred in connection with post judgment<br />

23<br />

ADD D-28


motions, contempt proceedings, garnishment, levy, and debtor and third-party examinations,<br />

discovery and bankruptcy litigation.<br />

5.5 Choice of Law. This Security Agreement shall be construed in accordance with<br />

and governed by the laws of the State of California, except choice of law rules that would require<br />

the application of the laws of any other jurisdiction.<br />

5.6 Compliance with Laws. Debtor shall comply with all applicable laws,<br />

ordinances, codes and regulations of federal, state and local governments, including without<br />

limitation laws that require Debtor to disclose any economic interest or relationship with Secured<br />

Party.<br />

5.7 Confidentiality. Neither Party shall disclose this Security Agreement or any of<br />

its terms to any person or entity, other than its attorneys and accountants, without the prior<br />

written consent of the other Party, unless and only to the extent such disclosure is required by<br />

law.<br />

5.8 Counterparts. This Security Agreement may be executed in one or more<br />

counterparts, each of which shall be deemed to be an original, but all of which together shall<br />

constitute one and the same instrument.<br />

5.9 Entire Agreement. This Security Agreement (including all agreements<br />

incorporated herein by referenced or mentioned herein) together with the Agreement constitutes<br />

the entire understanding and agreement of the Parties regarding its subject matter, and supersedes<br />

any prior oral or written agreements, representations, understandings or discussions between the<br />

Parties. No other understanding between the Parties shall be binding on them unless set forth in<br />

writing, signed and attached to this Security Agreement.<br />

5.10 Exhibits. The attached exhibits, together with all documents incorporated by<br />

reference in the exhibits, form an integral part of this Security Agreement and are incorporated<br />

into this Security Agreement wherever reference is made to them to the same extent as if they<br />

were set out in full at the point at which such reference is made.<br />

5.11 Force Majeure. Neither Party is liable for nonperformance or defective or late<br />

performance of any of its obligations under this Security Agreement to the extent and for such<br />

periods of time as such nonperformance, defective performance or late performance is due to<br />

reasons outside such Party’s control, including acts of God, war (declared or undeclared), action<br />

of any governmental authority, riots, revolutions, fire, floods, explosions, sabotage, nuclear<br />

incidents, lightning, weather, earthquakes, storms, sinkholes, epidemics, or strikes (or similar<br />

nonperformance or defective performance or late performance of employees, suppliers or<br />

subcontractors).<br />

5.12 Headings. The headings in this Security Agreement are intended solely for<br />

convenience of reference and shall be given no effect in the construction or interpretation of this<br />

Security Agreement.<br />

5.13 Notices. All notices or communications required or permitted under this Security<br />

Agreement shall be given in writing and delivered personally, sent by United States registered or<br />

24<br />

ADD D-29


certified mail with postage prepaid and return receipt requested or by overnight delivery service<br />

(e.g., Federal Express). In each case, notice shall be delivered or sent to the address set forth for<br />

Debtor or Secured Party, as applicable, in the Agreement. Notice is deemed given when sent, if<br />

sent as specified in this paragraph, or otherwise deemed given when received.<br />

5.14 Severability. If any provision of this Security Agreement is determined to be<br />

illegal or unenforceable, that provision shall be severed from this Security Agreement, and such<br />

severance shall have no effect upon the enforceability of the remainder of this Security<br />

Agreement, unless the purposes of this Security Agreement is thereby destroyed.<br />

5.15 No Third-Party Beneficiary Rights. The Parties do not intend to confer and this<br />

Security Agreement shall not be construed to confer any rights or benefits to any person, firm,<br />

group, corporation or entity other than the Parties.<br />

5.16 Termination. This Security Agreement and the security interest in Collateral<br />

created hereby shall terminate after payment and performance in full of all obligations arising<br />

under the Agreement. Upon such termination, the Collateral shall be released from the security<br />

interest hereby created, and Secured Party will execute and deliver to Debtor such documents as<br />

Debtor shall reasonably request to evidence such release.<br />

5.17 Waiver. No delay, failure or discontinuance of Secured Party in exercising any<br />

right, power or remedy under this Security Agreement or the Agreement shall constitute a waiver<br />

of such right, power or remedy; nor shall any single or partial exercise of any such right, power<br />

or remedy preclude, waive or otherwise affect any other or further exercise thereof or the<br />

exercise of any other right, power or remedy. Any waiver, permit, consent or approval of any<br />

kind by Secured Party of any breach of or default under this Security Agreement or the<br />

Agreement must be in writing and shall be effective only to the extent expressly set forth in such<br />

writing.<br />

Secured Party and Debtor have executed this Security Agreement on the date first above<br />

written.<br />

SECURED PARTY<br />

PALOMAR POMERADO HEALTH, a local California<br />

health care district<br />

_____________________________________________<br />

By: _______________________________________<br />

Its: _______________________________________<br />

DEBTOR<br />

PALOMAR PHYSICIAN NETWORK, INC.<br />

_____________________________________________<br />

By: _______________________________________<br />

Its: _______________________________________<br />

25<br />

ADD D-30


ATTACHMENT A TO EXHIBIT 2.1(b)<br />

DESCRIPTION OF COLLATERAL<br />

Except to the extent the granting of a security interest is limited by application of<br />

law with respect to payments from governmental entities, all present and future right, title and<br />

interest of Debtor in and to: (a) donations and grants from all sources; (b) furniture, fixtures and<br />

equipment; (c) all monies from time to time on deposit in Debtor’s business bank accounts as<br />

established in accordance with this Agreement; (d) Accounts Receivable; (e) insurance proceeds;<br />

(f) all books, documents and records in respect to the foregoing; and (g) to proceeds of all the<br />

foregoing, whether now existing or hereafter acquired or arising (collectively, the “Collateral”).<br />

26<br />

ADD D-31


ATTACHMENT B TO EXHIBIT2.1(b)<br />

<strong>Palomar</strong> Pomerado <strong>Health</strong><br />

Bank of America<br />

1655 Grant Street Bldg A-10 th Floor<br />

Concord, CA 94520-2445<br />

Date:______________<br />

Re:<br />

Notice of Security Interest in Account<br />

Ladies and Gentlemen:<br />

Please take notice that PALOMAR POMERADO HEALTH, a local health care district<br />

organized under the laws of the State of California (“PPH”), holds a security interest in a<br />

business deposit account, number _______________ at Bank of America, maintained for<br />

PALOMAR PHYSICIAN NETWORK, INC. (“PPN”).<br />

The security interest is held pursuant to that certain Security Agreement by and between PPH<br />

and PPN, dated as of _______________, a copy of which is enclosed.<br />

Sincerely,<br />

Name:<br />

Title:<br />

27<br />

ADD D-32


EXHIBIT 4.2 BUSINESS ASSOCIATE AGREEMENT<br />

This Business Associate Agreement (“Agreement”), effective _______________, 2010<br />

(“Effective Date”), is entered into by and between <strong>Palomar</strong> Pomerado <strong>Health</strong> (the “Covered<br />

Entity”) and Secured Party and Debtor have executed this Security Agreement on the date first<br />

above written..(the "Business Associate") (each a "Party" and collectively the “Parties”). The<br />

Business Associate is a Secured Party and Debtor have executed this Security Agreement on the<br />

date first above written, and the Covered Entity, is a local healthcare district organized pursuant<br />

to Division 23 of the California <strong>Health</strong> and Safety Code. The Business Associate is providing<br />

services to the Covered Entity that may require the disclosure and use of Protected <strong>Health</strong><br />

Information (PHI). Both Parties are committed to complying with the Privacy Rules<br />

promulgated pursuant to the <strong>Health</strong> Insurance Portability and Accountability Act of 1996<br />

(“HIPAA”), the <strong>Health</strong> Information Technology for Economic and Clinical <strong>Health</strong> Act<br />

(“HITECH”) privacy provisions of the American Recovery and Reinvestment Act, as well as to<br />

the California privacy laws which are codified in the California <strong>Health</strong> and Safety Code and in<br />

the Confidentiality of Medical Information Act (CMIA). The parties agree as follows:<br />

1. DEFINITIONS<br />

1.1. Business Associate. "Business Associate" shall have the same meaning as the<br />

term “Business Associate” is defined under 45 C.F.R. § 160.103, or as may be amended. For<br />

purposes of this Agreement, Business Associate shall include the named Business Associate<br />

herein. In the event that the Business Associate is otherwise a covered entity under the Privacy<br />

Rule, that entity may appropriately designate a health care component of the entity, pursuant to<br />

45 C.F.R. § 164.504(a), as the Business Associate for purposes of this Agreement “Business<br />

Associate” shall also include organization that provides data transmission of protected health<br />

information and requires access to such information on a routine basis as defined under Section<br />

13408 of the HITECH Act.<br />

1.2. Breach. “Breach” shall have the same meaning as the term “breach” in 45 C.F.R.<br />

§ 164.402 (Section 13400(1) of the HITECH Act), as such provision is currently drafted and as it<br />

is subsequently updated, amended or revised.<br />

1.3 Covered Entity. Covered Entity shall include all entities covered by the joint<br />

notice of information practices (or privacy notice), which includes <strong>Palomar</strong> Pomerado <strong>Health</strong><br />

and all of its subsidiaries, including but not limited to <strong>Palomar</strong> Medical Center, Pomerado<br />

Hospital, <strong>Palomar</strong> Continuing Care Center, Villa Pomerado, PPH Home <strong>Health</strong> and PPH Wound<br />

Care Centers.<br />

1.4. Designated Record Set. “Designated Record Set” shall have the same meaning as<br />

the term "designated record set" in 45 C.F.R. § 160.103, as such provision is currently drafted<br />

and as it is subsequently updated, amended or revised.<br />

28<br />

ADD D-33


1.5. <strong>Health</strong> Care Operations. “<strong>Health</strong> Care Operations” shall have the same meaning<br />

as the term "health care operations" in 45 C.F.R. § 164.502(g), as such provision is currently<br />

drafted and as it is subsequently updated, amended or revised.<br />

1.6. Individual. “Individual” shall have the same meaning as the term “individual” in<br />

45 C.F.R. § 164.501, as such provision is currently drafted and as it is subsequently updated,<br />

amended or revised, and shall include a person who qualifies as a personal representative in<br />

accordance with 45 C.F.R. § 164.502(g).<br />

1.7. Privacy Officer. “Privacy Officer” shall have the same meaning as the term<br />

“privacy officer” in 45 C.F.R. § 164.530(a)(l), as such provision is currently drafted and as it is<br />

subsequently updated, amended or revised.<br />

1.8. Privacy Rule. “Privacy Rule” shall mean the Standards for Privacy of<br />

Individually Identifiable <strong>Health</strong> Information at 45 C.F.R. part 160 and part 164, subparts A and<br />

E.<br />

1.9. Protected <strong>Health</strong> Information (“PHI”). “Protected <strong>Health</strong> Information” shall have<br />

the same meaning as the term "protected health information" in 45 C.F.R. § 164.501, as such<br />

provision is currently drafted and as it is subsequently updated, amended or revised, limited to<br />

the information created or received by Business Associate from or on behalf of Covered Entity.<br />

1.10. Required by Law. Required by Law shall have the same meaning as the term<br />

“required by law” in 45 C.F.R. § 164.501, as such provision is currently drafted and as it is<br />

subsequently updated, amended or revised.<br />

1.11. Secretary. “Secretary” shall mean the Secretary of the Department of <strong>Health</strong> and<br />

Human Services or his/her designee.<br />

1.12. Unsecured Protected <strong>Health</strong> Information. “Unsecured Protected <strong>Health</strong><br />

Information” shall have the same meaning as the term “Unsecured Protected <strong>Health</strong> Information”<br />

in 45 C.F.R. § 164.402 (Section 13402 of the HITECH Act).<br />

2. PERMITTED USES AND DISCLOSURES BY BUSINESS ASSOCIATE<br />

2.1 Except as otherwise limited in this Agreement, Business Associate may use or<br />

disclose Protected <strong>Health</strong> Information to perform functions, activities, or services for, or on<br />

behalf of, Covered Entity as agreed upon by the parties or to carry out the legal responsibilities<br />

of the Business Associate, and for the proper management and administration of the Business<br />

Associate provided that such use or disclosure does not violate the federal or state patient privacy<br />

laws.<br />

2.2 Except as otherwise limited in this Agreement, Business Associate may disclose<br />

Protected <strong>Health</strong> Information for the proper management and administration of the Business<br />

Associate, provided that disclosures are Required By Law, or Business Associate obtains<br />

reasonable assurances from the person to whom the information is disclosed that it will remain<br />

29<br />

ADD D-34


confidential and used or further disclosed only as Required By Law or for the purpose for which<br />

it was disclosed to the person, and the person notifies the Business Associate of any instances of<br />

which it is aware in which the confidentiality of the information has been breached.<br />

2.3 Business Associate may disclose to its subcontractors, agents or other third parties<br />

only the minimum Protected <strong>Health</strong> Information necessary to perform or fulfill a specific<br />

function required or permitted under the Services Agreement or this Agreement. If Protected<br />

<strong>Health</strong> Information must be disclosed in order for Business Associate to perform it duties<br />

pursuant to its Agreement with the Covered Entity, or to fulfill any present or future legal<br />

responsibilities, the Protected <strong>Health</strong> Information may be disclosed only if (i) the disclosures are<br />

Required by Law or (ii) the Business Associate has received from the third party written<br />

assurances regarding its confidential handling of such Protected <strong>Health</strong> Information as required<br />

under 45 C.F.R. § 164.504(e)(4).<br />

2.4 Except as otherwise limited in this Agreement, Business Associate may use<br />

Protected <strong>Health</strong> Information to provide Data Aggregation services to Covered Entity as<br />

permitted by 45 C.F.R 164.504(e)(2)(i)(B).<br />

2.5 Business Associate may use Protected <strong>Health</strong> Information to report violations of<br />

law to appropriate Federal and State authorities, consistent with 45 C.F.R. 164.502(j)(1).<br />

3. RESPONSIBILITIES OF THE BUSINESS ASSOCIATE<br />

3.1 Safeguards. Business Associate must develop, implement, maintain and use<br />

appropriate administrative, technical and physical safeguards, in compliance with the regulations<br />

in federal and state law, as now in effect and as may be amended, to protect the confidentiality,<br />

integrity and availability of Protected <strong>Health</strong> Information in order to maintain the security of the<br />

Protected <strong>Health</strong> Information and to prevent the unauthorized or unlawful access, use or<br />

disclosure of Protected <strong>Health</strong> Information. Development of these safeguards must be in<br />

compliance with the requirements under HITECH (HITECH Act § 13401 et. seq., see also 42<br />

USC § 1793(a); 45 C.F.R. §§ 164.308-312 and 164.316 in order to ensure administrative,<br />

physical and technical safeguards for electronic protected health information.)<br />

3.2 Audit. For as long as the Business Associate shall be in possession of any<br />

Protected <strong>Health</strong> Information in any form, the Business Associate shall periodically test, monitor<br />

and audit their information security systems, measures and procedures in order to ensure that<br />

such systems, measures and procedures are consistent with industry best practices and standards.<br />

If any audit or review reveals any material security defects, problems, weaknesses, or<br />

vulnerabilities, Business Associate shall correct the defect, problem, weakness or vulnerability<br />

immediately, and if this is not possible, the Business Associate shall notify the Privacy Officer of<br />

the Covered Entity immediately. Covered Entity also reserves the right to audit Business<br />

Associate to ensure compliance with privacy and security laws and regulations.<br />

3.3 Duty to Mitigate. Business Associate agrees to establish and maintain safeguards<br />

to mitigate any harmful effect that is known to Business Associate that would result in the<br />

30<br />

ADD D-35


improper use and/or disclosure of Protected <strong>Health</strong> Information by Business Associate in<br />

violation of the requirements of this Agreement.<br />

3.4 Reporting Violations to Covered Entity. Business Associate agrees to notify the<br />

Covered Entity’s Privacy Officer immediately by facsimile or telephone, of any security incident<br />

as defined 45 C.F.R. § 164.304, or any other unauthorized access or unlawful access, use, or<br />

disclosure of Protected <strong>Health</strong> Information that would constitute a violation under federal or state<br />

privacy law. If the Business Associate discovers a breach of “unsecured protected health<br />

information” under HITECH, notification to the Covered Entity’s Privacy Officer shall be made<br />

immediately, by facsimile or telephone, unless the notification would impede a criminal<br />

investigation or harm nation security. (See HITECH Act § 13402; 45 C.F.R. 164.402)<br />

3.4.1 Notice Requirements. Such notice shall include the identification of each<br />

individual whose unsecured protected health information has been, or is reasonably believed by<br />

the Business Associate to have been, accessed, acquired, or disclosed during such breach. The<br />

notice shall also include a contact person for the Business Associate; a summary of how the<br />

breach/violation occurred; the date of breach/incident and date of discovery of breach/incident;<br />

description of the types of unsecured PHI that were involved in the breach/incident; name of<br />

alleged violator; brief description of what Business Associate is doing to mitigate harm to<br />

individuals involved in the breach/incident and to protect against further breaches.<br />

3.5 Information Requested by Covered Entity. Within five (5) days of receiving a<br />

written request from the Covered Entity, provide to the Covered Entity such information as is<br />

requested by the Covered Entity to permit the Covered Entity to respond to a request by an<br />

Individual for an accounting of the disclosures of the Individual's Protected <strong>Health</strong> Information<br />

in accordance with 45 C.F.R. § 164.528.<br />

3.6 Agents and Subcontractors. Business Associate agrees to ensure that any agent,<br />

independent contractor, subcontractor, or any other business partner to whom it provides<br />

Protected <strong>Health</strong> Information, which was received from, created or received by Covered Entity,<br />

will agree to the same restrictions and conditions that apply to Business Associate with respect to<br />

such information. Business Associate will also ensure any agent, including a subcontractor to<br />

whom Business Associate provides electronic Protected <strong>Health</strong> Information agrees to implement<br />

reasonable and appropriate safeguards to protect it.<br />

3.7 Availability of Records. Make available all records, books, agreements, policies<br />

and procedures relating to the use and/or disclosure of Protected <strong>Health</strong> Information to the<br />

Secretary, in the time and manner designated by the Secretary, for purposes of the Secretary<br />

determining the Covered Entity's compliance with the Privacy Rule, subject to attorney-client<br />

and other applicable legal privileges.<br />

3.8 Accounting of Disclosures. Business Associate agrees to document such<br />

disclosures of Protected <strong>Health</strong> Information and information related to such disclosures as would<br />

be required for Covered Entity to respond to a request by an Individual for an accounting of<br />

disclosures of Protected <strong>Health</strong> Information in accordance with 45 CFR 164.528. Business<br />

Associate agrees to provide to Covered Entity or an Individual, in timely manner, information<br />

31<br />

ADD D-36


equested in order for Covered Entity to respond to a request by an Individual for an accounting<br />

of disclosures of Protected <strong>Health</strong> Information in accordance with 45 C.F.R 164.528 and<br />

HITECH Act § 13405(c).<br />

3.9 Aggregating Data. Where it is agreed upon by the parties through a Services<br />

Agreement, the Business Associate may aggregate the Protected <strong>Health</strong> Information in its<br />

possession with the Protected <strong>Health</strong> Information of other covered entities that the Business<br />

Associate has in its possession through its capacity as a Business Associate to said other covered<br />

entities, provided that the purpose of such aggregation is to provide the Covered Entity with data<br />

analyses relating to the <strong>Health</strong> Care Operations of the Covered Entity. Under no circumstances<br />

may the Business Associate disclose Protected <strong>Health</strong> Information of one Covered Entity to<br />

another Covered Entity absent the explicit authorization from the Covered Entity.<br />

3.10 De-Identifying Protected <strong>Health</strong> Information. Business Associate shall de-identify<br />

any and all Protected <strong>Health</strong> Information, provided that the de-identification conforms to the<br />

requirements of 45 C.F.R. § 164.514(b), and further provided that the Covered Entity maintains<br />

the documentation required by 45 C.F.R. § 164.514(b) which may be in the form of a written<br />

assurance from the Business Associate. Pursuant to 45 C.F.R. § 164.502(d)(2), de-identified<br />

information does not constitute Protected <strong>Health</strong> Information and is not subject to the terms of<br />

this Agreement.<br />

3.11 Prohibition on Sale of Electronic <strong>Health</strong> Records or Protected <strong>Health</strong> Information.<br />

Except as provided in 13405(d)(2), Business Associate shall not directly or indirectly receive<br />

remuneration in exchange for any protected health information of an individual unless the<br />

Covered Entity obtained from the Individual, in accordance with 45 C.F.R. § 164.508, a valid<br />

authorization that includes, in accordance with such section, a specification of whether the<br />

Protected <strong>Health</strong> Information can be further exchanged for remuneration by the entity receiving<br />

Protected <strong>Health</strong> Information of that Individual.<br />

4. RESPONSIBILITIES OF THE COVERED ENTITY<br />

4.1 Notification in Limitation of Privacy Practices. Covered Entity shall notify the<br />

Business Associate of any limitation(s) in its notice of privacy practices (“Notice”) that the<br />

Covered Entity provides to Individuals pursuant to 45 C.F.R. §164.520, to the extent such<br />

limitation(s) may affect Business Associate’s use of Protected <strong>Health</strong> information.<br />

4.2 Changes in Consent or Authorization. Covered Entity shall notify the Business<br />

Associate of any changes in, or revocation of, the consent or authorization provided to the<br />

Covered Entity by Individuals pursuant to 45 C.F.R. §§ 164.506 or 164.508, to the extent such<br />

changes may affect Business Associate's use or disclosure of Protected <strong>Health</strong> Information.<br />

4.3 Changes in Access. Covered Entity shall notify the Business Associate, in writing<br />

and in a timely manner, arrangements permitted or required of the Covered Entity under<br />

45 C.F.R. parts 160 and 164 that may impact in any manner the access, use and/or disclosure of<br />

Protected <strong>Health</strong> Information by the Business Associate under this Agreement, including, but not<br />

limited to, restrictions on use and/or disclosure of Protected <strong>Health</strong> Information as provided for<br />

32<br />

ADD D-37


in 45 C.F.R. §164.522 agreed to by the Covered Entity, to the extent such restrictions may affect<br />

Business Associate's use or disclosure of Protected <strong>Health</strong> Information.<br />

4.4 Use and Disclosure. The Covered Entity agrees not to request Business Associate<br />

to use or disclose Protected <strong>Health</strong> Information in any manner that would not be permissible<br />

under the HIPAA Privacy Rule if done by the Covered Entity.<br />

4.5 Amendments. The Covered Entity shall notify the Business Associate, in writing,<br />

of any amendment(s) to the Protected <strong>Health</strong> Information contained in a Designated Record Set<br />

in the possession of the Business Associate and inform the Business Associate of the time, form<br />

and manner in which such amendment(s) shall be implemented.<br />

4.6 Prohibition on Sale of Electronic <strong>Health</strong> Records or Protected <strong>Health</strong> Information.<br />

Except as provided in 13405(d)(2), Covered Entity shall not directly or indirectly receive<br />

remuneration in exchange for any protected health information of an individual unless the<br />

Covered Entity obtained from the Individual, in accordance with 45 C.F.R. § 164.508, a valid<br />

authorization that includes, in accordance with such section, a specification of whether the<br />

Protected <strong>Health</strong> Information can be further exchanged for remuneration by the entity receiving<br />

Protected <strong>Health</strong> Information of that Individual.<br />

5. RESPONSIBILITIES OF THE PARTIES WITH RESPECT TO HANDLING<br />

DESIGNATED RECORD SETS<br />

5.1 Responsibilities of Business Associate. In the event that the Parties mutually<br />

agree in writing that the Protected <strong>Health</strong> Information constitutes a Designated Record Set, the<br />

Business Associate hereby agrees to do the following:<br />

5.1.1 At the request of, and in the time and manner designated by the Covered<br />

Entity, provide access to the Protected <strong>Health</strong> Information contained in a Designated Record Set<br />

to the Covered Entity or the Individual to whom such Protected <strong>Health</strong> Information relates or his<br />

or her authorized representative in order to meet a request by such Individual under 45 C.F.R.<br />

§ 164.524.<br />

5.1.2 At the request of, and in the time and manner designated by the Covered<br />

Entity, make any amendment(s) to the Protected <strong>Health</strong> Information contained in a Designated<br />

Record Set that the Covered Entity directs pursuant to 45 C.F.R. § 164.526. Provided, however,<br />

that the Covered Entity makes the determination that the amendment(s) are necessary because<br />

the Protected <strong>Health</strong> Information that is the subject of the amendment(s) has been, or could<br />

foreseeably be, relied upon by the Business Associate or others to the detriment of the Individual<br />

that is the subject of the Protected <strong>Health</strong> Information to be amended.<br />

5.2 Responsibilities of Covered Entity. In the event that the Parties mutually agree in<br />

writing that the Protected <strong>Health</strong> Information constitutes a Designated Record Set, the Covered<br />

Entity hereby agrees to do the following:<br />

33<br />

ADD D-38


5.2.1 Notify the Business Associate, in writing, of any Protected <strong>Health</strong><br />

Information contained in a Designated Record Set that the Covered Entity seeks to make<br />

available to an Individual pursuant to 45 C.F.R. § 164.524 and the time, manner and form in<br />

which the Business Associate shall provide such access.<br />

6. REPRESENTATIONS AND WARRANTIES<br />

6.1 Each Party represents and warrants to the other Party:<br />

6.1.1 That it is duly organized, validly existing, and in good standing under the<br />

laws of the jurisdiction in which it is organized or licensed; it has the full power to enter into this<br />

Agreement and to perform its obligations hereunder; and that the performance by it of its<br />

obligations under this Agreement have been duly authorized by all necessary corporate actions or<br />

other actions, as may be necessary, and will not violate any provision of any license, corporate<br />

charter or bylaws.<br />

6.1.2 That neither the execution of this Agreement, nor its performance<br />

hereunder, will directly or indirectly violate or interfere with the terms of another agreement to<br />

which it is a party, or give any governmental entity the right to suspend, terminate, or modify any<br />

of its governmental authorizations or assets required for its performance hereunder. Each Party<br />

represents and warrants to the other Party that it will not enter into any agreement the execution<br />

and/or performance of which would violate or interfere with this agreement.<br />

6.1.3 That it is not currently the subject of a voluntary or involuntary petition of<br />

bankruptcy; does not currently contemplate filing any such voluntary petition, and is not aware<br />

of any claim for the filing of an involuntary petition.<br />

6.1.4 That all of its employees, agents, representatives and members of its<br />

workforce, whose services may be used to fulfill obligations under this Agreement, are or shall<br />

be appropriately informed of the terms of this Agreement and are under legal obligation to each<br />

Party, respectively, by contract or otherwise, sufficient to enable each Party to fully comply with<br />

all provisions of this Agreement including, without limitation, the requirement that modifications<br />

or limitations that the Covered Entity has agreed to adhere to with regard to the use and<br />

disclosure of Protected <strong>Health</strong> Information of an individual that materially affects and/or limits<br />

the uses and disclosures that are otherwise permitted under the Privacy Rule will be<br />

communicated to the Business Associate, in writing, and in a timely fashion.<br />

6.1.5 That it will reasonably cooperate with the other Party in the performance<br />

of the mutual obligations under this Agreement.<br />

7. TERM AND TERMINATION<br />

7.1 Term. This Agreement shall become effective on the Effective date detailed<br />

above and shall continue in effect until all obligations of the Parties have been met, unless<br />

terminated as provided in this Section 7. In addition, certain provisions and requirements of this<br />

34<br />

ADD D-39


Agreement shall survive its expiration or other termination in accordance with terms set forth<br />

herein.<br />

7.2 Termination by the Covered Entity. As provided for under 45 C.F.R.<br />

§ 164.504(e)(2)(iii), the Covered Entity may immediately terminate this Agreement and any<br />

other Agreement between the parties if the Covered Entity makes the determination that the<br />

Business Associate has breached a material term pursuant to the terms of this Agreement or any<br />

other Agreement between the parties, including but not limited to multiple patient privacy<br />

breaches or multiple instances of inappropriate use or disclosure of Protected <strong>Health</strong><br />

Information, if cure is not possible. If cure is possible, the Covered Entity may choose to: (i)<br />

provide the Business Associate with thirty (30) days written notice of the existence of an alleged<br />

material breach; and (ii) afford the Business Associate an opportunity to cure said alleged<br />

material breach upon mutually agreed upon terms. Failure to cure in the manner agreed upon by<br />

the parties is grounds for the immediate termination of this Agreement and any other Agreement<br />

between the parties. Nothing contained in this Section shall be deemed to require the Covered<br />

Entity to terminate this Agreement or the other Agreement between the parties upon breach by<br />

Business Associate of a material term of this Agreement if termination is not feasible, and the<br />

Covered Entity shall have the right to report any such breach to the Secretary as provided for<br />

under 45 C.F.R. § 164.504(e)(1)(ii).<br />

7.4 Effect of Termination. Upon the event of termination pursuant to this Section 7,<br />

Business Associate agrees to return or destroy all Protected <strong>Health</strong> Information pursuant to<br />

45 C.F.R. § 164.504(e)(2)(ii)(I), if it is feasible to do so. Prior to doing so, the Business<br />

Associate further agrees to recover any Protected <strong>Health</strong> Information in the possession of its<br />

employees, contractors, subcontractors or agents. If it is not feasible for the Business Associate<br />

to return or destroy said Protected <strong>Health</strong> Information, the Business Associate will notify the<br />

Privacy Officer of the Covered Entity in writing. Said notification shall include: (i) a statement<br />

that the Business Associate has determined that it is infeasible to return or destroy the Protected<br />

<strong>Health</strong> Information in its possession; and (ii) the specific reasons for such determination.<br />

Business Associate further agrees to extend any and all protections, limitations and restrictions<br />

contained in this Agreement to the Business Associate’s use and/or disclosure of any Protected<br />

<strong>Health</strong> Information retained after the termination of this Agreement, and to limit any further uses<br />

and/or disclosures to the purposes that make the return or destruction of the Protected <strong>Health</strong><br />

Information infeasible. If it is infeasible for the Business Associate to obtain from employees,<br />

contractors, subcontractors or agents any Protected <strong>Health</strong> Information in the possession of the<br />

employees, contractors, subcontractors or agents, the Business Associate must provide a written<br />

explanation to the Covered Entity and require the employees, contractors, subcontractors or<br />

agents to agree to extend any and all protections, limitations and restrictions contained in this<br />

Agreement to the employees’, contractors’, subcontractors’ or agents’ use and/or disclosure of<br />

any Protected <strong>Health</strong> Information retained after the termination of the Agreement, and to limit<br />

any further uses and/or disclosures to the purposes that make the return or destruction of the<br />

Protected <strong>Health</strong> Information infeasible.<br />

8. INDEMNIFICATION<br />

35<br />

ADD D-40


8.1 Business Associate’s Indemnification. Business Associate shall hold harmless,<br />

defend and indemnify Covered Entity and its subsidiaries, parents, affiliates, agents, officers,<br />

directors and employees from and against all claims, liabilities, damages, losses, demands, fines,<br />

fees, penalties, costs, or suits (including reasonable attorneys’ fees), costs, claims, suits and<br />

damages, including damages for personal injury (including death), of any nature whatsoever,<br />

caused by Business Associate, or its employees, representatives, or agents, for property damage,<br />

personal injury or death, breach of state or federal patient privacy law, or otherwise arising out<br />

of, or in connection with, or incidental to Business Associate’s performance of or failure to<br />

perform services pursuant to this Agreement. This indemnity shall include, without limitation,<br />

costs, expenses, and attorney's fees occasioned by said loss, damage, liabilities, claims, demands,<br />

or suits as well as the full amount of any judgment rendered or compromise settlement made,<br />

plus court costs and interest. Business Associate agrees to notify Covered Entity of the existence<br />

of any such claims or causes of action within a reasonable period of time after Business<br />

Associate becomes aware of same.<br />

8.2 Covered Entity’s Indemnification. To the extent allowed by law, Covered Entity<br />

shall hold harmless, defend and indemnify Business Associate and its subsidiaries, parents,<br />

affiliates, agents, officers, directors and employees from and against all claims, liabilities,<br />

damages, losses, demands, fines, fees, penalties, costs, or suits (including reasonable attorney’s<br />

fees) of any nature whatsoever, caused by Covered Entity, or its employees, representatives, or<br />

agents, for property damage, personal injury or death, or otherwise arising out of, or in<br />

connection with, or incidental to Covered Entity’s performance of or failure to perform services<br />

pursuant to this Agreement. This indemnity shall include, without limitation, costs, expenses,<br />

and attorney's fees occasioned by said loss, damage, liabilities, claims, demands, or suits as well<br />

as the full amount of any judgment rendered or compromise settlement made, plus court costs<br />

and interest. Covered Entity agrees to notify Business Associate of the existence of any such<br />

claims or causes of action within a reasonable period of time after Covered Entity becomes<br />

aware of same.<br />

9. MISCELLANEOUS<br />

9.1 Survival. The respective rights and obligations of Business Associate and<br />

Covered Entity under the provisions of agreement solely with respect to Protected <strong>Health</strong><br />

Information Business Associate retains in accordance with Section 7.5 because it is not feasible<br />

to return or destroy such Protected <strong>Health</strong> Information, shall survive termination of this<br />

Agreement. In addition, Section 5 shall survive termination of this Agreement, provided that the<br />

Covered Entity determines that the Protected <strong>Health</strong> Information being retained pursuant to<br />

Section 7.5 herein constitutes a Designated Record Set.<br />

9.2 Amendments; Waiver. This Agreement may not be modified, nor shall any<br />

provision hereof be waived or amended, except in a writing duly signed by authorized<br />

representatives of the Parties. The Parties agree to take such action as is necessary to amend this<br />

Agreement from time to time as is necessary for Covered Entity to comply with the requirements<br />

of the Privacy Rule and HIPAA as well HITECH. A waiver with respect to one event shall not<br />

be construed as continuing, or as a bar to or waiver of, any right or remedy as to subsequent<br />

events. PPH reserves the right to make unilateral modifications or amendments to this<br />

36<br />

ADD D-41


Agreement to the extent necessary to comply with any future changes to the HIPAA or HITECH<br />

laws.<br />

9.3 No Third Party Beneficiaries. Nothing expressed or implied in this Agreement is<br />

intended to confer, nor shall anything herein confer, upon any person other than the Parties and<br />

the respective successors or assigns of the Parties, any rights, remedies, obligations, or liabilities<br />

whatsoever.<br />

9.4 Notices. Any notices to be given hereunder to a Party shall be made via U.S.<br />

Mail or express courier to such Party's address given below:<br />

If to Business Associate:<br />

If to Covered Entity:<br />

General Counsel<br />

Legal Department<br />

<strong>Palomar</strong> Physician Network Inc<br />

<strong>Palomar</strong> Pomerado <strong>Health</strong><br />

_________________________<br />

456 E. Grand Ave<br />

_________________________ Escondido, CA 92025<br />

Each Party named above may change its address and that of its representative for notice by the<br />

giving of notice thereof in the manner herein above provided.<br />

9.5 Counterparts/Facsimiles. This Agreement may be executed in any number of<br />

counterparts, each of which shall be deemed an original. Facsimile copies hereof shall be<br />

deemed to be originals.<br />

9.6 Disputes. If any controversy, dispute or claim arises between the Parties with<br />

respect to this Agreement, the Parties shall make good faith efforts to resolve such matters<br />

informally via mediation or otherwise prior to any lawsuits being filed.<br />

9.7 Laws. The laws of the State of California shall govern this document.<br />

9.8 Regulatory References. A reference in this Agreement to a section in the C.F.R.,<br />

HIPAA, or HITECH means the section as in effect or as amended.<br />

9.9 Interpretation. Any ambiguity in this Agreement shall be resolved to permit<br />

Covered Entity to comply with HIPAA and HITECH.<br />

//<br />

//<br />

//<br />

//<br />

//<br />

//<br />

//<br />

Deleted: <br />

<br />

<br />

<br />

37<br />

ADD D-42


By signing below each party hereby certifies that it has read the HIPAA and HITECH in full and<br />

understands it’s obligations under these laws independently of what is detailed in this<br />

Agreement.<br />

BUSINESS ASSOCIATE<br />

________________________________<br />

By:<br />

________________________________<br />

Printed Name:<br />

________________________________<br />

Title:<br />

_________________________________<br />

Date:<br />

COVERED ENTITY<br />

_____________________________<br />

By:<br />

______________________________<br />

Print Name:<br />

______________________________<br />

Title:<br />

______________________________<br />

Date:<br />

38<br />

ADD D-43


ADDENDUM E<br />

ADD E-1


PALOMAR POMERADO HEALTH<br />

HOSPITAL, EMERGENCY CARE, TRAUMA CENTER IMPROVEMENT AND<br />

REPAIR MEASURE BONDS<br />

INDEPENDENT CITIZENS’ OVERSIGHT <strong>COMMITTEE</strong><br />

1. <strong>COMMITTEE</strong> ESTABLISHED.<br />

PROCEDURES, POLICIES AND GUIDELINES<br />

The Board of Directors (the “Board”) of <strong>Palomar</strong> Pomerado <strong>Health</strong> (the “District”)<br />

hereby establishes the Independent Citizens’ Oversight Committee (the “Committee”) which<br />

shall have the purposes and duties set forth in these Procedures, Policies and Guidelines (the<br />

“Guidelines”).<br />

2. PURPOSE.<br />

The purpose of the Committee is to ensure that the proceeds of bonds authorized by the<br />

“Hospital, Emergency Care, Trauma Center Improvement and Repair Measure”<br />

(“Measure BB”), approved by the voters on November 2, 2004 (the “Bond Proceeds”), are<br />

expended only for purposes permitted by Measure BB.<br />

3. DUTIES.<br />

To carry out its stated purpose, the Committee shall perform the duties specified in this<br />

Section 3:<br />

3.1 Review Expenditures. The Committee shall review each annual expenditure report<br />

produced by the District in accordance with Measure BB (each, a “District Expenditure Report”)<br />

to ensure that (a) Bond Proceeds are expended only for the purposes set forth in Measure BB;<br />

and (b) no Bond Proceeds are used for staff or administrator salaries or other operating expenses.<br />

3.2 Report of the Committee. The Committee shall prepare and provide to the Board for<br />

the Board’s consideration and response and for dissemination to the public an annual report<br />

concerning the Committee’s review of each District Expenditure Report. The Committee shall<br />

consider the response provided by the Board pursuant to Section 7.4 herein and provide a reply<br />

to the Board. Such report and reply shall be reviewed at the next Committee meeting and, as<br />

approved, or corrected and amended and approved, be submitted to the Board for inclusion in the<br />

Board’s public records in accordance with Section 6.4.<br />

4. <strong>COMMITTEE</strong> ACTIVITIES.<br />

4.1 Power of the Committee. In order to perform the duties set forth in Section 3 hereof,<br />

the Committee may engage only in the following activities:<br />

(a) Receive and review copies of each District Expenditure Report and personally<br />

conduct such physical examination of the construction sites as it deems reasonably necessary to<br />

verify the expenditures reported therein.<br />

(b) In accordance with Section 6.4, report to the Board any exceptions, discrepancies,<br />

issues and/or concerns regarding the use of Bond Proceeds for the Board’s consideration and<br />

response and for dissemination to the public.<br />

(c) Review and reply to the Board’s response to any report submitted pursuant to Section<br />

4.1(b) above and provided to the Committee in accordance with Section 7.4.<br />

ADD E-2


(d) Submit a final report upon the termination of the Committee’s activities in accordance<br />

with Section 10.<br />

5. MEMBERSHIP.<br />

5.1 Number. The Committee shall consist of not less than nine members, the exact<br />

number to be determined from time to time by the Board, appointed by the Board from a list of<br />

candidates who have submitted written applications.<br />

5.2 General Qualification Standards.<br />

(a) To be a qualified member of the Committee, a person must:<br />

(1) be at least 18 years of age and a citizen of the State of California and reside<br />

within the boundaries of the District;<br />

(2) not be an employee, official, vendor, contractor or consultant of the District;<br />

and<br />

(3) not have an immediate family member who is an employee, official, vendor,<br />

contractor or consultant of the District.<br />

(b) If a member fails to meet the applicable qualification standards set forth above at any<br />

time during his or her term of service, such member shall be disqualified from service on the<br />

Committee and his or her position shall be declared vacant. The Board shall appoint a new<br />

person to serve the remainder of the term, in accordance with the appointment process set forth<br />

in Section 5.4 below.<br />

5.3 Required Committee Members.<br />

(a) The Committee shall at all times, except during the period of a vacancy, include the<br />

following members (collectively, the “Required Members”):<br />

(1) one member who is active in a business organization;<br />

(2) one member who is active in a senior citizens’ organization;<br />

(3) one member who is active in a bona fide taxpayers’ organization; and<br />

(4) one member who is a nurse or physician.<br />

(b) Any Required Member who resigns from his or her business organization, senior<br />

citizens’ organization or bona fide taxpayers’ organization (as applicable) shall be deemed to<br />

concurrently resign from the Committee and the position shall be declared vacant. The Board<br />

shall appoint a new person to serve the remainder of the term, in accordance with the<br />

appointment process set forth in Section 5.4 below.<br />

5.4 Appointment. The Board shall appoint members to the Committee through the<br />

following process:<br />

(a) The Board shall solicit applications from the general public through appropriate<br />

means as determined by the Board, which may include, without limitation, (i) advertisements on<br />

the District’s internet web site; (ii) advertisements posted in libraries within the District; (iii)<br />

advertisements posted in District hospitals; and (iv) advertisements in newspapers in general<br />

circulation within all or part of the District.<br />

(b) If necessary, the Board shall solicit applications from the membership of appropriate<br />

local business organizations, senior citizens’ organizations, bona fide taxpayers’ organizations<br />

and physician and nursing groups.<br />

(c) The Board or its designee shall review all applications.<br />

ADD E-3


(d) The Board’s designee, if any, shall make recommendations to the Board regarding<br />

Committee membership.<br />

(e) Following the Board’s review or its designee’s recommendations, as applicable, the<br />

Board shall select and appoint members to the Committee and shall designate the Required<br />

Members. If fewer than nine applications are initially received, or if no applications are initially<br />

received that meet the requirements of one or more of the Required Members, then the Board<br />

shall appoint, or take such action as is necessary to allow it to appoint, members of the<br />

Committee such that the Committee is composed as required by Section 5 hereof.<br />

5.5 Ethics; Conflicts of Interest. By accepting appointment to the Committee, each<br />

member agrees to comply with Articles 4 (commencing with Section 1090) and 4.7<br />

(commencing with Section 1125) of Division 4 of Title 1 of the Government Code and the<br />

Political Reform Act of 1974 (Government Code §§ 81000 et seq.). Additionally, each member<br />

shall comply with the Committee’s Ethics Policy Statement attached hereto as Attachment A.<br />

5.6 Term. Committee members shall be divided into three classes, as nearly equal in<br />

number as the then total number of members constituting the entire Committee permits, with the<br />

term of office of one class expiring each year. At the Committee’s first meeting, members shall<br />

draw lots or otherwise select the membership of each class, with the members of one class to<br />

serve for an initial term expiring June 30, 2006, members of another class to serve for an initial<br />

term expiring June 30, 2007 and members of another class to serve for an initial term expiring<br />

June 30, 2008. Each initial term shall commence upon each member’s respective appointment.<br />

Each subsequent term shall commence on July 1 and expire on June 30. Subsequent to the initial<br />

term of one year, two years or three years, as applicable, each class shall serve a term of two<br />

years. No Committee member may serve for more than two consecutive terms.<br />

(a) A Committee member who has served two consecutive terms may apply for<br />

reappointment after a period of two years following expiration of such Committee member’s<br />

second consecutive term.<br />

5.8 Removal; Vacancy. The Board may remove any Committee member for failure to<br />

perform the duties specified in Section 3 or other cause, including failure to attend Committee<br />

meetings, upon the recommendation of the Committee Chair. Upon the removal of a member,<br />

his or her seat shall be declared vacant. The Board shall fill any vacancies on the Committee<br />

within 90 days from the initial date of such vacancy in accordance with the requirements of<br />

Section 5.3 and the appointment process set forth in Section 5.4 hereof.<br />

5.9 Compensation. The Committee members shall not be compensated for their services,<br />

but may be reimbursed for their reasonable out of pocket costs incurred in connection with their<br />

service on the Committee and previously approved by the Committee Chair.<br />

5.10 Authority of Members. Committee members shall not have the authority to direct<br />

staff of the District. With the exception of the District Expenditure Report, which the Committee<br />

shall receive concurrently with the Board, the Committee may only receive copies of reports,<br />

records and documents that have been previously presented to the Board and which are in the<br />

public record unless otherwise directed by the Board. Any requests for such reports, records and<br />

documents shall be made in writing to the Secretary of the Board of Directors or the Secretary’s<br />

designee.<br />

ADD E-4


6. <strong>MEETING</strong>S OF THE <strong>COMMITTEE</strong>.<br />

6.1 Regular Meetings. The Committee shall establish a schedule for the date and time of<br />

regular meetings to be held at least annually. The Committee shall meet more frequently as it<br />

deems reasonably necessary or as requested by the Board. The Committee shall hold an initial<br />

organizational meeting within 30 days’ of the Board’s appointment of the Committee as set forth<br />

in Section 5.4.<br />

6.2 Location. All meetings shall be held at the administrative offices of the District<br />

located at 15255 Innovation Drive, San Diego, California 92128, or other District facilities, or<br />

such other public space as designated by the Committee, provided, however, that all meetings<br />

shall be held within the District.<br />

6.3 Procedures. All meetings shall be open and public in accordance with the Ralph M.<br />

Brown Act, Government Code Sections 54950 et seq. (the “Brown Act”). Meetings shall be<br />

conducted according to such procedural rules as the Committee may adopt. Committee members<br />

may participate in a meeting by means of conference telephone or similar communications<br />

equipment by means of which all persons participating in the meeting can hear each other, and<br />

such participation in a meeting shall constitute presence in person at such meeting. A majority<br />

of the number of Committee members shall constitute a quorum for the transaction of any<br />

business except adjournment. The Committee shall apply the same standards as used by the<br />

Board in giving notice of its meetings. All Committee decisions, including without limitation all<br />

decisions regarding reports to the Board, shall be made by a majority vote of those Committee<br />

members in attendance.<br />

6.4 Reports of Committee Meetings. The Secretary of the Committee shall keep or cause<br />

to be kept a report of all Committee meetings and shall submit such report, which may be in the<br />

form of minutes, initially marked as a “DRAFT,” to the Board within thirty days of the meeting<br />

from which such minutes were taken so that the Board may cause such minutes to become part<br />

of the Board’s public records and made available on the Board’s web site or other electronic<br />

means of communication then in use.<br />

7. DISTRICT SUPPORT AND <strong>BOARD</strong> REVIEW OF <strong>COMMITTEE</strong> REPORT.<br />

7.1 The District shall provide to the Committee necessary technical and administrative<br />

assistance as follows:<br />

(a) preparation of and posting of public notices as required by the Brown Act ensuring<br />

that all notices to the public are provided in the same manner as notices regarding meetings of<br />

the Board;<br />

(b) provision of a meeting room, including any necessary audio/visual equipment;<br />

(c) preparation and copies of any documentary meeting materials, such as agendas and<br />

reports, including oral or recorded presentations by District staff and consultants;<br />

(d) retention of all Committee records and provision of public access to such records; and<br />

(e) in consultation with the Committee Chair, such other support as the Committee Chair<br />

and the Board deem necessary.<br />

7.2 District staff may, from time-to-time, attend Committee meetings to explain material<br />

provided by the Committee as deemed reasonably necessary by the Committee Chair.<br />

ADD E-5


7.3 District staff shall maintain all Committee records and provide public access to such<br />

records.<br />

7.4 The Board shall consider any exceptions, discrepancies, issues and/or concerns<br />

regarding the use of Bond Proceeds set forth in Committee reports and shall provide a response<br />

in writing to the Committee for consideration by the Committee as soon as reasonably possible.<br />

7.5 The District shall not use any Bond Proceeds to provide the support set forth in this<br />

Section 7.<br />

8. OFFICERS.<br />

The Board shall annually appoint a Committee Chair, Committee Vice-Chair and<br />

Committee Secretary. The Committee Vice-Chair shall act as Committee Chair when the<br />

Committee Chair is absent. Each such appointment shall expire on June 30 each year (except<br />

that the initial appointments shall not expire until June 30, 2006). No person shall serve as<br />

Committee Chair for more than three consecutive annual terms.<br />

9. AMENDMENT OF GUIDELINES.<br />

Any amendment to these Guidelines must be approved by the Board prior to becoming<br />

effective.<br />

10. TERMINATION.<br />

The Committee shall automatically terminate and disband when all Bond Proceeds have<br />

been expended and the Committee has reviewed the final District Expenditure Report. The<br />

Committee shall prepare a report summarizing its findings and submit it to the Board as its last<br />

official act.<br />

11. ADVISORY PANEL.<br />

The Board hereby establishes an Advisory Panel (the “Panel”) to provide for continuity<br />

of knowledge. The Panel shall consist of at least one member appointed by the Board from a list<br />

of candidates submitted by the Committee Chair. To serve as a member of the Panel, the<br />

candidate shall have previously served as a member of the Committee. Each member of the<br />

Panel shall serve for a term of one (1) year, commencing on July 1 and expiring on June 30 of<br />

the following year. No member of the Panel may serve for more than two consecutive terms. By<br />

accepting appointment to the Panel, each member of the Panel agrees to comply with Section 5.5<br />

of the Guidelines and acknowledges that no compensation shall be provided in connection with<br />

serving as a member of the Panel. No member of the Panel may vote on any matters voted upon<br />

by the Committee nor exercise any of the duties or rights of any member of the Committee.<br />

ADD E-6


ATTACHMENT A<br />

INDEPENDENT CITIZENS’ OVERSIGHT <strong>COMMITTEE</strong><br />

ETHICS POLICY STATEMENT<br />

This Ethics Policy Statement provides general guidelines for Committee members to<br />

follow. The guidelines set forth in this Statement are not exhaustive and do not excuse<br />

Committee members from existing laws, rules, policies and procedures as well as from concepts<br />

that define generally accepted good business practices and professional conduct. Committee<br />

members are expected to adhere strictly to the provisions of this Ethics Policy Statement. All<br />

capitalized terms used herein shall have the meanings set forth in the Guidelines of the<br />

Committee.<br />

CONFLICT OF INTEREST. A Committee member shall not make or attempt to<br />

influence a District decision related to any contract funded by Bond Proceeds or any construction<br />

project which will benefit a Committee member’s outside employment, business or personal<br />

finances or benefit an immediate family member, such as a spouse, child or parent.<br />

OUTSIDE EMPLOYMENT. A Committee member shall not use his or her position as a<br />

Committee member to negotiate future employment with any person or organization that relates<br />

to any contract funded by Bond Proceeds or any construction project. A Committee member<br />

shall not make or influence a District decision related to any construction project involving the<br />

interests of a person with whom the member has an agreement concerning current or future<br />

employment or remuneration of any kind. For a period of two years after leaving the Committee,<br />

a former Committee member may not represent any person or organization for compensation in<br />

connection with any matter pending before the District that, as a Committee member, he or she<br />

participated in personally and substantially. Specifically, for a period of two years after leaving<br />

the Committee, a former Committee member and the companies and businesses for which the<br />

member works shall be prohibited from contracting with the District with respect to (i) bidding<br />

on projects funded by the Bond Proceeds, and (ii) any construction project.<br />

COMMITMENT TO UPHOLD LAW. A Committee member shall uphold the federal<br />

and California Constitutions, the laws and regulations of the United States and the State of<br />

California and all other applicable government entities, and the policies, procedures, rules and<br />

regulations of the District.<br />

COMMITMENT TO DISTRICT. A Committee member shall place the interests of the<br />

District above any personal or business interests of the member.<br />

ADD E-7


ADDENDUM F<br />

ADD F-1


ADDENDUM F<br />

Financial Statements<br />

Fiscal Year 2010<br />

February<br />

ADD F-2


Table of Contents<br />

ADD F-2<br />

Balanced Scorecard Comparisons ......................................................................3<br />

Executive Summary of Key Indicators ..................................................................4-5<br />

Key Variance<br />

Month-To-Date.............................................................................................6-8<br />

Year-To-Date ................................................................................................9-11<br />

Balance Sheet – Consolidated..............................................................................12<br />

Income Statements<br />

Month-To-Date.............................................................................................13<br />

Year-To-Date ................................................................................................14<br />

Current vs. Prior Year-to-Date ....................................................................15<br />

Fiscal Year Projection..................................................................................16<br />

Monthly Trend...............................................................................................17<br />

Cash Flow Statement – Consolidated..................................................................18<br />

Financial Report Narrative .....................................................................................19-22<br />

Key Statistical Indicators .........................................................................................23-25<br />

YTD Supplies Expense by Account........................................................................26<br />

Bond Covenant Ratios............................................................................................27<br />

Budget Comparison Graphs<br />

Statistical Indicators.....................................................................................28-44<br />

Payor Mix ......................................................................................................45<br />

Case Mix Index Graphs...........................................................................................46-48<br />

Budget Comparison Graphs – Adjusted Discharges..........................................49-54<br />

Cash Collections......................................................................................................55<br />

<strong>Health</strong>WoRx Dashboard .........................................................................................56<br />

SUPPLEMENTAL INFORMATION ..........................................................................................................57<br />

Flash Report ...............................................................................................................................58-59 ADD F-3


Balanced Scorecard Comparisons<br />

ADD F-3<br />

November December January<br />

February<br />

Actual Actual Actual Actual Budget Variance<br />

YTD 2010<br />

% Actual<br />

to Budget Actual Budget Variance<br />

PPH Indicators:<br />

% Actual to<br />

Budget<br />

10.53% 11.15% 10.70% 10.87% 10.35% 0.52% 105.0% OEBITDA Margin w/Prop Tax 10.87% 10.76% 0.11% 101.0%<br />

$ 11,761.43 $ 10,967.78 $ 10,833.14 $ 11,448.22 $ 11,116.43 $ (331.79) 103.0% Expenses/Adj Discharge $ 11,128.76 $ 10,980.02 $ (148.74) 101.4%<br />

$ 7,075.48 $ 6,428.14 $ 6,752.23 $ 6,883.77 $ 6,477.14 $ (406.63) 106.3% SWB/Adj Discharge $ 6,647.74 $ 6,473.03 $ (174.71) 102.7%<br />

6.47 6.51 6.17 6.21 6.21 0.00 100.0% Prod FTE's/Adj Occupied Bed 6.35 6.21 (0.14) 102.3%<br />

PPH North Indicators:<br />

10.25% 6.35% 5.59% 7.21% 10.07% (2.86%) 71.6% OEBITDA Margin w/Prop Tax 8.47% 10.47% (2.00%) 80.9%<br />

$ 10,921.70 $ 10,222.87 $ 10,175.64 $ 10,336.34 $ 10,239.01 $ (97.33) 101.0% Expenses/Adj Discharge $ 10,274.41 $ 10,119.65 $ (154.76) 101.5%<br />

$ 5,659.87 $ 5,261.42 $ 5,648.20 $ 5,424.91 $ 5,269.82 $ (155.09) 102.9% SWB/Adj Discharge $ 5,390.72 $ 5,262.90 $ (127.82) 102.4%<br />

5.32 5.29 5.09 5.07 5.07 0.00 100.0% Prod FTE's/Adj Occupied Bed 5.16 5.05 (0.11) 102.2%<br />

PPH South Indicators:<br />

7.30% 18.97% 17.55% 15.70% 8.09% 7.61% 194.1% OEBITDA Margin w/Prop Tax 13.20% 9.06% 4.14% 145.7%<br />

$ 12,844.82 $ 11,678.96 $ 11,528.44 $ 13,112.45 $ 12,395.46 $ (716.99) 105.8% Expenses/Adj Discharge $ 12,236.22 $ 12,224.77 $ (11.45) 100.1%<br />

$ 6,415.16 $ 6,179.62 $ 6,103.30 $ 6,544.88 $ 6,072.19 $ (472.69) 107.8% SWB/Adj Discharge $ 6,169.47 $ 6,070.09 $ (99.38) 101.6%<br />

6.42 6.85 6.34 6.44 6.25 (0.19) 103.0% Prod FTE's/Adj Occupied Bed 6.65 6.22 (0.43) 106.9%<br />

ADD F-4


Executive Summary of Key Indicators<br />

ADD F-4<br />

Statistics:<br />

FEBRUARY 2010 FY 10 Y-T-D @ FEBRUARY 2010<br />

Actual Budget Variance Actual Budget Variance<br />

Adjusted Discharges 3,154 3,116 38 26,688 27,027 (339)<br />

Acute Admissions 2,142 2,217 (75) 18,052 19,237 (1,185)<br />

Acute Patient Days 8,673 8,651 22 71,507 75,081 (3,574)<br />

Acute ALOS 4.02 3.90 0.12 3.91 3.90 0.01<br />

Case Mix Index (w/o Births) 1.54 1.46 0.08 1.52 1.46 0.06<br />

Total Surgeries 1,510 1,476 34 12,117 12,803 (686)<br />

Births 321 404 (83) 3,204 3,512 (308)<br />

E/R Visits & Admissions 7,285 6,769 516 63,828 58,748 5,080<br />

ER to Admit Rate 16.3% 17.4% (1.1%) 15.6% 17.4% (1.8%)<br />

Productivity % 100.4% 100.0% 0.4% 99.1% 100.0% (0.9%)<br />

Income Statement:<br />

Net Patient Revenue 36,589,034 34,657,315 1,931,719 301,766,900 300,623,033 1,143,867<br />

Total Net Revenue 37,311,278 35,294,568 2,016,710 306,794,174 305,721,057 1,073,117<br />

Sal., Wages, Cont. Lbr 17,275,361 16,265,727 (1,009,634) 141,750,110 140,981,104 (769,006)<br />

Supplies 5,913,367 5,619,325 (294,042) 47,621,894 48,728,623 1,106,729<br />

Total Expenses 36,107,691 34,638,792 (1,468,899) 297,003,238 296,756,716 (246,522)<br />

Net Inc. (Loss) before Non-Op 1,203,587 655,776 547,811 9,790,936 8,964,341 826,595<br />

Net Income (Loss) 2,352,896 1,685,094 667,802 18,435,608 17,198,885 1,236,723<br />

Cash Flow:<br />

Cash Collections 40,100,000 38,800,000 1,300,000 302,900,000 310,400,000 (7,500,000)<br />

Days Cash on Hand 130 65.0 65.0 130 65.0 65.0<br />

Moody<br />

Benchmark<br />

Ratios:<br />

OEBITDA w/ Prop. Tax 10.87% 10.35% 0.52% 10.87% 10.76% 0.11%<br />

Net Income Margin 6.31% 4.77% 1.54% 6.01% 5.63% 0.38%<br />

Bad Debt % of Net Revenue 14.7% 15.1% 0.4% 15.1% 15.2% 0.1% 6.6%<br />

Return On Assets 2.2% 2.1% (0.1%) 2.3%<br />

Annual Debt Service Coverage 3.5 3.1<br />

Cushion Ratio 11.0 9.6<br />

ADD F-5


Executive Summary & Highlights<br />

ADD F-5<br />

Stat MTD Budget YTD Budget PY<br />

Patient Days - Acute 8,673 8,651 71,507 75,081 73,613<br />

Discharges - Acute 2,158 2,217 18,284 19,237 18,832<br />

OP Registrations 4,729 3,784 31,569 32,844 33,803<br />

Total ER Visits 7,285 6,769 63,828 58,748 59,053<br />

Deliveries 321 404 3,204 3,512 3,456<br />

Profit & Loss (in millions) MTD Budget YTD Budget PY<br />

Capitation Breakeven Breakeven Breakeven (1.0) (0.4)<br />

Net Patient Revenue 36.6 34.7 301.8 300.6 290.4<br />

Total Revenue 37.3 35.3 306.8 305.7 295.2<br />

SWB 21.6 19.9 175.8 172.1 166.3<br />

Contract Labor 0.1 0.3 1.7 2.8 5.7<br />

Supplies 5.9 5.6 47.6 48.7 46.5<br />

Total Expense 36.1 34.6 297.0 296.8 289.6<br />

Net Income from Ops 1.2 0.7 9.8 9.0 5.6<br />

Net Income 2.4 1.7 18.4 17.2 15.0<br />

ADD F-6


Key Variance Explanations<br />

Month-To-Date<br />

ADD F-6<br />

Actual Budget Variance Detail Variance<br />

Net Income From Operations 1,203,587 655,776 547,811<br />

Total Net Revenue 1,931,719<br />

Net Patient Revenue 1,931,719<br />

Other Operating Revenue 84,991<br />

Welcome Home Baby (26,427)<br />

Other 111,418<br />

Salaries & Wages (1,203,376)<br />

Volume Variance (194,389)<br />

Rate & Efficiency (1,008,987)<br />

Benefits (519,005)<br />

Group <strong>Health</strong> Insurance (349,684)<br />

FICA (92,393)<br />

Pension (43,126)<br />

Workers Comp (15,797)<br />

Other (18,005)<br />

Contract Labor 193,742<br />

Volume Variance (3,974)<br />

Rate & Efficiency 197,716<br />

Professional Fees 49,081<br />

Internal Audit Consulting (17,413)<br />

Organizational Development - contra to purchased services (10,583)<br />

Other 77,077 ADD F-7


Key Variance Explanations<br />

Month-To-Date (cont’d)<br />

ADD F-7<br />

Actual Budget Variance Detail Variance<br />

Supplies (294,042)<br />

Volume Variance (68,528)<br />

Rate & Efficiency (225,514)<br />

Breakdown of Variance:<br />

Prosthesis 28,462<br />

Pharmaceutical (19,057)<br />

Other (303,447)<br />

Purchased Services (518,875)<br />

North County Radiology Agreement - Nighthawk (240,000)<br />

Information Systems (228,855)<br />

Patient Financial Services - contra to revenue (269,013)<br />

San Diego Radiosugery - contra to revenue (80,000)<br />

Other 298,993<br />

Depreciation 144,786<br />

Depreciation 144,786<br />

Other Direct Expenses 678,790<br />

Docusys (220,110)<br />

Utilities 506,722<br />

Rent Equipment 62,761<br />

Other 329,417<br />

Total Actual to Budget MTD Variance for February 2010 547,811 547,811<br />

ADD F-8


Key Variance Explanations<br />

Month-To-Date (cont’d)<br />

ADD F-8<br />

Actual Budget Variance Detail Variance<br />

Total Actual to Budget MTD Variance for February 2010 547,811<br />

Non-Operating Income (Expense) 1,149,309 1,029,318 119,991<br />

Property Tax 1,166,666 1,166,666 0<br />

Investment Income (Loss) 282,333 314,432 (32,099)<br />

Breakdown of Actual:<br />

Salomon Bros (70% Gov't Sec, 29% Corp Bonds; 1% MMF) 115,801<br />

Pacific Inc (94% Gov't Sec, 5% Corp Bonds, 1% MMF) 134,413<br />

LAIF 15,573<br />

Other 16,546<br />

Interest Expense (359,543) (481,154) 121,611<br />

Other 59,853 29,374 30,479<br />

Net Income 2,352,896 1,685,094 667,802<br />

ADD F-9


Key Variance Explanations<br />

Year-To-Date<br />

ADD F-9<br />

Actual Budget Variance Detail Variance<br />

Net Income From Operations 9,790,936 8,964,341 826,595<br />

Total Net Revenue 1,143,867<br />

Net Patient Revenue 1,143,867<br />

Other Operating Revenue (70,750)<br />

Welcome Home Baby (228,575)<br />

Other 157,825<br />

Salaries & Wages (1,933,107)<br />

Volume Variance 1,732,869<br />

Rate & Efficiency (3,665,976)<br />

Benefits (1,699,403)<br />

Group <strong>Health</strong> Insurance (977,401)<br />

FICA (294,770)<br />

Pension (246,676)<br />

Work Comp (117,325)<br />

Other (63,231)<br />

Contract Labor 1,164,101<br />

Volume Variance 35,459<br />

Rate & Efficiency 1,128,642<br />

Professional Fees 91,684<br />

Organizational Development- contra to Purchased Services (269,328)<br />

Internal Audit Consulting (59,239)<br />

Dr. Recruitment 399,524<br />

Other 20,727<br />

ADD F-10


Key Variance Explanations<br />

Year-To-Date (cont’d)<br />

ADD F-10<br />

Actual Budget Variance Detail Variance<br />

Supplies 1,106,729<br />

Volume Variance 611,204<br />

Rate & Efficiency 495,525<br />

Breakdown of Variance:<br />

Prosthesis (196,003)<br />

Pharmaceutical 1,326,203<br />

Other (23,471)<br />

Purchased Services (2,251,721)<br />

Information Systems (780,375)<br />

Patient Financial Services - contra to revenue (619,916)<br />

Plant Maintenance (Room a Day Program, Fire Watch Program, other) (539,415)<br />

San Diego Radiosugery - contra to revenue (499,500)<br />

Patient Access - contra to revenue (403,273)<br />

North County Radiology Agreement - Nighthawk (240,000)<br />

Organizational Development- contra to Professional Fees 124,543<br />

Human Resources 250,455<br />

Other 455,760<br />

Depreciation 378,150<br />

Depreciation 378,150<br />

Other Direct Expenses 2,897,045<br />

Docusys (220,110)<br />

Utilities 1,390,797<br />

Rent Equipment 512,984<br />

Insurance 417,318<br />

Other 796,056<br />

ADD F-11<br />

Total Actual to Budget YTD Variance for February 2010 826,595 826,595


Key Variance Explanations<br />

Year-To-Date (cont’d)<br />

ADD F-11<br />

Actual Budget Variance Detail Variance<br />

Total Actual to Budget YTD Variance for February 2010 826,595<br />

Non-Operating Income (Expense) 8,644,672 8,234,544 410,128<br />

Property Tax 9,333,328 9,333,328 0<br />

Investment Income (Loss) 2,199,718 2,515,456 (315,738)<br />

Breakdown of Actual:<br />

Salomon Bros (70% Gov't Sec, 29% Corp Bonds; 1% MMF) 1,198,249<br />

Pacific Inc (94% Gov't Sec, 5% Corp Bonds, 1% MMF) 637,926<br />

LAIF 171,362<br />

Other 192,182<br />

Interest Expense (3,120,018) (3,849,232) 729,214<br />

Other 231,644 234,992 (3,348)<br />

Net Income 18,435,608 17,198,885 1,236,723<br />

ADD F-12


Balance Sheet<br />

Consolidated<br />

ADD F-12<br />

Current Prior Prior Fiscal Current Prior Prior Fiscal<br />

Month Month Year End Month Month Year End<br />

Assets<br />

Liabilities<br />

Current Assets<br />

Current Liabilities<br />

Cash on Hand $6,628,440 $11,412,969 $10,354,783 Accounts Payable $35,741,182 $23,484,399 $49,101,571<br />

Cash Marketable Securities 132,893,990 111,441,574 107,135,131 Accrued Payroll 14,849,625 14,416,964 12,894,999<br />

Total Cash & Cash Equivalents 139,522,430 122,854,543 117,489,914 Accrued PTO 14,550,683 14,146,108 14,113,565<br />

Accrued Interest Payable 4,556,786 8,405,751 5,384,506<br />

Patient Accounts Receivable 210,673,685 245,815,568 196,918,121 Current Portion of Bonds 7,393,445 7,393,445 9,780,000<br />

Allowance on Accounts (117,024,622) (151,927,414) (102,639,179) Est Third Party Settlements 5,192,145 2,766,661 2,343,270<br />

Net Accounts Receivable 93,649,063 93,888,154 94,278,942 Other Current Liabilities 24,454,111 24,463,748 16,996,638<br />

Total Current Liabilities 106,737,977 95,077,076 110,614,549<br />

Inventories 6,498,652 6,401,148 6,346,391<br />

Prepaid Expenses 2,944,019 6,956,839 3,996,246 Long Term Liabilities<br />

Other 13,638,659 13,471,807 4,443,168 Bonds & Contracts Payable 892,308,281 891,218,065 662,496,664<br />

Total Current Assets 256,252,823 243,572,491 226,554,661<br />

General Fund Balance<br />

Non-Current Assets Unrestricted 343,195,987 339,573,266 328,536,409<br />

Restricted Assets 374,191,299 394,748,799 278,894,137 Restricted for Other Purpose 314,052 314,052 312,345<br />

Restricted by Donor 314,052 314,052 312,345 Board Designated 11,773,309 12,043,135 0<br />

Board Designated 11,773,309 12,043,135 0 Total Fund Balance 355,283,348 351,930,453 328,848,754<br />

Total Restricted Assets 386,278,660 407,105,986 279,206,482<br />

Total Liabilities / Fund Balance $1,354,329,606 $1,338,225,594 $1,101,959,967<br />

Property Plant & Equipment 385,536,147 386,711,329 395,014,891<br />

Accumulated Depreciation (230,928,219) (230,517,485) (227,431,539)<br />

Construction in Process 529,399,277 503,319,935 400,568,817<br />

Net Property Plant & Equipment 684,007,205 659,513,779 568,152,169<br />

Investment in Related Companies 646,210 799,372 1,418,426<br />

Deferred Financing Costs 22,544,024 22,650,801 19,951,541<br />

Other Non-Current Assets 4,600,684 4,583,165 6,676,688<br />

Total Non-Current Assets 1,098,076,783 1,094,653,103 875,405,306<br />

Total Assets $1,354,329,606 $1,338,225,594 $1,101,959,967<br />

ADD F-13


Income Statement: Month-to-Date<br />

Consolidated – Adjusted Discharges<br />

ADD F-13<br />

Variance $/Adjusted Discharges<br />

Actual Budget Variance Volume Rate/Eff Actual Budget Variance<br />

Statistics:<br />

Admissions - Acute 2,142 2,217 (75)<br />

Admissions - SNF 73 83 (10)<br />

Patient Days - Acute 8,673 8,651 22<br />

Patient Days - SNF 6,014 5,950 64<br />

ALOS - Acute 4.02 3.90 0.12<br />

ALOS - SNF 79.13 72.56 6.57<br />

Adjusted Discharges 3,154 3,116 38<br />

Revenue:<br />

Gross Revenue $ 135,273,836 $ 129,589,949 $ 5,683,887 F $ 1,580,365 $ 4,103,522 $ 42,889.61 $ 41,588.56 $ 1,301.05<br />

Deductions from Rev (98,684,802) (94,932,634) (3,752,168) U (1,157,715) (2,594,453) (31,288.78) (30,466.19) (822.59)<br />

Net Patient Revenue 36,589,034 34,657,315 1,931,719 F 422,650 1,509,069 11,600.84 11,122.37 478.46<br />

Other Oper Revenue 722,244 637,253 84,991 F 7,771 77,220 228.99 204.51 24.48<br />

Total Net Revenue 37,311,278 35,294,568 2,016,710 F 430,422 1,586,288 11,829.83 11,326.88 502.94<br />

Expenses:<br />

Salaries, Wages & Contr Labor 17,275,361 16,265,727 (1,009,634) U (198,363) (811,271) 5,477.29 5,220.07 (257.22)<br />

Benefits 4,436,047 3,917,042 (519,005) U (47,769) (471,236) 1,406.48 1,257.07 (149.41)<br />

Supplies 5,913,367 5,619,325 (294,042) U (68,528) (225,514) 1,874.88 1,803.38 (71.50)<br />

Prof Fees & Purch Svc 5,141,155 4,671,361 (469,794) U (56,968) (412,826) 1,630.04 1,499.15 (130.89)<br />

Depreciation 1,685,227 1,830,013 144,786 F (22,317) 167,103 534.31 587.30 52.98<br />

Other 1,656,534 2,335,324 678,790 F (28,480) 707,270 525.22 749.46 224.25<br />

Total Expenses 36,107,691 34,638,792 (1,468,899) U (422,424) (1,046,475) 11,448.22 11,116.43 (331.79)<br />

Net Inc Before Non-Oper Income 1,203,587 655,776 547,811 F 7,997 539,814 381.61 210.45 171.15<br />

Property Tax Revenue 1,166,666 1,166,666 - - 14,228 (14,228) 369.90 374.41 (4.51)<br />

Non-Operating Income (17,357) (137,348) 119,991 F (1,675) 121,666 (5.50) (44.08) 38.58<br />

Net Income (Loss) $ 2,352,896 $ 1,685,094 $ 667,802 F $ 20,550 $ 647,252 $ 746.00 $ 540.79 $ 205.22<br />

Net Income Margin 6.31% 4.77% 1.54%<br />

OEBITDA Margin w/o Prop Tax 7.74% 7.04% 0.70%<br />

OEBITDA Margin with Prop Tax 10.87% 10.35% 0.52%<br />

F= Favorable variance<br />

U= Unfavorable variance<br />

ADD F-14


Income Statement: Fiscal Year-to-Date<br />

Consolidated – Adjusted Discharges<br />

ADD F-14<br />

Variance<br />

$/Adjusted Discharges<br />

Actual Budget Variance Volume Rate/Eff Actual Budget Variance<br />

Statistics:<br />

Admissions - Acute 18,052 19,237 (1,185)<br />

Admissions - SNF 680 714 (34)<br />

Patient Days - Acute 71,507 75,081 (3,574)<br />

Patient Days - SNF 51,934 51,640 294<br />

ALOS - Acute 3.91 3.90 0.01<br />

ALOS - SNF 77.28 73.14 4.14<br />

Adjusted Discharges 26,688 27,027 (339)<br />

Revenue:<br />

Gross Revenue $ 1,132,843,167 $ 1,124,566,305 $ 8,276,862 F $ (14,105,449) $ 22,382,311 $ 42,447.66 $ 41,608.99 $ 838.67<br />

Deductions from Rev (831,076,267) (823,943,272) (7,132,995) U 10,334,731 (17,467,726) (31,140.45) (30,485.93) (654.52)<br />

Net Patient Revenue 301,766,900 300,623,033 1,143,867 F (3,770,718) 4,914,585 11,307.21 11,123.06 184.15<br />

Other Oper Revenue 5,027,274 5,098,024 (70,750) U (63,945) (6,805) 188.37 188.63 (0.25)<br />

Total Net Revenue 306,794,174 305,721,057 1,073,117 F (3,834,663) 4,907,780 11,495.59 11,311.69 183.89<br />

Expenses:<br />

Salaries, Wages & Contr Labor 141,750,110 140,981,104 (769,006) U 1,768,328 (2,537,334) 5,311.38 5,216.31 (95.07)<br />

Benefits 35,664,785 33,965,382 (1,699,403) U 426,028 (2,125,431) 1,336.36 1,256.72 (79.64)<br />

Supplies 47,621,894 48,728,623 1,106,729 F 611,204 495,525 1,784.39 1,802.96 18.57<br />

Prof Fees & Purch Svc 41,239,759 39,079,722 (2,160,037) U 490,177 (2,650,214) 1,545.25 1,445.95 (99.30)<br />

Depreciation 14,220,620 14,598,770 378,150 F 183,113 195,037 532.85 540.16 7.31<br />

Other 16,506,070 19,403,112 2,897,042 F 243,373 2,653,669 618.48 717.92 99.43<br />

Total Expenses 297,003,238 296,756,716 (246,522) U 3,722,223 (3,968,745) 11,128.72 10,980.01 (148.71)<br />

Net Inc Before Non-Oper Income 9,790,936 8,964,341 826,595 F (112,440) 939,035 366.87 331.68 35.19<br />

Property Tax Revenue 9,333,328 9,333,328 - - (117,068) 117,068 349.72 345.33 4.39<br />

Non-Operating Income (688,656) (1,098,784) 410,128 F 13,782 396,346 (25.80) (40.66) 14.85<br />

Net Income (Loss) $ 18,435,608 $ 17,198,885 $ 1,236,723 F $ (215,726) $ 1,452,449 $ 690.78 $ 636.36 $ 54.42<br />

Net Income Margin 6.01% 5.63% 0.38%<br />

OEBITDA Margin w/o Prop Tax 7.83% 7.71% 0.12%<br />

OEBITDA Margin with Prop Tax 10.87% 10.76% 0.11%<br />

F= Favorable variance<br />

ADD F-15


Income Statement: Current vs. Prior Year-to-date<br />

Consolidated – Adjusted Discharges<br />

ADD F-15<br />

February 10<br />

YTD<br />

Statistics:<br />

Admissions - Acute 18,052 18,645 (593)<br />

Admissions - SNF 680 704 (24)<br />

Patient Days - Acute 71,507 73,613 (2,106)<br />

Patient Days - SNF 51,934 50,861 1,073<br />

ALOS - Acute 3.91 3.91 -<br />

ALOS - SNF 77.28 71.53 5.75<br />

Adjusted Discharges 26,688 26,693 (5)<br />

Variance<br />

$/Adjusted Discharges<br />

February 09<br />

YTD Variance Volume Rate/Eff Actual FY10 Actual FY09 Variance<br />

Revenue:<br />

Gross Revenue $ 1,132,843,167 $ 1,037,226,472 $ 95,616,695 F $ (194,288) $ 95,810,983 $ 42,447.66 $ 38,857.62 $ 3,590.04<br />

Deductions from Rev (831,076,267) (746,865,559) (84,210,708) U 139,899 (84,350,607) (31,140.45) (27,979.83) (3,160.62)<br />

Net Patient Revenue 301,766,900 290,360,913 11,405,987 F (54,389) 11,460,376 11,307.21 10,877.79 429.42<br />

Other Oper Revenue 5,027,274 4,816,309 210,965 F (902) 211,867 188.37 180.43 7.94<br />

Total Net Revenue 306,794,174 295,177,222 11,616,952 F (55,291) 11,672,243 11,495.59 11,058.23 437.36<br />

Expenses:<br />

Salaries, Wages & Contr Labor 141,750,110 137,660,566 (4,089,544) U 25,786 (4,115,330) 5,311.38 5,157.18 (154.20)<br />

Benefits 35,664,785 34,259,784 (1,405,001) U 6,417 (1,411,418) 1,336.36 1,283.47 (52.89)<br />

Supplies 47,621,894 46,541,033 (1,080,861) U 8,718 (1,089,579) 1,784.39 1,743.57 (40.83)<br />

Prof Fees & Purch Svc 41,239,759 38,291,050 (2,948,709) U 7,172 (2,955,881) 1,545.25 1,434.50 (110.76)<br />

Depreciation 14,220,620 14,602,665 382,045 F 2,735 379,310 532.85 547.06 14.21<br />

Other 16,506,070 18,201,280 1,695,210 F 3,409 1,691,801 618.48 681.87 63.39<br />

Total Expenses 297,003,238 289,556,378 (7,446,860) U 54,238 (7,501,098) 11,128.72 10,847.65 (281.07)<br />

Net Inc Before Non-Oper Income 9,790,936 5,620,844 4,170,092 F (1,053) 4,171,145 366.87 210.57 156.29<br />

Property Tax Revenue 9,333,328 9,333,328 - - (1,748) 1,748 349.72 349.65 0.07<br />

Non-Operating Income (688,656) 37,123 (725,779) U (7) (725,772) (25.80) 1.39 (27.19)<br />

Net Income (Loss) $ 18,435,608 $ 14,991,295 $ 3,444,313 F $ (2,808) $ 3,447,121 $ 690.78 $ 561.62 $ 129.16<br />

Net Income Margin 6.01% 5.08% 0.93%<br />

OEBITDA Margin w/o Prop Tax 7.83% 6.85% 0.98%<br />

OEBITDA Margin with Prop Tax 10.87% 10.01% 0.86%<br />

F= Favorable variance<br />

U= Unfavorable variance<br />

ADD F-16


Income Statement: Fiscal Year Projection<br />

Consolidated – Adjusted Discharges<br />

ADD F-16<br />

Variance<br />

$/Adjusted Discharges<br />

8 Act + 4 Bud FY 10 Budget Variance Volume Rate/Eff Actual Budget Variance<br />

Statistics:<br />

Admissions - Acute 27,716 28,901 (1,185)<br />

Admissions - SNF 1,043 1,077 (34)<br />

Patient Days - Acute 109,214 112,788 (3,574)<br />

Patient Days - SNF 77,854 77,560 294<br />

Adjusted Discharges 40,274 40,613 (339)<br />

Revenue:<br />

Gross Revenue $ 1,697,533,047 $ 1,689,256,185 $ 8,276,862 F $ (14,100,358) $ 22,377,220 $ 42,149.60 $ 41,593.98 $ 555.62<br />

Deductions from Rev (1,244,788,179) (1,237,655,184) (7,132,995) U 10,330,808 (17,463,803) (30,907.98) (30,474.36) (433.62)<br />

Net Patient Revenue 452,744,868 451,601,001 1,143,867 F (3,769,550) 4,913,417 11,241.62 11,119.62 122.00<br />

Other Oper Revenue 7,576,286 7,647,036 (70,750) U (63,830) (6,920) 188.12 188.29 (0.17)<br />

Total Net Revenue 460,321,154 459,248,037 1,073,117 F (3,833,381) 4,906,498 11,429.74 11,307.91 121.83<br />

Expenses:<br />

Salaries, Wages & Contr Labor 212,543,108 211,774,102 (769,006) U 1,767,696 (2,536,702) 5,277.43 5,214.44 (62.99)<br />

Benefits 52,718,755 51,019,352 (1,699,403) U 425,863 (2,125,266) 1,309.00 1,256.23 (52.77)<br />

Supplies 72,068,016 73,174,745 1,106,729 F 610,796 495,933 1,789.44 1,801.76 12.31<br />

Prof Fees & Purch Svc 60,871,314 58,711,277 (2,160,037) U 490,068 (2,650,105) 1,511.43 1,445.63 (65.80)<br />

Depreciation 21,540,672 21,918,822 378,150 F 182,958 195,192 534.85 539.70 4.85<br />

Other 26,236,324 29,133,366 2,897,042 F 243,179 2,653,863 651.45 717.34 65.90<br />

Total Expenses 445,978,189 445,731,669 (246,522) U 3,720,558 (3,967,078) 11,073.60 10,975.10 (98.50)<br />

Net Inc Before Non-Oper Income 14,342,965 13,516,368 826,595 F (112,822) 939,419 356.13 332.81 23.33<br />

Property Tax Revenue 13,999,992 13,999,992 - U (116,859) 116,859 347.62 344.72 2.90<br />

Non-Operating Income (1,238,048) (1,648,176) 410,128 F 13,757 396,371 (30.74) (40.58) 9.84<br />

Net Income (Loss) $ 27,104,909 $ 25,868,184 $ 1,236,723 F $ (215,924) $ 1,452,649 $ 673.01 $ 636.94 $ 36.07<br />

ADD F-17


Income Statement: Monthly Trend<br />

Consolidated<br />

ADD F-17<br />

Jul Aug Sep Oct Nov Dec Jan Feb YTD<br />

Statistics:<br />

Admissions - Acute 2,318 2,188 2,260 2,276 2,220 2,313 2,335 2,142 18,052<br />

Admissions - SNF 96 91 93 94 86 74 73 73 680<br />

Patient Days - Acute 9,067 8,998 8,745 8,862 9,049 8,920 9,193 8,673 71,507<br />

Patient Days - SNF 6,497 6,563 6,346 6,525 6,480 6,723 6,786 6,014 51,934<br />

ALOS - Acute 3.86 4.03 3.84 3.79 4.07 3.80 3.90 4.02 3.91<br />

ALOS - SNF 65.63 73.74 69.74 75.00 74.48 96.04 92.96 79.13 77.28<br />

Adjusted Discharges 3,416 3,298 3,355 3,473 3,203 3,375 3,419 3,154 26,688<br />

Revenue:<br />

Gross Revenue $ 148,271,360 $ 140,677,712 $ 137,924,256 $ 143,276,871 $ 141,799,562 $ 143,054,500 $ 142,565,070 $ 135,273,836 $ 1,132,843,167<br />

Deductions from Rev (108,819,120) (102,084,134) (102,149,929) (105,293,252) (103,695,669) (105,344,918) (105,004,445) (98,684,802) (831,076,267)<br />

Net Patient Revenue 39,452,240 38,593,578 35,774,327 37,983,619 38,103,893 37,709,582 37,560,625 36,589,034 301,766,900<br />

Other Oper Revenue 496,566 608,956 706,193 524,546 658,524 579,423 730,822 722,244 5,027,274<br />

Total Net Revenue 39,948,806 39,202,534 36,480,520 38,508,165 38,762,417 38,289,005 38,291,447 37,311,278 306,794,174<br />

Expenses:<br />

Salaries, Wages & Contr Labor 18,174,843 17,838,866 16,785,894 17,755,755 18,260,411 17,487,038 18,171,942 17,275,361 141,750,110<br />

Benefits 4,804,941 4,715,266 3,948,844 4,235,454 4,402,364 4,207,949 4,913,921 4,436,047 35,664,785<br />

Supplies 6,504,026 6,214,913 6,041,313 6,147,000 5,596,443 5,784,674 5,420,158 5,913,367 47,621,894<br />

Prof Fees & Purch Svc 4,813,171 5,026,545 4,730,236 5,024,273 5,476,662 5,845,276 5,182,441 5,141,155 41,239,759<br />

Depreciation 1,773,400 1,789,000 1,820,103 1,821,843 1,822,888 1,829,379 1,678,778 1,685,227 14,220,620<br />

Other 2,479,232 2,365,131 2,094,906 2,264,486 2,113,088 1,861,434 1,671,259 1,656,534 16,506,070<br />

Total Expenses 38,549,613 37,949,721 35,421,296 37,248,811 37,671,856 37,014,352 37,038,499 36,107,691 297,003,238<br />

Net Inc Before Non-Oper Income 1,399,193 1,252,813 1,059,224 1,259,354 1,090,561 1,273,255 1,252,948 1,203,587 9,790,936<br />

Property Tax Revenue 1,166,666 1,166,666 1,166,666 1,166,666 1,166,666 1,166,666 1,166,666 1,166,666 9,333,328<br />

Non-Operating Income (124,084) 115,689 (81,916) (153,066) 230,458 (939,778) 281,397 (17,357) (688,656)<br />

Net Income (Loss) $ 2,441,775 $ 2,535,168 $ 2,143,974 $ 2,272,954 $ 2,487,685 $ 1,500,143 $ 2,701,011 $ 2,352,896 $ 18,435,608<br />

Net Income Margin 6.11% 6.47% 5.88% 5.90% 6.42% 3.92% 7.05% 6.31% 6.01%<br />

OEBITDA Margin w/o Prop Tax 7.94% 7.76% 7.89% 8.00% 7.52% 8.11% 7.66% 7.74% 7.83%<br />

OEBITDA Margin with Prop Tax 10.86% 10.74% 11.09% 11.03% 10.53% 11.15% 10.70% 10.87% 10.87%<br />

ADD F-18


Cash Flow Statement<br />

ADD F-18<br />

February<br />

YTD<br />

CASH FLOWS FROM OPERATING ACTIVITIES:<br />

Income (Loss) from operations 1,203,587 9,790,936<br />

Adjustments to reconcile change in net assets to net cash<br />

provided by operating activities:<br />

Depreciation Expense 1,685,227 14,220,620<br />

Provision for bad debts 5,381,928 45,550,180<br />

Changes in operating assets and liabilities:<br />

Patient accounts receivable (5,142,837) (44,920,301)<br />

Property Tax and other receivables (913,647) (23,507,991)<br />

Inventories (97,504) (152,261)<br />

Prepaid expenses and Other Non-Current assets 4,165,982 1,824,443<br />

Accounts payable 12,256,783 (13,360,389)<br />

Accrued compensation 837,236 2,391,744<br />

Estimated settlement amounts due third-party payors 2,425,484 2,848,875<br />

Other current liabilities 2,157,030 24,790,803<br />

Net cash provided by operating activities 23,959,269 19,476,657<br />

CASH FLOWS FROM INVESTING ACTIVITIES:<br />

Net (purchases) sales of investments (625,090) (132,831,037)<br />

Income (Loss) on investments 282,333 2,199,718<br />

Investment in affiliates 223,673 3,264,330<br />

Net cash used in investing activities (119,084) (127,366,989)<br />

CASH FLOWS FROM NON-CAPITAL FINANCING ACTIVITIES:<br />

Receipt of G.O. Bond Taxes 336,622 6,426,745<br />

Receipt of District Taxes 410,173 7,350,337<br />

Net cash used in non-capital financing activities 746,795 13,777,082<br />

CASH FLOWS FROM CAPITAL AND RELATED FINANCING ACTIVITIES:<br />

Acquisition of property plant and equipment (23,061,555) (106,674,568)<br />

Proceeds from sale of asset 0 0<br />

Deferred Financing Costs 106,777 (2,592,483)<br />

G.O. Bond Interest paid (6,003,413) (12,025,725)<br />

Revenue Bond Interest paid (413,318) (6,380,497)<br />

Proceeds from issuance of debt 0 227,840,181<br />

Payments of Long Term Debt 0 (9,780,000)<br />

Net cash used in activities (29,371,509) 90,386,907<br />

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (4,784,529) (3,726,343)<br />

CASH AND CASH EQUIVALENTS - Beginning of period 11,412,969 10,354,783<br />

CASH AND CASH EQUIVALENTS - End of period 6,628,440 6,628,440<br />

ADD F-19


Financial Report Narrative<br />

ADD F-19<br />

Statistics<br />

Jan vs Feb Feb Act vs Bud<br />

CONSOLIDATED Jan Feb % Change Budget % Variance<br />

Patient Days Acute 9,193 8,673 (5.7%) 8,651 0.3%<br />

Patient Days SNF 6,786 6,014 (11.4%) 5,950 1.1%<br />

ADC Acute 296.56 309.77 4.5% 308.97 0.3%<br />

ADC SNF 218.90 214.79 (1.9%) 212.50 1.1%<br />

Surgeries CVS Cases 10 11 10.0% 11 0.0%<br />

Surgeries Total 1,480 1,510 2.0% 1,476 2.3%<br />

Number of Births 385 321 (16.6%) 404 (20.5%)<br />

NORTH<br />

Patient Days Acute 6,850 6,577 (4.0%) 6,442 2.1%<br />

Patient Days SNF 2,843 2,510 (11.7%) 2,506 0.2%<br />

ADC Acute 220.97 234.91 6.3% 230.07 2.1%<br />

ADC SNF 91.71 89.64 (2.3%) 89.50 0.2%<br />

SOUTH<br />

Patient Days Acute 2,343 2,096 (10.5%) 2,209 (5.1%)<br />

Patient Days SNF 3,943 3,504 (11.1%) 3,444 1.7%<br />

ADC Acute 75.58 74.86 (1.0%) 78.87 (5.1%)<br />

ADC SNF 127.19 125.14 (1.6%) 123.00 1.7%<br />

ADD F-20


Financial Report Narrative<br />

ADD F-20<br />

Balance Sheet<br />

Current Cash & Cash Equivalents increased $16.6 million from<br />

$122.9 million in January to $139.5 million in February. Total Cash and<br />

Investments are $151.6 million, compared to $135.2 million at January.<br />

Days Cash on Hand went from 116.8 days in January to 130.0 days in<br />

February.<br />

Net Accounts Receivable decreased $0.2 million from $93.9 million in<br />

January to $93.7 million in February. Gross A/R days decreased from<br />

52.9 days in January to 45.7 days in February.<br />

February YTD collections including capitation are $302.9 million compared<br />

to budget of $310.4 million.<br />

Construction in Progress increased $26.1 million from $503.3 million in<br />

January to $529.4 million in February. The increase is attributed to Building<br />

Expansion A & E services, construction and permitting costs of $25.8 million<br />

and Other $0.3 million.<br />

Other Current Liabilities remained unchanged with a $1.2 million<br />

realization of deferred property tax revenue offset by a $1.2 million<br />

increase in capitation liability.<br />

ADD F-21


Financial Report Narrative<br />

ADD F-21<br />

Income Statement<br />

Gross Patient Revenue reflects a YTD favorable budget variance of<br />

8.3 million. Reference table for detail.<br />

North South Outreach Consolidated<br />

Total 5,909,906 2,638,350 (271,394) 8,276,862<br />

Routine (6,915,184) (4,286,826) - (11,202,010)<br />

IP Ancillary (9,275,749) (4,676,761) - (13,952,510)<br />

OP 22,100,839 11,601,937 (271,394) 33,431,382<br />

Net Capitation reflects a YTD favorable budget variance of $1.2 million.<br />

Cap Premium shows a favorable budget variance of $2.7 million. This<br />

favorable variance is due to retro 2008 premium adjustments in July and<br />

August. Cap Valuation and Out of Network Claim Expense both show an<br />

unfavorable budget variance of $0.8 million and $0.7 million, respectively.<br />

Other Operating Revenue has a YTD unfavorable budget variance of<br />

$0.1 million primarily due to Grant programs.<br />

ADD F-22


Financial Report Narrative<br />

ADD F-22<br />

Income Statement (cont’d)<br />

Salaries, Wages & Contract Labor has a YTD unfavorable budget variance<br />

of $0.8 million. Reference table for detail.<br />

YTD Actual YTD Budget Variance<br />

Consolidated 141,750,110 140,981,104 (769,006)<br />

North 83,621,261 83,693,228 71,967<br />

South 35,287,117 36,032,204 745,087<br />

Central 17,879,790 16,401,102 (1,478,688)<br />

Outreach 4,961,942 4,854,570 (107,372)<br />

Employee Benefits Expense has a YTD unfavorable budget variance of<br />

$1.7 million due to unfavorable budget variances in Group <strong>Health</strong><br />

Insurance $1.0 million, FICA $0.3 million, Pension expense $0.2 million, and<br />

Other $0.2 million.<br />

Supplies Expense reflects a YTD favorable budget variance of $1.1 million<br />

primarily due to Pharmaceutical expense.<br />

Professional Fees & Purchased Services reflect a YTD unfavorable budget<br />

variance of $2.2 million due to Information Systems $0.8 million,<br />

Maintenance Programs $0.5 million, and Other $0.9 million.<br />

Ratios & Margins<br />

All required Bond Covenant Ratios were achieved in February, 2010. ADD F-23


Key Statistical Indicators<br />

Fiscal Year-to-Date<br />

ADD F-23<br />

ACTUAL BUDGET VARIANCE FY 2009<br />

ADMISSIONS - Acute:<br />

<strong>Palomar</strong> Medical Center 13,665 14,438 (773) 13,981<br />

Pomerado Hospital 4,387 4,799 (412) 4,664<br />

Total: 18,052 19,237 (1,185) 18,645<br />

ADMISSIONS - SNF:<br />

<strong>Palomar</strong> Medical Center 276 283 (7) 276<br />

Pomerado Hospital 404 431 (27) 428<br />

Total: 680 714 (34) 704<br />

PATIENT DAYS - Acute:<br />

<strong>Palomar</strong> Medical Center 54,232 55,916 (1,684) 54,781<br />

Pomerado Hospital 17,275 19,165 (1,890) 18,832<br />

Total: 71,507 75,081 (3,574) 73,613<br />

PATIENT DAYS- SNF:<br />

<strong>Palomar</strong> Medical Center 21,717 21,751 (34) 21,575<br />

Pomerado Hospital 30,217 29,889 328 29,286<br />

Total: 51,934 51,640 294 50,861<br />

ADD F-24


Key Statistical Indicators<br />

Fiscal Year-to-Date<br />

ADD F-24<br />

ACTUAL BUDGET VARIANCE FY 2009<br />

EMERGENCY ROOM VISITS & TRAUMA CASES:<br />

<strong>Palomar</strong> Medical Center 36,938 32,733 4,205 33,144<br />

Pomerado Hospital 16,948 15,787 1,161 15,836<br />

Total: 53,886 48,520 5,366 48,980<br />

EMERGENCY & TRAUMA ADMISSIONS:<br />

<strong>Palomar</strong> Medical Center 7,456 7,454 2 7,408<br />

Pomerado Hospital 2,486 2,774 (288) 2,665<br />

Total: 9,942 10,228 (286) 10,073<br />

SURGERIES:<br />

<strong>Palomar</strong> Medical Center 7,920 8,199 (279) 7,994<br />

Pomerado Hospital 4,197 4,604 (407) 4,590<br />

Total: 12,117 12,803 (686) 12,584<br />

BIRTHS:<br />

<strong>Palomar</strong> Medical Center 2,459 2,728 (269) 2,668<br />

Pomerado Hospital 745 784 (39) 788<br />

ADD F-25<br />

Total: 3,204 3,512 (308) 3,456


Key Statistical Indicators<br />

Fiscal Year-to-Date<br />

ADD F-25<br />

ACTUAL BUDGET VARIANCE FY 2009<br />

ADJUSTED DISCHARGES<br />

<strong>Palomar</strong> Medical Center 19,409 19,592 (183) 19,275<br />

Pomerado Hospital 7,102 7,251 (149) 7,232<br />

Other Activities 177 184 (7) 186<br />

Total: 26,688 27,027 (339) 26,693<br />

AVERAGE LENGTH OF STAY- Acute:<br />

<strong>Palomar</strong> Medical Center 3.92 3.87 0.05 3.88<br />

Pomerado Hospital 3.87 3.99 (0.12) 3.98<br />

Total: 3.91 3.90 0.01 3.91<br />

AVERAGE LENGTH OF STAY - SNF:<br />

<strong>Palomar</strong> Medical Center 80.73 79.09 1.64 78.17<br />

Pomerado Hospital 74.98 69.35 5.63 67.32<br />

Total: 77.28 73.14 4.14 71.53<br />

ADD F-26


Supplies Expense<br />

Year-to-Date<br />

ADD F-26<br />

Account Description Actual Budget Variance<br />

634000 Supplies Surgery General 3,748,155 3,351,875 (396,280)<br />

632000 Sutures/Surgical Needles 1,347,438 1,098,652 (248,786)<br />

633000 Supplies Surgical Pack 1,529,605 1,329,120 (200,485)<br />

631000 Prosthesis 12,724,138 12,528,135 (196,003)<br />

649000 Other Minor Equipment 698,253 612,291 (85,962)<br />

639000 Supplies Radioactive 470,230 404,946 (65,284)<br />

646000 Supplies Office/Administration 642,007 592,492 (49,515)<br />

645000 Supplies Cleaning 317,334 287,156 (30,178)<br />

648000 Instruments/Minor Equipment 340,479 322,096 (18,383)<br />

647000 Supplies Employee Apparel 117,803 103,827 (13,976)<br />

640000 Supplies X-ray Material 24,919 14,240 (10,679)<br />

637000 Supplies IV Solutions 329,565 323,775 (5,790)<br />

635000 Supplies Anesthesia Material 33,509 31,352 (2,157)<br />

642000 Supplies Food/Meat 351,876 408,395 56,519<br />

644000 Supplies Linen 21,564 79,916 58,352<br />

646100 Supplies Forms 261,544 330,980 69,436<br />

636000 Supplies Oxygen/Gas 53,596 148,843 95,247<br />

643000 Supplies Food Other 1,593,075 1,833,462 240,387<br />

641000 Supplies Other Medical 10,177,222 10,458,049 280,827<br />

650000 Other Non Medical 4,848,990 5,152,226 303,236<br />

638000 Supplies Pharmaceutical 7,990,592 9,316,795 1,326,203<br />

TOTAL 47,621,894 48,728,623 1,106,729 ADD F-27


Bond Covenant Ratios<br />

ADD F-27<br />

Cushion Ratio Jun-08 Jun-09 Feb-10<br />

Cash and Cash Equivalents 86,122,696 117,489,914 139,522,430<br />

Board Designated Reserves 12,117,325 - 11,773,309<br />

Trustee-held Funds (Revenue Fund only) 185,981 34,351 8,293<br />

Total 98,426,002 117,524,265 151,304,032<br />

Divided by:<br />

Annual Debt Service (excludes GO Bonds) * 16,972,692 16,639,112 13,766,910<br />

(Bond Year 11/1/2010)<br />

Cushion Ratio 5.8 7.1 11.0<br />

REQUIREMENT 1.5 1.5 1.5<br />

Achieved Achieved Achieved<br />

Days Cash on Hand Jun-08 Jun-09 Feb-10<br />

Cash and Cash Equivalents 86,122,696 117,489,914 139,522,430<br />

Board Designated Reserves 12,117,325 - 11,773,309<br />

Trustee-held Funds (Revenue Fund only) 185,981 34,351 8,293<br />

Total 98,426,002 117,524,265 151,304,032<br />

Divide Total by Average Adjusted Expenses per Day<br />

Total Expenses 428,153,444 436,536,225 297,003,238<br />

Less: Depreciation 21,572,031 21,214,879 14,220,620<br />

Adjusted Expenses 406,581,413 415,321,346 282,782,618<br />

Number of days in period 366 365 243<br />

Average Adjusted Expenses per Day 1,110,878 1,137,867 1,163,714<br />

Days Cash on Hand 88.6 103.3 130.0<br />

REQUIREMENT 80 80 65<br />

Achieved Achieved Achieved<br />

Net Income Available for Debt Service Jun-08 Jun-09 Feb-10<br />

Excess of revenue over expenses Cur Mo. (12,441,012) (8,535,867) 2,352,896<br />

Excess of revenues over expenses YTD (4,053,517) 11,477,380 18,435,608<br />

(General Funds)<br />

ADD:<br />

Depreciation and Amortization 21,391,200 21,214,879 14,220,620<br />

Interest Expense 14,912,181 16,079,661 3,120,018<br />

Net Income Available for Debt Service 32,249,864 48,771,920 35,776,246<br />

Aggregate Debt Service *<br />

1999 Insured Refunding Revenue Bonds 8,248,018 8,252,512 5,500,933<br />

2006 Certificates of Participation 8,316,457 8,497,794 4,634,407<br />

Aggregate Debt Service 16,564,475 16,750,305 10,135,341<br />

Net Income Available for Debt Service 1.95 2.91 3.53<br />

Required Coverage 1.15 1.15 1.15<br />

Achieved Achieved Achieved<br />

* The 2009 Certificates of Participation interest is pre-funded through November 1, 2011 and is excluded from<br />

the aggregate debt service total for these ratios.<br />

ADD F-28


Statistical Indicators<br />

Admissions – Acute<br />

ADD F-28<br />

3,000<br />

2,500<br />

2,000<br />

1,500<br />

1,000<br />

500<br />

-<br />

PY<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 1,733 1,681 1,714 1,761 1,674 1,721 1,748 1,633 - - - - 13,665 14,438<br />

ADD F-29<br />

POM 585 507 546 515 546 592 587 509 - - - - 4,387 4,799<br />

CON 2,318 2,188 2,260 2,276 2,220 2,313 2,335 2,142 - - - - 18,052 19,237


Statistical Indicators<br />

Patient Days – Acute<br />

ADD F-29<br />

12,000<br />

10,000<br />

8,000<br />

6,000<br />

4,000<br />

2,000<br />

-<br />

PY<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 6,896 6,977 6,613 6,840 6,728 6,751 6,850 6,577 - - - - 54,232 55,916<br />

ADD F-30<br />

POM 2,171 2,021 2,132 2,022 2,321 2,169 2,343 2,096 - - - - 17,275 19,165<br />

CON 9,067 8,998 8,745 8,862 9,049 8,920 9,193 8,673 - - - - 71,507 75,081


Statistical Indicators<br />

Average Length of Stay – Acute<br />

4.40<br />

ADD F-30<br />

4.30<br />

4.20<br />

4.10<br />

4.00<br />

3.90<br />

3.80<br />

3.70<br />

3.60<br />

3.50<br />

PY<br />

BUD<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 3.95 4.13 3.79 3.81 4.03 3.82 3.93 3.96 - - - -<br />

ADD<br />

3.92F-313.87<br />

POM 3.58 3.75 4.01 3.72 4.21 3.73 3.82 4.21 - - - - 3.87 3.99<br />

CON 3.86 4.03 3.84 3.79 4.07 3.80 3.90 4.02 - - - - 3.91 3.90<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON


Statistical Indicators<br />

Average Daily Census – Acute<br />

350<br />

ADD F-31<br />

300<br />

250<br />

200<br />

150<br />

100<br />

50<br />

-<br />

PY<br />

BUD<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 222 225 220 221 224 218 221 235 - - - - 223 230<br />

ADD F-32<br />

POM 70 65 71 65 77 70 76 75 - - - - 71 79<br />

CON 292 290 291 286 302 288 297 310 - - - - 294 309<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON


Statistical Indicators<br />

Patient Days<br />

ADD F-32<br />

JUN<br />

-<br />

MAY<br />

-<br />

APR<br />

-<br />

MAR<br />

-<br />

FEB<br />

1,155<br />

369<br />

661<br />

1,006<br />

826<br />

791<br />

752<br />

1,158<br />

211<br />

680<br />

357<br />

707<br />

JAN<br />

1,222<br />

355<br />

733<br />

1,086<br />

835<br />

796<br />

828<br />

1,134<br />

172<br />

840<br />

462<br />

730<br />

DEC<br />

1,198<br />

276<br />

710<br />

1,031<br />

862<br />

842<br />

857<br />

1,026<br />

184<br />

878<br />

428<br />

628<br />

NOV<br />

1,222<br />

354<br />

730<br />

1,084<br />

819<br />

822<br />

871<br />

1,102<br />

164<br />

843<br />

450<br />

588<br />

OCT<br />

1,188<br />

319<br />

663<br />

960<br />

816<br />

788<br />

717<br />

1,076<br />

206<br />

881<br />

440<br />

808<br />

SEP<br />

1,073<br />

370<br />

591<br />

987<br />

840<br />

763<br />

778<br />

1,059<br />

154<br />

936<br />

448<br />

746<br />

AUG<br />

1,134<br />

294<br />

635<br />

1,047<br />

888<br />

799<br />

824<br />

1,162<br />

138<br />

923<br />

454<br />

700<br />

JUL<br />

1,209<br />

272<br />

708<br />

1,088<br />

884<br />

819<br />

829<br />

1,204<br />

137<br />

915<br />

399<br />

603<br />

- 2,000 4,000 6,000 8,000 10,000<br />

ICU/CCU NICU Telemetry IMC<br />

Med-Oncology Surg-Ortho Medical Tele Med Surg<br />

Pediatrics Labor Delivery Recovery Rehb Acute MHU<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 6,896 6,977 6,613 6,840 6,728 6,751 6,850 6,577 - - - - 54,232 55,916<br />

ADD F-33<br />

POM 2,171 2,021 2,132 2,022 2,321 2,169 2,343 2,096 - - - - 17,275 19,165<br />

CON 9,067 8,998 8,745 8,862 9,049 8,920 9,193 8,673 - - - - 71,507 75,081


Statistical Indicators<br />

Surgeries (Inpatient only)<br />

800<br />

ADD F-33<br />

700<br />

600<br />

500<br />

400<br />

300<br />

200<br />

100<br />

-<br />

PY<br />

BUD<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 441 425 460 444 418 428 404 429 - - - - 3,449 3,864<br />

ADD F-34<br />

POM 184 141 168 178 189 197 193 174 - - - - 1,424 1,490<br />

CON 625 566 628 622 607 625 597 603 - - - - 4,873 5,354<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON


Statistical Indicators<br />

Surgeries (Outpatient only)<br />

ADD F-34<br />

1,400<br />

1,200<br />

1,000<br />

800<br />

600<br />

400<br />

200<br />

-<br />

PY<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 624 560 545 486 522 541 527 566 - - - - 4,371 4,242<br />

ADD F-35<br />

POM 336 355 369 354 335 348 346 330 - - - - 2,773 3,114<br />

CON 960 915 914 840 857 889 873 896 - - - - 7,144 7,356


Statistical Indicators<br />

Surgeries – CVS (PMC only)<br />

25<br />

ADD F-35<br />

20<br />

15<br />

10<br />

5<br />

PY<br />

BUD<br />

-<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 19 13 8 20 5 14 10 11 - - - - 100 93<br />

ADD F-36<br />

POM - - - - - - - - - - - - - -<br />

CON 19 13 8 20 5 14 10 11 - - - - 100 93


Statistical Indicators<br />

Total Surgeries<br />

ADD F-36<br />

2,000<br />

1,800<br />

1,600<br />

1,400<br />

1,200<br />

1,000<br />

800<br />

600<br />

400<br />

200<br />

-<br />

PY<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 1,084 998 1,013 950 945 983 941 1,006 - - - - 7,920 8,199<br />

ADD F-37<br />

POM 520 496 537 532 524 545 539 504 - - - - 4,197 4,604<br />

CON 1,604 1,494 1,550 1,482 1,469 1,528 1,480 1,510 - - - - 12,117 12,803


Statistical Indicators<br />

Outpatient Registrations (excludes Lab)<br />

ADD F-37<br />

6,000<br />

5,000<br />

Beginning in August,<br />

recurring patients<br />

have been omitted<br />

as new registrations.<br />

Beginning in January,<br />

POM includes the<br />

addition of CHC<br />

imaging services.<br />

4,000<br />

3,000<br />

2,000<br />

1,000<br />

-<br />

PY<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 3,587 2,533 2,510 2,488 2,152 2,245 2,301 2,235 - - - - 20,051 25,311<br />

ADD F-38<br />

POM 1,512 1,074 1,039 1,077 924 1,061 2,337 2,494 - - - - 11,518 7,533<br />

CON 5,099 3,607 3,549 3,565 3,076 3,306 4,638 4,729 - - - - 31,569 32,844


Statistical Indicators<br />

ER Visits (includes Trauma, Outpatient only)<br />

ADD F-38<br />

8,000<br />

7,000<br />

6,000<br />

5,000<br />

4,000<br />

3,000<br />

2,000<br />

1,000<br />

-<br />

PY<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 4,788 4,632 4,787 4,884 4,872 4,307 4,509 4,159 - - - - 36,938 32,733<br />

POM 2,211 2,059 2,078 2,250 2,207 2,204 2,004 1,935 - - - - ADD 16,948F-39<br />

15,787<br />

CON 6,999 6,691 6,865 7,134 7,079 6,511 6,513 6,094 - - - - 53,886 48,520<br />

CON/DAY 226 216 229 230 236 210 210 218 - - - - 222 200


Statistical Indicators<br />

ER Admissions (includes Trauma, Inpatient only)<br />

ADD F-39<br />

1,600<br />

1,400<br />

1,200<br />

1,000<br />

800<br />

600<br />

400<br />

200<br />

-<br />

PY<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 973 889 896 913 970 961 968 886 - - - - 7,456 7,454<br />

ADD F-40<br />

POM 330 284 280 289 310 332 356 305 - - - - 2,486 2,774<br />

CON 1,303 1,173 1,176 1,202 1,280 1,293 1,324 1,191 - - - - 9,942 10,228


Statistical Indicators<br />

Total ER Visits (includes Trauma & Admissions)<br />

ADD F-40<br />

9,000<br />

8,000<br />

7,000<br />

6,000<br />

5,000<br />

4,000<br />

3,000<br />

2,000<br />

1,000<br />

-<br />

PY<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 5,761 5,521 5,683 5,797 5,842 5,268 5,477 5,045 - - - - 44,394 40,187<br />

ADD F-41<br />

POM 2,541 2,343 2,358 2,539 2,517 2,536 2,360 2,240 - - - - 19,434 18,561<br />

CON 8,302 7,864 8,041 8,336 8,359 7,804 7,837 7,285 - - - - 63,828 58,748


Statistical Indicators<br />

ER Conversion (ER Admits as % of ER Visits)<br />

25<br />

ADD F-41<br />

20<br />

15<br />

10<br />

5<br />

-<br />

PY<br />

BUD<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 16.9 16.1 15.8 15.8 16.6 18.2 17.7 17.6 - - - - 16.8 18.5<br />

ADD F-42<br />

POM 13.0 12.1 11.9 11.4 12.3 13.1 15.1 13.6 - - - - 12.8 14.9<br />

CON 15.7 14.9 14.6 14.4 15.3 16.6 16.9 16.3 - - - - 15.6 17.4<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON


Statistical Indicators<br />

Trauma Cases (PMC only)<br />

140<br />

ADD F-42<br />

120<br />

100<br />

80<br />

60<br />

40<br />

20<br />

PY<br />

BUD<br />

-<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 116 95 99 102 119 108 96 91 - - - - 826 816<br />

ADD F-43<br />

POM - - - - - - - - - - - - - -<br />

CON 116 95 99 102 119 108 96 91 - - - - 826 816


Statistical Indicators<br />

Trauma Admissions (PMC only)<br />

120<br />

ADD F-43<br />

100<br />

80<br />

60<br />

40<br />

20<br />

PY<br />

BUD<br />

-<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 101 85 86 90 99 94 75 82 - - - - 712 737<br />

ADD F-44<br />

POM - - - - - - - - - - - - - -<br />

CON 101 85 86 90 99 94 75 82 - - - - 712 737


Statistical Indicators<br />

Deliveries<br />

600<br />

ADD F-44<br />

500<br />

400<br />

300<br />

200<br />

100<br />

-<br />

PY<br />

BUD<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 321 313 342 327 304 296 296 260 - - - - 2,459 2,728<br />

ADD F-45<br />

POM 100 96 114 93 89 103 89 61 - - - - 745 784<br />

CON 421 409 456 420 393 399 385 321 - - - - 3,204 3,512<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON


Payor Mix<br />

Based on Gross Revenue<br />

ADD F-45<br />

JUN<br />

-<br />

MAY<br />

-<br />

APR<br />

-<br />

MAR<br />

-<br />

FEB<br />

29<br />

8<br />

16<br />

4<br />

5<br />

25<br />

11<br />

4<br />

JAN<br />

29<br />

9<br />

13<br />

4<br />

6<br />

25<br />

12<br />

3<br />

DEC<br />

28<br />

8<br />

14<br />

3<br />

3<br />

30<br />

10<br />

4<br />

NOV<br />

25<br />

10<br />

16<br />

3<br />

4<br />

28<br />

10<br />

4<br />

OCT<br />

25<br />

8<br />

15<br />

5<br />

5<br />

27<br />

11<br />

3<br />

SEP<br />

27<br />

8<br />

14<br />

4<br />

6<br />

26<br />

11<br />

4<br />

AUG<br />

25<br />

7<br />

15<br />

3<br />

7<br />

26<br />

11<br />

5<br />

JUL<br />

25<br />

7<br />

15<br />

3<br />

5<br />

30<br />

10<br />

4<br />

0% 20% 40% 60% 80% 100%<br />

MEDICARE MCAR MGD MEDI-CAL MCAL MGD SELF PAY MGD CARE CAP OTHER<br />

ADD F-46


Case Mix Index<br />

ADD F-46<br />

1.40<br />

1.35<br />

1.30<br />

1.25<br />

1.20<br />

1.15<br />

1.10<br />

1.05<br />

1.00<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

PMC 1.33 1.31 1.28 1.24 1.36 1.38 1.32 1.37 - - -<br />

ADD<br />

-F-471.33<br />

POM 1.32 1.26 1.24 1.27 1.33 1.37 1.32 1.34 - - - - 1.31<br />

CON 1.33 1.30 1.27 1.25 1.35 1.38 1.32 1.36 - - - - 1.32


Case Mix Index by Region<br />

(excludes Deliveries)<br />

ADD F-47<br />

1.60<br />

1.50<br />

1.40<br />

1.30<br />

1.20<br />

1.10<br />

1.00<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

PMC 1.54 1.52 1.50 1.42 1.57 1.59 1.51 1.56 - - -<br />

ADD<br />

-F-481.53<br />

POM 1.49 1.43 1.44 1.44 1.50 1.54 1.46 1.46 - - - - 1.47<br />

CON 1.53 1.50 1.49 1.43 1.55 1.57 1.50 1.54 - - - - 1.52


Case Mix Index by Region<br />

Medicare<br />

ADD F-48<br />

1.90<br />

1.80<br />

1.70<br />

1.60<br />

1.50<br />

1.40<br />

1.30<br />

1.20<br />

1.10<br />

1.00<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

BUD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

PMC 1.52 1.50 1.59 1.48 1.54 1.68 1.69 1.77 - - -<br />

ADD<br />

-F-491.60<br />

POM 1.56 1.49 1.46 1.44 1.57 1.65 1.50 1.54 - - - - 1.54<br />

CON 1.53 1.50 1.55 1.47 1.55 1.67 1.62 1.69 - - - - 1.58


Adjusted Discharges<br />

Gross Patient Revenue per Adjusted Discharges<br />

ADD F-49<br />

44,500<br />

Dollars per Adjusted Discharge<br />

42,500<br />

40,500<br />

38,500<br />

36,500<br />

PY<br />

BUD<br />

34,500<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 44,320 43,521 40,373 41,393 44,426 42,251 41,545 42,095 - - - -<br />

ADD<br />

42,477F-50<br />

41,779<br />

POM 40,910 40,127 43,371 40,844 43,833 42,758 42,082 45,356 - - - - 42,363 41,128<br />

CON 43,405 42,655 41,110 41,254 44,271 42,387 41,698 42,890 - - - - 42,448 41,609


Adjusted Discharges<br />

Net Patient Revenue per Adjusted Discharges<br />

ADD F-50<br />

14,500<br />

13,500<br />

Dollars per Adjusted Discharge<br />

12,500<br />

11,500<br />

10,500<br />

9,500<br />

PY<br />

BUD<br />

8,500<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 11,005 11,032 9,404 10,365 11,345 10,183 10,020 10,370 - - - -<br />

ADD<br />

10,459F-51<br />

10,523<br />

POM 12,371 12,936 13,812 12,046 12,850 13,325 12,997 14,434 - - - - 13,073 12,296<br />

CON 11,549 11,702 10,663 10,937 11,896 11,173 10,986 11,601 - - - - 11,307 11,123


Adjusted Discharges<br />

Salaries per Adjusted Discharges<br />

ADD F-51<br />

6,000<br />

5,500<br />

Dollars per Adjusted Discharge<br />

5,000<br />

4,500<br />

4,000<br />

PY<br />

BUD<br />

3,500<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 4,429 4,253 4,063 4,123 4,585 4,190 4,521 4,323 - - - - 4,308 4,272<br />

ADD F-52<br />

POM 4,608 4,987 5,005 4,820 5,210 4,988 4,923 5,266 - - - - 4,969 4,969<br />

CON 5,321 5,409 5,003 5,113 5,701 5,181 5,315 5,477 - - - - 5,311 5,216


Adjusted Discharges<br />

Supplies per Adjusted Discharges<br />

ADD F-52<br />

2,300<br />

2,200<br />

2,100<br />

Dollars per Adjusted Discharge<br />

2,000<br />

1,900<br />

1,800<br />

1,700<br />

1,600<br />

1,500<br />

PY<br />

BUD<br />

1,400<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 1,823 1,816 1,647 1,685 1,715 1,716 1,588 1,613 - - - -<br />

ADD<br />

1,701<br />

F-53<br />

1,736<br />

POM 1,984 1,882 2,075 1,870 1,746 1,489 1,660 1,996 - - - - 1,835 1,833<br />

CON 1,904 1,884 1,801 1,770 1,747 1,714 1,585 1,875 - - - - 1,784 1,803


Adjusted Discharges<br />

Total Expenses per Adjusted Discharges<br />

ADD F-53<br />

13,600<br />

13,100<br />

12,600<br />

Dollars per Adjusted Discharge<br />

12,100<br />

11,600<br />

11,100<br />

10,600<br />

10,100<br />

9,600<br />

PY<br />

BUD<br />

9,100<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 10,751 10,458 9,570 9,814 10,922 10,223 10,176 10,336 - - - -<br />

ADD<br />

10,274<br />

F-54<br />

10,120<br />

POM 11,623 12,925 12,317 12,057 12,845 11,679 11,528 13,112 - - - - 12,236 12,225<br />

CON 11,285 11,507 10,558 10,725 11,761 10,968 10,833 11,448 - - - - 11,129 10,980


Adjusted Discharges<br />

Net Operating Income per Adjusted Discharges<br />

ADD F-54<br />

2,000<br />

1,500<br />

Dollars per Adjusted Discharge<br />

1,000<br />

500<br />

-<br />

(500)<br />

(1,000)<br />

(1,500)<br />

PY<br />

BUD<br />

(2,000)<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

PMC<br />

POM<br />

CON<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD<br />

JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN YTD B-YTD<br />

PMC 340 654 (86) 621 502 13 (42) 107 - - - -<br />

ADD<br />

264<br />

F-55<br />

486<br />

POM 795 67 1,565 43 75 1,712 1,520 1,377 - - - - 895 136<br />

CON 410 380 316 363 340 377 366 382 - - - - 367 332


PBS Monthly Cash Collections<br />

ADD F-55<br />

PPH Monthly Collections<br />

in Millions<br />

$44.0<br />

$40.0<br />

$36.0<br />

$32.0<br />

$28.0<br />

$24.0<br />

$20.0<br />

July Aug. Sept. Oct. Nov. Dec. Jan. Feb. March April May June<br />

FY10 Goal $38.8 $38.8 $38.8 $38.8 $38.8 $38.8 $38.8 $38.8 $38.8 $38.8 $38.8 $38.8<br />

Pr. Yr Actual $32.8 $27.3 $39.3 $34.5 $30.5 $32.3 $36.3 $36.5 $39.5 $41.5 $38.6 $37.7<br />

Curr. Yr Actual $39.2 $40.6 $35.5 $37.5 $35.9 $38.0 $36.1 $40.1<br />

ADD F-56


<strong>Health</strong>WorRx Dashboard<br />

Revenue Cycle Key Indicators<br />

ADD F-56<br />

Charge Services<br />

CDM Build/Rebuild Clean Claim<br />

Current<br />

Goal<br />

52% 70%<br />

MTD<br />

Trend<br />

YTD<br />

312<br />

4<br />

FY10 Cash Goal<br />

(in Millions)<br />

310.4<br />

Case Management<br />

CDI (Monthly)<br />

CDI (YTD)<br />

$ 798 K $ 250 K<br />

$2,973 K $1,500 K<br />

308<br />

Patient Access<br />

Co-Pay Collections (Monthly)<br />

Co-Pay Collections (YTD)<br />

$618 K $ 741 K<br />

$ 4,445 K $ 5,928 K<br />

304<br />

302.9<br />

Coding<br />

DNFB<br />

0.3 days 0.5 Days<br />

300 0<br />

0<br />

0<br />

Patient Financial Services<br />

Billing Edits<br />

$8.5 M < $ 6 M<br />

296<br />

September FYTD<br />

#REF! #REF!<br />

RAC<br />

Case Mgmt Review Medicare 1 Day Stays<br />

100% 100%<br />

February FYTD<br />

FYTD Actual<br />

ADD F-57


ADD F-57<br />

SUPPLEMENTAL INFORMATION<br />

ADD F-58


Weekly Flash Report<br />

ADD F-58<br />

Volume<br />

3/4/2010 3/11/2010 3/18/2010 3/25/2010 MTD Total MTD Budget % Variance<br />

<strong>Palomar</strong> Medical Center<br />

Average daily census 227 229 234 - 230 230 (0.08)<br />

Acute Patient Days 1,586 1,602 1,641 4,829 4,833 (0.08)<br />

PCCC Days 609 614 610 1,833 1,880 (2.49)<br />

Acute Discharges 410 422 400 1,232 1,248 (1.28)<br />

Births 70 68 60 198 236 (16.10)<br />

OP Visits w/o Lab 582 584 554 1,720 2,187 (21.35)<br />

Lab Registrations 602 686 624 1,912 2,087 (8.39)<br />

ED Visits 1,245 1,202 1,324 3,771 3,473 8.58<br />

Trauma Admits 14 15 23 52 64 (18.75)<br />

Trauma Outpatient 2 2 7 11 7 57.14<br />

Inpatient surgeries 113 103 108 324 342 (5.26)<br />

Outpatient surgeries 133 139 133 405 366 10.66<br />

Pomerado Hospital<br />

Average daily census 73 73 79 - 75 79 (4.75)<br />

Acute Patient Days 510 514 553 1,577 1,656 (4.75)<br />

VP Days 872 854 873 2,599 2,583 0.62<br />

Acute Discharges 130 133 147 410 415 (1.20)<br />

Births 18 22 17 57 68 (16.18)<br />

OP Visits w/o Lab 636 695 649 1,980 651 204.15<br />

Lab Registrations 445 455 430 1,330 1,219 9.11<br />

ED visits 533 532 576 1,641 1,604 2.31<br />

Inpatient surgeries 35 33 35 103 106 (2.83)<br />

Outpatient surgeries 57 54 42 153 127 20.47<br />

ADD F-59


Weekly Flash Report<br />

ADD F-59<br />

Financial and Acuity<br />

3/4/2010 3/11/2010 3/18/2010 3/25/2010 MTD Total MTD Budget % Variance<br />

<strong>Palomar</strong> Medical Center<br />

Gross Inpatient Charges $ 17,886,710 $ 16,530,977 $ 18,211,833<br />

$ 52,629,520 $ 53,126,305 (0.94)<br />

Gross Outpatient Charges $ 6,801,674 $ 6,197,388 $ 6,881,734<br />

$ 19,880,796 $ 17,613,656 12.87<br />

Net Revenue per Adj. Patient Day (est.) $ 2,216 $ 2,026 $ 2,195<br />

$ 2,146 $ 2,136 0.47<br />

Total Expense per Adj. Patient Day (est.) $ 2,067 $ 2,067 $ 2,067<br />

$ 2,067 $ 2,094 1.29<br />

Supply Expense per Adj. Patient Day (est.) $ 337 $ 337 $ 337<br />

$ 337 $ 343 1.75<br />

Acute Case Mix Index 1.35 1.24 1.55<br />

Pomerado Hospital<br />

Gross Inpatient Charges $ 6,369,418 $ 6,266,585 $ 6,401,784<br />

$ 19,037,787 $ 18,587,695 2.42<br />

Gross Outpatient Charges $ 3,246,370 $ 2,912,515 $ 2,989,361<br />

$ 9,148,246 $ 7,182,048 27.38<br />

Net Revenue per Adj. Patient Day (est.) $ 1,766 $ 1,722 $ 1,681<br />

$ 1,723 $ 1,593 8.16<br />

Total Expense per Adj. Patient Day (est.) $ 1,549 $ 1,549 $ 1,549<br />

$ 1,549 $ 1,502 (3.13)<br />

Supply Expense per Adj. Patient Day (est.) $ 253 $ 253 $ 253<br />

$ 253 $ 246 (2.85)<br />

Acute Case Mix Index 1.26 1.44 1.26<br />

Cash Collection 5,607,910 8,966,110 8,805,078 23,379,098 25,278,927 (7.52)<br />

Days Cash on Hand 136 137 140 140 80<br />

Productivity and Cash<br />

Productivity Hrs (PP 19) 220,701 224,699 445,400 450,116 1.05<br />

PMC 130,000 130,993 260,993 259,540 (0.56)<br />

POM 58,607 59,836 118,443 118,917 0.40<br />

Others 32,094 - 33,870 65,964 71,659 7.95<br />

Productivity $$$ (PP 19) 7,588,894 7,502,986 15,091,880 15,344,346 1.65<br />

PMC 4,457,025 4,353,896 8,810,921 8,873,271 0.70<br />

POM 1,927,227 1,907,968 3,835,195 3,894,722 1.53<br />

Others 1,204,642 - 1,241,122 2,445,764 2,576,353 5.07<br />

ADD F-60

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!